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The Abstract 
The endothelins were discovered in 1988 and are known to be the most active pressor 
molecules in the mammalian vascular system. Endothelin-1, which shows potent and 
long-lasting vasoconstricting activity has been isolated from the culture medium of 
porcine aortic endothelial cells and implicated in a novel cardiovascular control system. 
The first member of endothelin family, Endothelin- 1, is a 21 amino acid peptide whose 
structure is constrained by two disulphide bridges between residues 1-15 and 3-11. 
Increasing evidence for the involvement of endothelins in human disease has prompted 
a major effort in drug design, pharmacological evaluation and structure elucidation. In 
this thesis, the three dimensional solution structure of Endothelin-1 and modified linear 
Endothelin-1 derivatives are presented using one- and two-dimensional NMR methods 
followed by structure calculations DIANA, DSA and MD. This is the first report of 
solution structures of modified linear Endothelin-1 derivatives. 
The Panax family plants (P. ginseng and P. notoginseng) are well known in traditional 
Chinese medicine with the popular name "ginseng". Major compounds isolated from the 
Panax family plants are saponins and the most of the saponins are also biologically 
active. The last chapter of this thesis presents the elucidation by one- and two-
dimensional NMR methods of the structure and stereochemistry of a compound isolated 
from the roots of Panax notoginseng shown to release tissue plasminogen activator 
(tPA) from hemi-pituitary glands in vitro. The compound was identified as the saponin, 
ginsenoside-Rd, and its NMR spectra fully assigned for the first time. 
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CHAPTER 1 
BASIC FEATURES OF POLYPEPTIDES 
1.1 Introduction 
A protein is built up from a long chain polymer of amino acids called polypeptide chain. 
Polypeptides are more versatile because of the great number of different side chains that 
may be present. It is the variety of possible side groups that makes proteins so useful. 
There are four major categories of side chains; hydrophobic {glycine, alanine, valine, 
leucine, isoleucine, methionine, proline, phenylalanine and tryptophan}, acid 
hydrophilic {aspartic acid, glutamic acid and tyrosine}, basic hydrophilic {lysine, 
arginine and histidine}, and neutral {asparagine, glutamine, threonine, serine and 
cysteine (glycine, alanine, tyrosine, histidine and tryptophan also belong to neutral 
group)}. 
Proteins have evolved for operation in an aqueous environment. The nonpolar side 
chains hold the protein molecule together. When a hydrocarbon chain is in an aqueous 
medium, it forces the neighbouring water molecules to form a cage-like structure. This 
formation restricts the motion and number of possible arrangements of the water 
molecule. If hydrocarbon side chains are segregated in one place instead, then the 
liberated molecules of water are free to adopt a much less ordered arrangement. The 
segregation of hydrophobic side chains is a powerful factor in stabilising a protein 
molecule in an aqueous solution. 
The neutral polar residues are usually outside the molecule, but can be inside if their 
polar groups are neutralised by hydrogen bonding to other like residues or to the 
carbonyl CO group of the main chain. Asparagine, serine, threonine and glutamine are 
often used to cross-link two chains by means of hydrogen bonds. Tyrosine and 
tryptophan have been found inside and outside, but when tyrosine is inside, its OH 
group is always hydrogen bonded. 
The charged polar groups, acidic or basic, can exist in either uncharged or charged form, 
depending on the pH of the surroundings. Under acidic conditions, aspartic acid and 
2 
glutamic acid have an uncharged carboxyl group, whereas histidine, lysine and arginine 
each are protonated and carry a positive charge. Under basic conditions, the carboxyl 
groups of aspartic acid and glutamic acid will be ionised, and histidine, lysine and 
arginine will be uncharged. The actual ratio of the acidic to basic form of a given 
residue depends on its strength as an acid or base. 
Under normal physiological conditions, near pH 7, aspartic acid and glutamic acid will 
be almost entirely in their basic form. Lysine and arginine will be in their acid form, 
possibly charged, but histidine will be largely uncharged. It will be about 10% 
protonated and is capable of playing a dual role. The tyrosine OH group is weakly 
acidic. Only about 0.1% will be ionised at pH 7, and hence tyrosine has been classed as 
an uncharged polar group. 
All the natural amino acids are L-amino acids. Most amino acids have more than one 
role in nature. The hydrocarbons alanine, valine, leucine and isoleucine increase in bulk 
and vary in shape. As they increase in bulk, the hydrophobic character increases 
correspondingly. Phenylalanine has the ability to interact with other aromatic rings by 
means of overlapping it electron clouds, a property it shares only with tyrosine and 
tryptophan. Besides aromatic ring, tyrosine and tryptophan have different 
functionalities. 
Cysteine plays a crucial role in determining the folding of many proteins because of the 
ability of two such residues on different polypeptide chains to be oxidised to form a 
disulphide bridge. Proline, the only amino acid in which the side chain loops back to 
reattach to the main, has the property of forcing a bend in the main chain. 
Other residues have been examined for other influence on (X-helix formation. Generally 
it has been suggested that side chains which branch at the 3 carbon would be so bulky as 
to make an a-helix unstable if they occurred adjacent to one another on successive turns 
of the helix, or every third or fourth residue along the chain. It is striking that most 
residues, no matter how complex their sides chain, do have a compact CH 2 group at 
their P carbon. 
3 
Proteins are polymers, often cross-linked but never branched and the reason lies in the 
way in which proteins are made. The two most common types of cross-linking are a 
covalent disulphide bridge with a bond strength of the order of 209 kJ/mole and a 
weaker hydrogen bond with about 25 kJ/mole. Although the protein is synthesised as a 
linear polymer, its subsequent quite specific folding is determined entirely by the kind 
of distribution of side chains. But there may be other factors which could account for 
global folding of a protein in an aqueous environment. 
Many of the special properties of a polypeptide chain arise from the nature of its 
backbone chain. Its distinctive feature is the -CO-NH- group called a peptide bond. 
The CO and NH groups are capable of forming cross-linking between chains when 
building up three dimensional structures. The peptide bond also severely limits the 
ways in which the chain can fold: all four atoms in the -CO-NH- group have to lie in the 
same plane. 
1.2 Regular Conformations of Polypeptides 
The random coil might be considered the natural state of a polymer, favoured by its 
conformational entropy and interactions with the solvent. However, other 
conformations will be adopted if sufficient interactions are possible, within or between 
molecules. The regularity of the conformation is a result of regularity of the primary 
structure. Each residue, or short sequence of residues that makes up the repetitive unit, 
will tend to adopt the same conformation; therefore, it may be specified by just a few 
dihedral angles. 
The polypeptide chain then will have some form of a helical conformation, which will 
be characterised by the number of residues per turn (n) of helix and by the distance 
traversed along the helix axis per residue (d). The product of these is the pitch of the 
helix (p) [p=d.n]. For a polypeptide chain of fixed dimensions, both n and d are 
determined once 4' and  w angles are specified. The Ramachandran plot' shows the 
variation of 4' and iji angles for particular conformation. The values for the regular 
conformations are given in Table 1.1. 
4 
Figure 1.1 : Peptide conformations; A single 13-strand (A), parallel 13-sheets (B), 
antiparallel 13—sheets (C) and the right-handed a-helix (D) 
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1.2.1 The a-Helix 
The right-handed a-helix is the most well known and prominent of the polypeptide 
regular structures (Figure 1.1). It has 3.6 residues per turn and a translation per residue 
of 1 .5A, or 5.41A per turn. The torsion angles w and  4 favourable for most residues, and 
the atoms of the backbone pack closely, making very favourable van der Waals contacts. 
Most conspicuously, the backbone carbonyl oxygen of each residue hydrogen bonds to 
the backbone NH of the fourth residue along the chain. These hydrogen bonds are 
2.86A long from the 0 atom to the N atom and are very nearly straight, close to the 
optimal geometry for such an interaction, and are nearly parallel to the helix axis. All 
the hydrogen bonds point in the same direction. 
The side chains project out from the helix and do not interfere with it, except in the 
bulkiest examples. Only proline residues are incompatible with this conformation, 
because the side chain is bonded to the backbone N atom, preventing its participation in 
hydrogen bonding and interfering in the packing. The stereochemical properties of the 
a-helix are so favourable that it is often considered the most natural conformation for a 
polypeptide. 
Table 1.1: Parameters for Regular Polypeptide Conformations 
- Bond Angle Residues Translation Per 
(degrees) Per Turn Residue Turn 
W (A) (A) 
Antiparallel n-sheet -139 +135 2.0 3.4 6.8 
Parallel 13-sheet -119 +113 2.0 3.2 6.4 
ic-Helix (4.416  helix) -57 -70 4.4 1.15 5.06 
aR-Helix (3.613 helix) -57 -47 3.6 1.5 5.4 
3 10 -Helix -49 -26 3.0 2.0 6.0 
27 Ribbon -75 70 2.0 2.80 5.6 
Polyproline I -83 +158 3.33 1.9 6.3 
Polyproline II -78 +149 3.00 3.12 9.36 
Polyglycine 11 -80 +150 3.0 3.1 9.3 
rei 
A left-handed a-helix is also sterically possible, with the same values of i and 4) but of 
opposite sign. The one important difference in left-handed structures is that the CO and 
NH groups are oriented almost perpendicular to the helix axis and are in no position to 
form hydrogen bonds with groups on the same chain. However, such a conformation is 
not favourable energetically, as the side chains are in close contact with the backbone, 
and it is generally not observed. 
1.2.2 Anitparallel and Parallel 3-sheets 
In the n-sheet conformation, the polypeptide chain is nearly fully extended, and 
individual strands aggregate side by side, forming hydrogen bonds between the carbonyl 
and NH groups of the backbone (Figure 1.1). In addition to the hydrogen bonds, the 
dipoles of the peptide bonds alternate along the chain, providing favourable conditions 
for interaction. The adjacent strands may be either parallel or antiparallel; the two 
forms differ slightly in dihedral angles (Table 1.1), but both are sterically favourable. 
Both types of sheets can be found in proteins. 
Most sheets that have been observed in detail are not planar but have a twisted 
conformation. The values of 4) and W are both somewhat more positive in value than 
those given in Table 1.1 and presumably are somewhat favoured energetically, to give a 
right-handed twist to the backbone. 
The extended conformation of the polypeptide chain results in the side chains 
protruding on alternating sides of the sheet. Most amino acids are stereochemically 
compatible with the n-sheet conformation, except for proline, which has no NH group to 
participate in hydrogen bonding and cannot adopt the appropriate value of 4). 3-Sheets 
may involve aggregation of different molecules, or the polypeptide chain may loop back 
on itself to form an intramolecular sheet, known as the cross-n conformation. 
1.2.3 Other Regular Conformations L 310 and 4 .416 (7r) Helices) 
Other regular conformations have been observed in proteins and are seen only with 
certain polypeptides in special instances. Variations on the a-helix in which the chain is 
either more tightly or more loosely coiled, so that hydrogen bonds between 
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corresponding groups are closer or further apart in the primary structure by one residue, 
are designated the 3 10-helix or the 4.416 (it) helix, respectively. The packing of the 
backbone atoms is too tight in the 3 10-helix; it has not been observed as a regular 
structure but occurs only at the ends of a-helices, where one turn may have this 
conformation locally. The it-helix would have a hole down the middle, so the backbone 
atoms would not be in contact, and the values of 4) and  w are rather unfavourable. 
Proline residues are incompatible with both a-helix and 3-sheet conformations, so it is 
not surprising that poly(Pro) forms other regular conformations, known as poly(Pro) I 
and II. Form I contains all cis peptide bonds, whereas II has trans; proline is the only 
amino acid where the cis form is generally significant. The former is a right-handed 
helix with 3.3 residues per turn, whereas the latter is a left-handed helix with 3.0 
residues per turn. Which form is adopted depends primarily on the solvent: Form II 
predominates in water. Glycine residues also have unique conformational flexibility 
and poly(Gly) likewise forms two regular conformations, designated I and II. 
1.2.4 27-Ribbon 
The helix coils tighter around its axis as i.i increases, with five, then four, three and 
finally two residues per turn. The 2 7-ribbon, which has 2 residues per turn and 7 atoms 
in the closed ring, is tolerable only if the too close oxygens and hydrogens are hydrogen 
bonded, and even the produces a shorter than normal hydrogen bond. 
1.2.5 P and ' Turns 
Proteins have rather spherical structures because the polypeptide chain generally makes 
rather sharp bends at the surface, thereby reversing the direction of the polypepitde 
chain. Turns are intrinsically polar structures with backbone groups pack together 
closely and side chains project outward. Presence of turns in bioactive conformations 
may in fact reflect the lack of alternative conformational possibilities. The terms 13 and 
turn have more restricted definitions and describe turns of four or three residues, 
respectively. These turns may or may not be stabilised by an intra-turn hydrogen bond; 
in 13-turns, the CO of residue i may be hydrogen bonded to the NH of residue i+3, while 
in y-turns, the CO of residue i may be hydrogen bonded to the NH of residue i+2. 
Figure 1.2 The most common types of turns. The hydrogen bond is shown as a 
dashed line. 
Classical y turn 
	










Substantial fractions of residues of every protein are involved in J-turns. They are also 
known as hairpin bends, n-bends, and reverse-turns, because they often connect 
antiparallel 3-strands (Figure 1.2). The terms "open" P or y  turns will be used for 
situations in which no hydrogen bond exists and the , and w angles are within 30 
degrees of the ones cited in Table 1.2. 
Four consecutive residues in the polypeptide chain are generally considered to comprise 
a n-turn, although it is only the torsion angles of the second and third residues that are 
critical. The first and fourth residues are usually included because a hydrogen bond 
between their backbone groups was originally considered necessary. Three such ideal 
n-turns, generally designated I, II and III were predicted on the basis of allowed 
geometry, with planar trans peptide bonds. Mirror images of the backbone may occur in 
variants I', II' and III'. All standard -turns orient the side chains of residues in position 
i+l equatorially and those of the residue in position i+2 axially (up and down). 
Type I is compatible with any amino acid residue at position 1 through 4, except that 
proline cannot occur at position 3. In contrast, type I' requires glycine at both positions 
2 and 3. Type II and IF require glycine at position 3 and 2, respectively. Type III is a 
portion of a 3 10-helix and any amino acids are permissible; type III' requires glycine at 
positions 2 and 3. Serine is a frequent participant in turns in proteins. 3 The special 
amino acids glycine and proline are often involved in reverse-turns. 
Most examples of 7-turns in linear peptides are only in poor solvents, particularly 
chloroform. It appears that solvation of amide NH and CO groups by hydrogen bonding 
solvents competes effectively with the intramolecular interactions. This is in contrast to 
13-turns which are observed in good hydrogen bonding solvents. 
Theoretical calculations of preferred 13-turn conformations led to a fundamental 
distinction between turns predicted for homochiral and heterochiral residues at positions 
i-H and i+2 positions. The former were predicted to favour type I (L-L) or I' (D-D) [3-
turns and the latter type II (L-D) or II' (D-L) [3-turns. Glycine could be accommodated 
at any position. 
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In the experimental data available to date from turn forming model peptides may lead to 
some general conclusions. 
13-Turns are stable in a variety of environments, including strong solvents and 
crystals. Hence, intramolecular hydrogen bonding is not playing an important role. 
'y-Turns are stable only in the absence of competing hydrogen bonding interactions 
with solvent. Hydrogen bonding seems to play a major role in their stability. 
Proline is strong favoured in position i+l of a 13-turn. 
Glycine promotes formation of 13-turns favoured by heterochiral sequences. 
More examples of heterochiral turns were observed than homochiral sequences. 
L amino acid residues in position i+l adopt inverse 7-turns. 
Bulky hydrophobic residues do not occur readily in position i+2 of 13-turns, and 
that serine has a preference for position i+2 of 13-turns. 
Table 1.2: Dihedral Angles of Hydrogen Bonded 13- and y—Turns 
Turn 	 C1 	 kvi+i 	 C2 	Wi+2 
13-Turns 
Type I -60 -30 -90 0 
Type I' 60 30 90 0 
Type II -60 120 80 0 
Type II' 60 -120 -80 0 
Type III -60 -30 -60 -30 
Type III' 60 30 60 30 
7-Turns 
Turn 70 to 85 -60 to -70 
Inverse Turn -70 to -85 60 to 70 
In summary, the only regular conformations encountered with polypeptides under 
normal conditions are the a-helix, parallel and antiparallel 13-sheets, and poly(Pro) II 
helix. The last one occurs only with two specific polyamino acids, so only the cc-helix 
and the 13-sheets are regular conformations likely to be encountered with a typical 
protein sequence. 
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1.3 The General Properties of Protein Structures 
Protein structure can be discussed in terms of four levels. The primary structure is the 
amino acid sequence. The secondary structure is any regular local structure of a linear 
segment of polypeptide chain, such as a helix, a sheet or a turn. Tertiary structure is the 
overall topology of the folded polypeptide chain and the quaternary structure is the 
aggregation of the polypeptides by specific interactions. 
Secondary structure in proteins is generally somewhat distorted. In the a-helices, the 
plane of the peptide bond is often rotated. 3-Sheets are generally twisted, rather than 
planar, with a right-handed twist of form 0-30 degrees between strands. Further 
distortions occur in 13-sheets. An extra residue is often present in a strand at the edge of 
a sheet, interrupting the hydrogen bond pattern and producing a "13-bulge". The 
segments of cc-helices and 13-sheets are generally rather short, being limited to the 
diameter of the protein globule. The length of an cc-helix is generally 10 to 15 residues, 
while that of a 13-sheet is 3 to 10 residues. 
It is often difficult to define exactly which residues are part of the secondary structure. 
For example, at both ends of an ideal a-helix there are four residues that participate in 
only one hydrogen bond each within the helix, whereas all other interior residues 
participate in two. Moreover, the ends are often irregular in conformation. Which 
residues should be counted as part of the helix, therefore is often not clear. Secondary 
structure is most apparent in the large proteins, where most of the interior is composed 
of such regular structure. One important property of secondary structure is that it 
provides an efficient way of pairing in hydrogen bonds the internal polar groups of the 
polypeptide backbone. 
Many studies have been made of the occurrence of the 20 amino acids in the various 
structural elements of proteins. Only arginine shows no tendency to occur preferentially 
in any particular structure. Amino acids with a branched or bulky side chain (valine, 
isoleucine and threonine) or aromatic residues occur most frequently in 13-sheets. All 
the rest occur most often in a-helices, except for those with short polar (serine, aspartic 
acid and asparagine) or special side chains (glycine and proline), which occur most 
often in reverse-turns. 
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1.4 Spectral Properties on Proteins 
The proportion of time the peptide spends in each of its conformational states and the 
rate of interconversions must be considered in choosing methods of conformational 
analysis and in interpreting data. Conformational interconversions may occur at 
millisecond or faster time scales in linear peptides and peptide bond rotations occur on 
the time scale of seconds. 4 
1.4.1 Fluorescence Spectroscopy 
The distance between specific groups of polypeptides may be estimated spectrally if the 
one group is a fluorescent energy donor and the other a suitable energy acceptor. If the 
absorption spectrum of the acceptor overlaps the emission spectrum of the donor, 
fluorescent light emitted by the donor will be absorbed by the acceptor. The efficiency 
of this process depends upon the sixth power of the distance between them, most 
usefully with in a range of 10 to 60 A. The observed efficiencies of energy transfer 
could be used to reconstruct the distribution function of the distances between the 
groups. 
1.4.2 ORD and CD Spectroscopy 
Optical rotatory dispersion (ORD) and circular dicbroism (CD) spectroscopy may be 
directly sensitive to the conformations of the polypeptide chain. Of greatest use is the 
optical activity of polypeptides due to the asymmetric centres of the L-amino acids and 
to their asymmetric conformations. If the right-circulary and left-circularly polarised 
light beams consequently travel at different speeds through the molecule, polarised light 
is rotated and the ORD spectrum can be obtained. There will also be unequal absorption 
of left-circulary and right-circularly polarised light, which is known as CD. Both 
phenomena have the same cause and consequently are related. Circular dicbroism is 
-15 	5 
exquisitely sensitive to conformation and has a very fast time scale (10 s). Detailed 
interpretation of CD spectra for molecules larger than di- or tripeptides is difficult. 
Furthermore, several different conformational features yield similar CD spectra. It 
appears that 7-turns give rise to a reliable CD band at long wavelength (-230 nm) and - 
turns yield three curve shapes that correlate with turn type. 
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Examples of the ORD and CD spectra of poly(Lys) in random, a-helical and 13-sheet 
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Figure 1.3: Optical rotatory dispersion (left) and circular dichroism (right) spectra of 
poly(Lys) in the cc-helical (cx), antiparallel 13-sheet (13) and random coil (r) 
conformations. 6 
1.4.3 NMR Spectroscopy 
Nuclear magnetic resonance (NMR) spectroscopy is the most useful method of peptide 
conformational analysis in solution. NMR yields information about chemical 
environments of nuclei (chemical shifts), geometric relationships between nuclei 
(coupling constants), distances between nuclei (nuclear Overhauser enhancements), 
accessibility and hydrogen bonding of amide protons (exchange kinetics and sensitivity 
of resonance positions and linewidths to temperature, solvent) and dynamics of nuclei 
(relaxation times). More details of NIvIR studies of proteins are discussed elsewhere. 
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CHAPTER 2 
PRINCIPLES OF NMR SPECTROSCOPY 
2.1 Importance of NMR Spectroscopy on Polypeptides 
NMR experiments for biopolymers were described over three and half decades ago and 
progress was slow because of the available instrumentation and lack of biological 
macromolecule samples. Since approximately 1981, the methods and instrumentation 
have been developed for obtaining nearly complete sequence-specific resonance 
assignments in biopolymers. These provide a basis for systematic procedures for 
obtaining spatial structure determination of noncrystalline biopolymers. 7 
The most important methods for determining the structures of molecules are X-ray 
diffraction and NMR studies. The X-ray diffraction technique is not particularly well 
suited for studies of peptides because many different conformations may be developed 
in the non-crystalline phase. NMR allows, in principle, analysis of peptide samples in 
the solution phase. NMR spectroscopy is the leading technique for obtaining structural 
and dynamic information at the atomic level about proteins in solution. It provides an 
efficient method for measuring dynamic, kinetic and thermodynamic parameters (e.g., 
correlation times, hydrogen exchange rates and pKa values) in peptides and small 
proteins. 
NMR analysis is complementary to crystallography in providing a means of determining 
whether the protein structure is the same in solution as in the solid state. X-ray 
diffraction and high resolution NMR have different strengths and different experimental 
requirements. With X-ray crystallography, it is necessary first to obtain suitable protein 
crystals; the ultimate spatial resolution depends on properties of the crystal and the 
effort expended in refining the structure. An X-ray study provides few answers at initial 
stages. The major hurdles are crystallization, preparation of suitable derivatives and 
solution of the phasing problem. 
By contrast, NIVIR analysis can yield limited, but useful, molecular information from the 
first spectrum: a resolved coupling constant, for example, can indicate the existence of a 
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particular chemical bond between two atoms, or a nuclear Overhauser effect can define 
the close proximity of two hydrogens in the molecule. The central problems in NMR 
spectroscopy are the resolution of signals from individual groups and their assignment 
in a sequence-specific and stereospecific manner. 
Relatively precise measurements of short (< 5A) interproton distances can be made 
between any pair of hydrogens whose 1 H signals can be resolved and assigned. 
Dynamic and static disorder usually can be distinguished by NMR results, and NMR 
can provide rates of dynamic processes over a wide time scale (nanoseconds to 
seconds). In very large proteins, the sharpest and most easily resolved NMR signals 
come from less ordered regions; by contrast, mobile regions in crystals frequently do 
not yield interpretable electron densities. 
Other differences can result from differential solubility or differential crystallization: an 
NMR spectrum provides signals from all species present in solution with the signal 
strength proportional to their concentrations. An X-ray analysis shows the structures of 
those species that have crystallized from solution and their relative abundance may 
differ from that of the original solution. As has been the case with several high 
resolution X-ray structures, NMR analysis can provide evidence for multiple stable 
conformational forms of a protein. The effective molecular weight places limits on the 
degree of detail to be obtained from NMR analysis. At present, one can contemplate 
determining detailed solution structures of nonaggregating proteins of MW 20 Kda. 
Much more limited one dimensional and two dimensional investigations are being 
carried out with larger proteins MW up to 100 Kda. 
The great power of two dimensional NIvIR methods 
8,9 
 for protein spectroscopy stems 
from their ability to assist in solving the problems of resolution and assignment. 
Application of these methods 
10 
 has led to nearly complete 1 H resonance assignments in 
numerous small proteins and extensive 13C assignments" and 15N assignments 
12 
 are 
proceeding rapidly. A list of polypeptides for which NTVIIR assignments or solution 
structures had been derived is sunimarrized by J.L. Markley. 13 
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The wide selection of 2D NMR methods currently available for solution studies sort into 
two categories based on the physical mechanism mediating interactions between spins: 
cross-relaxation, chemical exchange or spin-spin coupling. The cross-relaxation 
experiment most important for protein studies is 2D 'H{'H} nuclear Overhauser 
enhancement spectroscopy. The same kinds of pulse sequences employed to determine 
NOE's are used to investigate chemical exchange phenomena. The most important 
nuclei involved in spin-spin couplings in proteins are 1 H, ' 3C and 15N and the 
interactions may be homonuclear or heteronuclear in nature. To date, the vast majority 
of 2D NMR studies of proteins have involved 'H{'H} homonuclear interactions, 
because of the high sensitivity of the proton and its high natural abundance. Proton-X- 
nucleus heteronuclear correlation experiments are performed more efficiently, however 
by detecting 1 H. Isotope labelling also can enable 2D NMR approaches that take 
advantage of coupling between insensitive nuclei such as 13C-15N 
14,15 
 and 
 13 c- 
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2.2 History of the NMR Spectroscopy 
NMR spectroscopy is one of the most important tools for obtaining detailed information 
on chemical systems at a molecular level. It is based on the fact that atomic nuclei 
oriented by a magnetic field (0.70 -17.6 1) absorb radiofrequency radiation at particular 
frequencies. During last two and half decades there has been a enormous developments 
in the instrumentation and methods of NMR spectroscopy. These include; the 
construction of higher field spectrometers and accessories, development of FT methods 
and multi-dimensional NMR techniques and computer technology for data processing 
and analysis. 
The first NMR experiments were carried out in 1945 by two groups of physicists 
19 	 . 	 20,21  
(Purcell et al. 
18, 
 at Harvard University and Bloch et al. 	at Stanford University) 
working independently in solids and liquids. Useful chemical applications of NMR 
became possible only after the discovery of the chemical shift effect 
22,23 
 in 1949. 
17 
First high resolution NMR spectra were recorded by the continuous wave (CW) 
technique. In this method, the spectra is recorded point by point while applied magnetic 
field (Bo) or transmitter frequency (v 1 ) is altered continuously. The appearance of the 
first commercial CW proton NMR spectrometer in 1953 increased rapidly the use of 
NMR as a chemical tool. The CW method was really only suitable for recording the 




 P and 
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F. In 1966, introduction of the pulse 
Fourier Transform (FT) method by Ernst and Anderson 24  led to a significant gain in 
sensitivity and allowed for the first routine observation of low abundance nuclei such as 
13 
C and 15N. In 1971, J. Jeener25 proposed the idea of two dimensional FT NMR and at 
the same time commercial FT NMR spectrometers were introduced. Since then the 
development of NMR spectroscopy has been extremely rapid. 
2.3 Theory of NMR Spectroscopy 
The magnetic properties of the atomic nucleus form the basis of nuclear magnetic 
resonance spectroscopy. The fundamental property of the atomic nucleus involved is 
the nuclear spin quantum number (I) or angular momentum quantum number which has 
values of 0, 1/2,  1, 11/2,  2 .....upto 6 in units of h/27c where h is the Plank's constant. 
Many nuclei including 1 H, 13C, 15N and 19F which have odd mass numbers and half 
integral values of nuclear spin possess nuclear angular momentum (P). According to 
the quantum theory, this angular momentum is quantized. 
P1= h/I(I+1)127r ....................................................... 2.3.1 
The angular momentum P has associated with it a magnetic moment ('i). The two 
vector quantities are proportional to each other and the proportionality constant y  is 
called the gyromagnetic (magnetogyric) ratio. 
......................................2.3.2 
By combining equations 2.3.1 and 2.3.2, the magnetic moment ji can be obtained. 
According to the quantum theory, the magnetic moment is also quantized. 
II =yhVI(I+ 1 )/2 t ...................................................... 2 . 3 . 3 
In a magnetic field (Bo), the orientation (0) of t to the field direction (z-axis) is also 
quantized and depends on I. The orientation to the x- and y-axes is not quantised. 
When a magnetic field (Bo) is applied along the z-axis, the angular momentum 
component P which takes up an orientation of the applied field is equal to multiple of 
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m1 and bl27r where m 1 is the magnetic quantum number which characterises the 
corresponding stationary states of the nucleus. 
IPI=mi h/2it ..................................................................2.3.4 
As the energy of the nucleus is quantized then in can take any of the values m 1 = I, I-i, 
1-2. ........ I giving 21+1 possible orientations (Figure 2.1). From equations 2.3.2 and 
2.3.4, magnetic moment along the applied field direction z (j) can be obtained. 
IJ = in,  Yh ,'27t ................................................................ 2 . 3 . 5 
The magnetic moment ,.t never lines exactly with the field direction but is at an angle 
{cos e = m/ I (I + 1)} and behaves as if it precess about the field direction with an 
angular velocity (a) given co = - y Bo (Figure 2.2) where w is referred to as the Larmor 
frequency. 
The energy (E) of a magnetic dipole is simply proportional to the magnetic moment (p) 
and the applied field (Bo). 
E=-p.Bo=-j.tcos8.Bo=-j.tBo ...........................2.3.6 
E = - m1 y h Bo /27r (with the aid of 2.3.5) ..................... 2.3.7 
The selection rule for NMR transitions between orientations is Am = ±1 thus the energy 
difference between two adjacent energy levels can be given as 
AE=yhBo/2ir ................................................................2.3.8 
Transition between two adjacent energy levels may be induced by electromagnetic 
radiation of frequency V where AE = hv and thus this absorption frequency V is given 
CA 
..........2.3.9 
I = 1 /2  ('H, ' 3 C) 
	
1=1 (2H, 14 
m=-h/2 (13) 	E13=+Y2yhBo 




m=+'/2(a) 	Ea= - '/2 'yhBo 
	m=+1 	E+1 =-yhBo 
Figure 2.1: Energy level schemes for nuclei I = 2 and I = 1 
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Thus there are two possible orientations of the nuclear spin for protons. The ratio of the 
populations between these two energy states is given by the Boltzmann equation. 
Na/Na = exp (-AEIkT) 
= 1 -EE/kT (as E<<kT) (Ca. 1 in 10 5 for'I-  iI) ... 2.3.10 
where Na and N are the numbers of nuclei in the ground and excited states 
respectively. When N <N a, an NMR signal can be observed due to net absorption of 
energy. 
2.3.1 Behaviour of an ensemble of spins in a magnetic field; The NMR experiment 
Consider a sample contain only a single type of spin half nucleus (eg. CHC1 3). Vector 
diagrams can easily be used to understand the behaviour of the magnetisation in a 
magnetic field. In pictorial diagrams, z-axis usually points along the static magnetic 
field (Bo) direction. The net magnetisation, M, arises from the net sum of all the 
precessing nuclear magnetic moments along the magnetic field direction (z-axis). This 
net magnetisation will also be aligned with the applied magnetic field and will remain 
undisturbed (Figure. 2.2). 
The second magnetic field, Bi, which oscillates at the appropriate radiofrequency 
displaces the magnetisation from the z-direction. This magnetic field Bi which is 
generated by a current in a coil is perpendicular to the static magnetic field Bo. After the 
pulse from Bi a force generated by Bo on M is a torque that will cause M to precess 
about Bo at a frequency (y/27r)Bo hertz. This motion is known as Larmor precession as 
described before. The component of the precessing magnetisation in the xy-plane 
would be detected as a NMR signal. The final position of the magnetisation depends 
upon the length of time ([is) for which the radiofrequency is applied. The angle (0) 
which the magnetisation is tipped from the z-axis is called the flip angle or pulse angle. 
The visualisation of NMR experiments can be simplified using 'rotating reference 
frame' rather than fixed laboratory frame. The effect of a pulse is easy to describe in the 
rotating reference frame. If the rotating set of coordinates is chosen to rotate at the 
frequency of the pulse in the same direction as the nuclear precession, then the Bi field 
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appears static along, say, the x-axis in that frame. In this frame the field direction z-axis 
does not change but x-and y-axes rotate about the z-axis at the pulse frequency. 
Individual nuclear magnetic movements precess clockwise or anti-clockwise according 
to whether their resonance frequencies are greater or less than the pulse frequency. 
I Bo At "t = 0" 	 At "thermal equilibrium" (N/N = 1) Np/Na  = exp(-AE/kT) 
	
Longitudinal Relaxation 	 y 
........
.TT w5 from zero to 	
..i::::.. 
(a) 
Bo 	 Bo 
I 
y 	 y 
x  
(b) 	 (c) 
Figure 2.2 Growing of the net magnetisation M (a), the M at equilibrium (b) and at 
precession (c). 
As in the laboratory frame, the net magnetisation begins along the field axis, z, and 
perpendicular to x-axis and the precession about Bi is a rotation of magnetisation in the 
yz-plane. The magnetisation will remain perpendicular to the Bi field and a (t/2)x pulse 
will put the magnetisation along the y-axis (Fig. 2.3). When the pulse is switched off the 
magnetisation vector M precesses about the z-axis and its orientation can be specified in 
the rotating coordinate system by the three axial components Mx, My and Mz. The 
spin system now returns to its equilibrium state by relaxation with z component, 





Bo 	Z 	Bo 
Y - 
Z 	 z 	 z 
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Mz, returning to its original position while x and y components, Mx and My, approach 
zero. The motion of the magnetisation vector is described by two different relaxation 
times Ti (spin-lattice or longitudinal relaxation time) and T2 (spin-spin or transverse 
relaxation time). The Bloch equations for relaxation in the rotating frame are given 
below. 
dMz =-(MK-M) ........................................................... 2.3.11 
dt 	Ti 
	
dMx = - Mx 	and 	dMy = - My ...............................2.3.12 
dt 	T2 dt 	T2 
resonance on pulse 
My 
t 
Mz returns to M 
Longitudinal Relaxation 	Transverse Relaxation 
In the rotating frame, for a nucleus with resonance frequency equal to the pulse 
frequency, the y-axis rotates at the Larmor frequency and the transverse magnetisation 
in that direction remains constant while its magnitude only decreases with time. 
According to the equation 2.3.12, this exponential decrease rate is determined by the 
transverse relaxation time T2. This decay of the transverse magnetisation which is 
called the free induction decay (FID) is detected as a NMR signal. The z-component, 
Mz, returns to its original position via longitudinal relaxation. 
Laboratory frame 	Rotating frame 
(a) 	 (b) 
Figure 2.3 :Magnetisation vectors at laboratory frame (a) and rotating frame (b) after 
the (t/2)x is applied. 
t (time) 
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2.3.2 Chemical Shift 
The chemical shift is caused by the distribution of electrons of the chemical bonds in the 
molecule. In fixed external Bo, the exact resonance frequency for a given nucleus, x, 
depends on its environment in the molecule. When a molecule containing nuclei is 
placed in the magnetic field (Bo), it induces circulation in the electron cloud surrounding 
the nucleus such that a magnetic field opposed to Bo, is produced. In other words the 
electrons within the molecule shield the nuclei from the applied field Bo. This magnetic 
shielding is equal to aBo where a is known as shielding constant which depends on the 
electron density surrounding the nucleus. Although this shielding is molecule 
orientation dependent, molecule reorientation in solution is normally sufficiently fast for 
orientation effects to be averaged. 
The chemical shift (6) as defined below is quoted in units of parts per million (ppm) and 
will be same whatever the strength of field used. The resonance frequency of the signal 
is measured relative to that of a reference or standard compound. 
	
Vx  - Vstd 	6 
Chemical shift 6 = _______ X10 
Vstd 
where V, = ( 7/27c ) Bx where the local field experienced by nucleus x, Bx = Bo (1 - ax) 
2.3.3 Spin-Spin Coupling 
The individual resonance signals of the different groups are chemically nonequivalent 
and therefore the splitting of the signals can be observed. A nucleus of spin I splits 
resonance of another nucleus (any spin) into 21+1 lines. This arises from interactions 
between magnetic nuclei transmitted through bonding electrons. The splitting of signals 
can normally be seen no more than three bonds but some cases through four/five bonds 
depending on the geometry of the molecule. The fact that spin-spin coupling is 
transmitted through chemical bonds makes the coupling constant, J, a sensitive 
parameter for the types of bonds involved and for their spatial orientation in the 
molecule and is therefore geometry dependent. In complex molecules, it can be seen 
that each nucleus can interact with many others which can lead to very complicated 
multiplet spin patterns. The spin-spin couplings are field independent and are measured 
in hertz (Hz). 
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2.4 Solvent Suppression 
Proteins have characteristic amino proton resonances which can be observed under 
appropriate conditions. To prevent loss of cross peaks with labile protons, NMR spectra 
must often be recorded in protonated solvents. Most of the polypeptides are soluble in 
highly polar organic solvents or solvent mixtures such as DMSO (dimethylsulfoxide), 
CH30H, CH30HIH20, AcOH/H20 and H20. The amide protons in the above solutions 
of polypeptides can be studied in above solutions. 
Fourier transform proton NMR of dilute aqueous solutions is fraught with difficulties. 
The weak solute signals (0.001-0.01M) have to be detected in the presence of 
potentially enormous signal from the water protons (- 11 OM), when the NMR spectra 
are recorded in H 20 solution. 
Continuous weak radio frequency irradiation prior to excitation and acquisition to 
eliminate the water magnetisation is undoubtedly the simplest suppression 
method. 
10,26,27 
 The following points must be important. Irradiation should ideally be 
gated off during data acquisition to avoid Bloch-Siegert shifts despite the reduction in 
the level of suppression this entails. The choice of decoupler power and irradiation time 
is usually a compromise. High decoupler power will give efficient elimination of the 
solvent resonance but will also saturate protons with nearby chemical shifts. Long pre-
irradiation times give good saturation but reduce the efficiency of signal averaging if the 
delay between transients has to be increased. 
Saturation of the solvent resonance also has an affect on the resonances of protons 
which exchange with the solvent. This is called saturation transfer and the principal 
drawback is that saturation transfer may reduce the intensity of exchanging protons. 
28,29 
 
Appreciable loss of signal is to be expected unless the exchange rate is at least five 
times slower than the spin-lattice relaxation of the proton in question. Cross-relaxation 
from water to solute protons can have a similar effect. Cutting down the length of 
irradiation gives less time for saturation transfer and cross-relaxation but requires a 
stronger and thus less selective decoupler field to achieve the same level of suppression. 
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Conditions can be chosen to minimise the rates of exchange and hence the loss of signal 
(acidic pH for proteins and basic pH for nucleic acids) 10  but this may be undesirable or 
even impossible depending on the sample. Inevitably some protons lie directly under 
the water or are sufficiently close to it in frequency that they do not escape saturation. 
Any protons bleached in this way are invisible in both one and two dimensional 
experiments, but can sometimes be revealed by exploiting the temperature dependence 
of the water chemical shift. 
Strong solvent peaks give rise to ridges that may mask peaks of interest. This 
complication is overcome by various schemes such as 
Selective excitation strategies that minimise the solvent signal 
Selective saturation of solvent peaks 
Improvement of probe characteristics 
Postprocessing of the FT data by different methods 
Interior amide protons in proteins can often be observed in D 20, so that no special 
precautions are needed for suppression of the solvent line. 
2.5 One Dimensional NMR Studies of Proteins 
2.5.1 Variable Temperature Studies 
Temperature, one of the important solution conditions for NMR studies, can usually be 
varied over a wide range. It is therefore important to maintain the temperature control 
whilst studying proteins. Overall structure of a protein can be sensitive to changes in 
temperature in particular proteins can denature in solution. 
The temperature dependence of the chemical shift (AöIT) is widely used as a measure of 
the extent of hydrogen bonding in amide protons. One of the reasons for its popularity 
is that EWT is an easy parameter to measure. Interior amide protons hidden from the 
solvent shift 3-5ppb upfield per degree temperature increase, whereas solvent exposed 
amide protons shift more (6-8 ppb/K). 
2.5.2 Amide Proton Exchange Experiments 
Labile protons in amino acid residues have important roles in NMR studies of proteins. 
The intrinsic rates of exchange with the solvent are of great interest as a reference for 
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studies of macromolecules structure and dynamics. Most of the polypeptides are highly 
soluble in H20. The amide protons in the H20 solution can be studied using selective 
saturation of the solvent line. When the resonance is suppressed by saturation, the labile 
protons in the molecule will be replaced by saturated spins from the huge spin reservoir 
of the solvent, with concomitant loss of resonance intensity. Different solvent 
suppression methods have been developed to overcome this problem. 
1 H NMR observations of labile protons is only feasible when the exchange with the 
solvent is slow on the NMR time scale. The NMR time scale determined by the relative 
chemical shifts of the labile protons in proteins, water as the solvent, allows observation 
of protons exchanging with the rates up to approximately 1x10 3 mm'. The limiting 
value of the exchange rate constant, which enables observation in D 20, is of the order of 
0.1 mm'. In the entire pH range, surface amide proton exchange rates are slow on the 
NMR time scale defined by the chemical shifts relative to 1120, but too fast for 
observation in D20, all the amide protons, therefore, can be observed in 1120  solution. 
Because of the presence of labile protons, 1 H NMR spectra of proteins are simplified by 
changing the solvent from H 20 to D20. For surface amide protons, that are freely 
accessible to the solvent, the exchange rates are too fast for observation in D 20. But 
some of the NH protons, which are all located in the interior of the polypeptide, can 
often be observed in D 20. To prevent loss of resonances of labile protons, NMR 
spectra must often be recorded in 1120  solutions. 
In contrast to slowly exchanging protons, the rapidly exchanging surface protons may 
be obtained in 1120  solutions of proteins for which all labile protons had been replaced 
by deuterium previously. 
30 
 By observation of the interior labile protons at variable 
times after the sample preparation, information on the exchange kinetics can be 
obtained. Individual amide-proton exchange rates can provide fully independent 
supporting evidence for regular secondary structure. 
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2.5.3 Additional Data and Limitations 
Spin-spin coupling constants (J) characterise through-bond interactions between nuclei 
linked via a small number of covalent bonds in a chemical structure. For peptide NH 
protons, 3a  is frequently measurable directly from the 1D 1 H spectrum. The digital 
resolution of the spectrum should be higher than 0.2 Hz/point for accurate 
measurements of 
3 
 JHN(x. Coupling constants of the highly crowded proteins can be 
measured with the aid of a phase-sensitive COSY spectrum. 
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 The spin-spin coupling 
constants 3HNa  present supporting evidence for regular secondary structures found in 
proteins. Individual small (3a < 6.0 Hz) or large (3a>  7.0 Hz) 3I-Tha  coupling 
identify helical or 3-sheet structures, respectively. 
A normal one dimensional NMR experiment with a small molecule often provides 
information on the spin-spin coupling fine structure of the individual resonances and the 
chemical shifts in the spectrum. 1D double resonance experiments provide 
connectivities. Peak separation impose major problems on the assignment of 1D proton 
NMR spectrum of a macromolecule due to resonance peaks being spread along a line. 
For large molecules a very large number of measurements would be required for 
characterisation of the complete network of spin-spin connectivities in a 
macromolecular structure and is likely to be impossible due to signal overlap. The use 
of ID NMR experiments is naturally limited for work with the crowded spectra of 
macromolecules. Therefore NMR experiments should be expanded to overcome natural 
limitations of I  NMR. 
2.6 1D and 2D similarities; Background information 
21) NMR spectroscopy is an elaboration of the more familiar, one dimensional pulse FT 
experiment. iment. It s worth emphasising that 1D methods have advantages over 2D 
methods for certain applications because of the higher speed of data acquisition. Single 
pulse proton NMR spectra are acquired using the pulse sequence Dl-90 0-AQ with a 
relaxation delay Dl and acquisition time AQ. In 1D NMR experiments, a preparation 
period is followed immediately by the data acquisition period (Figure 2.4). 
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In 1 D NMR, a short intense pulse at a single radio frequency serves to excite spins from 
a particular isotope. The response of the sample following the pulse, as manifested by 
the current generated in the receiver coil (FID), is amplified, detected against the 
frequency of the transmitter, converted from analogue to digital form, and then stored in 
computer memory or on a disk as amplitude vs time 02). The sequence can be repeated 
after a suitable delay which allows the spins to return toward equilibrium. 
FID's digitised during the acquisition period are combined to improve the signal-to-
noise ratio. Signal processing (baseline correction, zero filling, apodization, 
convolution, or a combination of these) of the averaged time-domain data can be carried 
out to increase resolution or to increase the signal-to-noise ratio. The oscillatory 
components of the FID are separated by Fourier transformation to give spectral peaks at 
their characteristic frequencies. 
A 2D NMR experiment is recorded in a 2D time space and the general scheme is shown 
in Figure 2.4. A 2D NMR experiment differs from a 1D experiment by the addition to 
the pulse sequence of one or more transmitter pulses and one delay (t1) that is 
incremented from one acquisition or combined set of acquisitions to the next. In general 
terms, the time axis divides into four different periods. 
The general scheme for a 2D NMR experiment involves 
A preparation period; in which the desired order of coherence is generated. 
An evolution period; during which the spin system evolves under the influence 
of the chemical shifts and scalar couplings. 
A mixing period; during which there is usually some transfer of coherence. 
A detection period; where the NMR signal is recorded. 
In some experiments mixing takes place during t1 and therefore evolution period and 
mixing period cannot be separately distinguished. The influence of the first pulse on the 
FID recorded during t2 depends on the length of the t1 and the second time dimension is 
generated by repeating the same experiment with t1 incrementation. 
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Figure 2.4: One dimensional and two dimensional pulse sequences 
t1 	 tm 	 t2 
Preparation 	Evolution 	Mixing 	Detection 






Presaturation 	I I tj 	spin lock - 90 
DQF COSY experiment 
90 	90 90 
Presaturation I f1J12 
ROESY experiment 
lisp 90 	90 	 90 
Presaturation T —ti 	spin lock - 30 
NOESY experiment 
90 	90 	 90 





As in 1D NMR, the data are digitised as a function of time, t2. The 2D NMR raw data 
set consists initially of a series of these FID's stored in different computer files, each 
having a different evolution time t1. Hence the data can be viewed as a function of two 
time variables, m(t 1 ,t2). For each block with a given t 1 , a FT is carried out with respect 
to the t2 time axis. A second FT is carried out with respect to t1. The result is spectral 
intensity as a function of two frequencies, m(F 1 ,F2). Thus any signal in the 2D 
spectrum is defined by two frequencies; m1(F i ,F2 ), m being the magnitude of signal at 
any data point and Fx being the chemical shift dimension. The additional frequency 
axis allows the correlation of magnetic properties of one nucleus with those of one or 
more other nuclei that interact with it during the mixing time. Resolution in the F 2 
dimension is determined by the digitisation during the t2 period; resolution in the F 1 
dimension is limited by the number of incremented t1 values. Quadrature detection 
normally is used in acquiring in the t2 dimension to enhance sensitivity. By obtaining 
pure-phase spectra, one can avoid the degraded resolution characteristic of peaks in 
mixed phase. 
2.7 General Strategies in 2D NMR Studies of Proteins 
The 2D NMR techniques are mainly based on the interactions between nuclear dipoles 
and these may occur either directly through space or be transmitted through bonds. 
With biological macromolecules, the most important fundamental advantage of 2D 
NMR relative to 1D NMR is that experiments can in principle delineate all coupling 
connectivities between protons in a macromolecular structure in a single experiment, 
and it is thus much more efficient than the use of a large number of 1D spin-decoupling 
experiments. Comprehensive presentations of 2D NMR spectroscopy can be found in 
the books 
8,32-34 
 as well as in the variety of review papers 27,35-38 
General strategies in 2D NMR of proteins; data acquisition, data processing and data 
analysis can be divided into the following stages. 
(1). The sample solution is subjected to a particular 2D NMR pulse sequence and 
appropriate data are collected. 
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These raw time-domain data first are subjected to digital signal processing in the 
time-domain data and then are converted to the frequency domain via FT. 
Additional signal processing may be imposed at this point. 
The spectral parameters defined by the two frequency axes F 1 and F2 are extracted. 
The data to be derived depend on the type of 2D experiment. They include strings of 
chemical shift values belonging to a particular spin system and parameters associated 
with cross peaks at particular chemical shifts (coupling matrices, nOe matrices and 
relaxation rates). 
The chemical shift related data is converted to sequence related data with 
assignments of signals to particular atoms in particular amino acid residues. This stage 
requires logical analysis of the data with the imposition of knowledge of expected 
chemical shifts and NOB's spin-spin couplings. 
The sequenced related data finally are catalogued and analysed in terms of 
molecular structure, dynamics, kinetic properties such as hydrogen exchange rates. 
Refinement stages compare back-calculated spectra or spectral parameters to 
original data and adjustments are made to maximise the fit of the structural model to the 
primary data. 
Two dimensional NMR has a wide range of applications utilising homo and hetero 
nuclear experiments in liquid and solid states. Depending on the problem to be solved, 
a wide range of 2D experiments can be used. The COSY, DQF COSY, RELAYED-
COSY, HOHAHA/TOCSY, NOESY and ROESY experiments are a small selection of 
homonuclear 2D NMR experiments, which have been of central importance to studies 
of biological macromolecules. These are discussed briefly below. 
2.8 J Correlated Spectroscopy 
2.8.1 COSY: 2D Homonuclear Correlated Spectroscopy 
25,39,40 
2D homonuclear correlated spectroscopy (COSY) generally is the first 2D experiment to 
be used in analysing a protein. COSY provides the kind of information available from a 
single-frequency decoupling experiment (Fig. 2.5) in which spins are scalar coupled to 
one another. In a COSY plot, the 1D spectrum lies along the diagonal which runs from 
bottom left to top right, and the off-diagonal elements are present at the intersection of 
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chemical shifts of groups that are J coupled. The COSY spectra are acquired using the 
pulse sequence D1-90 °-t 1 -90°-AQ with a relaxation delay Dl and acquisition time AQ. 
A normal absolute value COSY spectrum can routinely be used as a fast technique for 
rapidly gathering information about spin systems. A single COSY spectrum presents a 
map of the complete spin-spin coupling network in a macromolecular structure. The 
fingerprint region contains NHIaH cross peaks from the peptide backbone. The degree 
of resolution of the fingerprint region of a COSY spectrum collected in H 20 is a good 









F2 	 F2 
Figure 2.5 : Single-frequency 1D decoupling experiment and the 2D COSY experiment 
2.8.2 12QF COSY: 2D Double Quantum Filtered Correlated Spectroscopy 
41-43 
The COSY experiment transfers magnetisation between coupling partners. For higher 
resolution, better detection of cross peaks near the diagonal, and suppression of the 
solvent signal, a DQF COSY spectrum obtained in the pure-absorption mode is the 
method of choice. The basic pulse sequence, D1-90 °-t 1 -900-90°-AQ, is used and pure-




Double quantum filtering is used to purge spectra of undesired features and to focus on 
2J and 3J couplings by selecting coherence transfer between evolution and detection 
periods for selective removal of magnetisation from non-coupled spins. The double 
quantum filter reduces the cross peak amplitudes by a factor of 2 due to restriction of 
coherence transfer and more scans are needed to obtain the same quality spectrum. 
Despite this sensitivity loss, in practice the DQF COSY experiment usually results in a 
net improvement in the quality of spectra and can provide information that cannot be 
obtained in COSY. 
The DQF COSY experiment has become popular as a result of its two major advantages 
over COSY. First, the diagonal peaks in DQF COSY spectra have antiphase multiplet 
structure instead of in-phase, and thus experience self cancellation to the same extent as 
do the cross peaks. For larger proteins this results in a significant reduction in the size 
of the diagonal peaks, which often results in less t1 noise. Second, the cross peaks in 
DQF COSY spectra and the major contribution to the diagonal peaks have absorption 
line shapes in both dimensions. Elimination of the dispersive character of the diagonal 
peaks allows identification of cross peaks lying immediately adjacent to the diagonal. 
The "active" coupling, which is actually responsible for the COSY cross peak, always 
appears in anti-phase in both F 1 and F2 dimensions. Any other couplings, which are 
called the "passive" couplings, appear in in-phase in both F 1 and F2 dimensions. 
2.8.3 RELAYED COSY: 2D Relayed Coherence Transfer Spectroscopy 
45,46 
The RELAYED COSY pulse sequence is used for identifying pairs of spins that are not 
coupled directly to one another but that share a mutual coupling partner. Therefore two 
or several subsequent COSY steps can be performed in a single experiment. The 
RELAYED COSY pulse sequence, D1-90 0-t 1 -t-180°-t-900-AQ, where t is a delay 
which is adjusted according to the coupling constants of the spin system. Eight step 
phase cycling plus additional CYCLOPS cycling completes the pulse program. 
RELAYED COSY data can be obtained in absolute value mode or pure phase mode 
depending on the phase cycling used. 
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2.8.4 HOHAHA 2D Homonuclear Hartmann - Hahn magnetisation transfer sequence 
or TOCSY: 2D Total Correlated Spectroscopy 
47-49 
The 2D homonuclear total correlated experiment (TOCSY) which is developed later is 
identical to the HOHAHA experiment. The TOCSY spectra are acquired with the DI -
90 O-t,-SL-(MLEV-17)-SL-AQ pulse sequence in which SL denotes a short spin-lock 
field (2-2.5ms) applied along the x-axis. The MLEV-17 pulse cycle is used for this 
experiment using low transmitter power. The magnetisation transfer period splits into 
two parts; the composite pulse part and the two trim pulses at the beginning and the end. 
The two trim pulses at the beginning and end of the mixing period ensures easy phasing 
of the 2D spectrum to the absorption mode. Presaturation of the water resonance is used 
only during the delay time between experiments. TOCSY spectra display both direct 
and relayed connectivities and are very useful for elucidating scalar-coupled networks. 
The intensities of peaks depend on the length of the spin-lock mixing time; typically 30-
90 ms for proteins. Smaller mixing times are in favour of large couplings such as 
glycine germinal couplings. This experiment is useful for identifying resonances from 
the set of spins in a particular 1 H spin system. Its advantages are that coherence transfer 
is efficient and data are largely pure phase. 
2.9 Cross-Relaxation 2D Spectroscopy 
2.9.1 NOESY : 2D Nuclear Overhauser Enhancement Spectroscopy 50,51  
The irradiation and saturation of the resonance of a nucleus S may result in the intensity 
changes of the resonance of another nucleus I if both S and I nuclei are sufficiently 
close. The two nuclei S and I do not need to be coupled or connected. The expected 
result is an alteration of the signal intensity of the I resonance. This is known as the 
nuclear Overhauser effect or nOe. The nuclear Overhauser enhancement (flOe) is a 
consequence of modulation of the dipole-dipole coupling between different nuclear 
spins by the Brownian motion of the molecules in solution. Since nOe intensities are 
usually small and difficult to detect in a complex spectrum, nOe measurements were 
hardly used over two decades ago. One dimensional steady state and transient nOe 
experiments have long been used for studies of small molecules and biopolymers 
respectively. Due to limitations of the techniques, these experiments cannot be 
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exploited for work with macromolecules and therefore the 2D transient NOESY 
experiment will in most instances be the preferred technique. Cross-relaxation is 
detected as a change in the intensity of one peak as a consequence of perturbing the 
population of spins involved in another transition. When the two resonances arise from 
the same nucleus residing in two conformational states of one molecule or two 
molecular species in dynamic equilibrium, the effect can provide information about the 
interconversion rates. When the two resonances arise from different nuclei and the 
cross-relaxation mechanism is via through-space diploe-diploe interaction, the results 
can provide information about the distance between the two nuclei. The nOe intensity 
can be related to the distance r between the pair of protons that cross-relax each other. 52 
nOect ' /r6 ..........................................................................................2.9.1 
The nuclear Overhauser enhancement, TI, varies with the multiple of rotational 
correlation time 't and nuclear resonance frequency w0 (Figure 2.6). 
Figure 2.6: Variation of ctco0  vs r (steady state value) for a two spin system. 
tcO)o 	<< 1 Tlmax = 0.5 small molecules (fast tumbling) in non-viscous solvents. 
MW ca. 800 or less 
tW0 	ca. 1 r = 0 	medium size molecules (intermediate tumbling) 
MW ca. 1000-2500 
TU)o 	>> I Tlmax = I macro molecules (slow tumbling) 
MW Ca. over 3000 
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According to the tioç value, three prominent NOE regions, positive, zero and negative 
can be clearly distinguished. In the positive region steady state NOEs are normally 
positive and the observed NOEs will depend on the relative positions of the nearby 
nuclei. At the zero point of Figure 2.6 all enhancements are zero and the useful data can 
be obtained from the ROESY experiment. The enhancements are always negative in the 
negative region and no spectrum is obtained in a steady state experiment. Therefore the 
NOESY is an extremely important experiment for molecules in the negative nOe region. 
The 2D versions of these experiments are provided by the three pulse 2D NMR 
sequence 	 where the delay t1 is incremented from one group 
of acquisitions to the next, tm  is the mixing time which controls the time period during 
which cross-relaxation occurs, and AQ is the spectral acquisition time. Typical values 
for the mixing time are 30-500ms for proteins. It is necessary to perform experiments 
for several mixing times, including very short values to obtain all possible 
information. 
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Two dimensional exchange spectroscopy can be used to correlate the chemical shifts of 
protons of two conformational forms, e.g. native and denatured states. 
53
The cross peak 
intensities on either side of the diagonal provide information about the rate of the 
reaction in each direction. The maximum distance sampled depends on the mixing time. 
Identification of pairs of nuclei more than 5A becomes unreliable owing to competing 
relaxation mechanisms. The NOESY spectrum provides extensive information on 
intramolecular and intermolecular proton-proton distances and hence on the three 
dimensional structures of biopolymers. 
2.9.2 ROESY 2D Rotating-frame Overhauser Enhancement Spectroscopy 
55,56 
The nuclear Overhauser effect that occurs under spin-lock conditions is known as the 
transverse or rotating-frame nOe. Cross-relaxation in the laboratory frame has become a 
very popular method for investigating interatomic distances in macromolecules and, for 
obtaining structural and conformational information. 
52 
 This experiment was originally 
proposed by Bothner-By et al. 
57 
 and termed CAMELSPIN, but was subsequently 
r.i 
named ROESY. As with NOESY, the 2D ROESY experiments allows all pairs of 
spatially proximal spins to be detected simultaneously. While NOESY analysis of the 
structures of moderate sized peptides is difficult or impractical, e.g., MW = 1000-2500, 
ROESY offers a variable alternative. 
The standard ROESY pulse sequence Dl-90°-t 1 -(spin-lock-30)-AQ, where spin-lock-30 
is a spin-lock pulse along the x-axis and AQ is the signal acquisition period t2. Pure 
absorption spectra can be obtained by the States-Haberkorn-Ruben method. 
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In ROESY experiments, cross-relaxation takes place perpendicular to the external, static 
magnetic field and is therefore dependent on spin-spin relaxation process. 
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 In contrast, 
in NOESY experiments cross-relaxation takes place parallel to the external, static 
magnetic field and is dependent on spin-lattice relaxation process. Cross-relaxation in 
the laboratory frame has a different dependence on molecular motion than cross-
relaxation in the laboratory frame. 
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 This results in three major characteristics which 
make cross-relaxation different. 
The cross-relaxation rate in the rotating frame (er)  is always positive. In contrast, 
the laboratory frame cross-relaxation rate () becomes zero for rigid body isotropic 
motion. This means that measurement of cross-relaxation rates in the rotating frame is 
particularly attractive for moderately sized molecules where cY1ç-'O and the NOESY 
experiment therefore shows low sensitivity. 
For isotropic, rigid body motion in the slow motional regime (r) 0 > 1), cross- 
relaxation in the laboratory frame leads to substantial spin diffusion. In contrast, for 
slow molecular motion cross-relaxation in the rotating frame is tempered by dipolar 
relaxation thereby attenuating spin diffusion. This means that more accurate 
measurements of cross-relaxation rates, and hence better descriptions of molecular 
structure, may be obtainable from measurements in the rotating frame. 
The different dependence of a- and ar  on molecular motion makes the 
measurement of both cross-relaxation rates an attractive method to study molecular 
motion. 
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In the ROESY spectrum the cross peaks have the opposite sign to those on the diagonal. 
This will always be true for ROESY cross-relaxation cross peaks since ar  is always 
positive. In contrast, the NOESY cross peaks show the same sign as the diagonal peaks. 
This indicates that an  is negative. 
Because ar  is always positive, cross-relaxation in the rotating frame will give cross 
peaks with (- 
1)m,60 
where m is the number of transfers in the cross-relaxation pathway. 
For example, for a cross-relaxation pathway A—*B---*C, the AB cross peak will be 
negative and the AC cross peak will be positive. Because of the strong attenuation of 
spin diffusion in ROESY experiments on macromolecules, it is unlikely that more than 
one relay of magnetisation will be observed. Qualitatively this means that any positive 
cross-relaxation cross peaks in ROESY must arise from spin diffusion and that all 
negative cross peaks are likely to be due to direct, one step cross-relaxation. 
In summary, for small molecules, for rapid molecular tumbling, a steady-state NOB 
measurement will generally be the most effective experiment. For medium sized 
molecules, ROESY is much more sensitive than NOESY. For large macromolecules, 
detection of cross-relaxation to a group of magnetically equivalent spins will in general 
be more efficient with NOESY than with ROESY. The DQF COSY, TOCSY, NOESY 
and ROESY connectivity patterns are given in Figure 2.7 and the experimental schemes 
are given in Figure 2.4. 
2.10 Sequential Assignment Strategies; Homonuclear Proton Approach 
Methods for achieving sequential assignments in proteins can be divided into three 
categories based on the NMR parameter that provides transpeptide information. 
Detection of short transpeptide contacts by 2D NOE spectroscopy; a1-IIN 1+1 H, 
1H!N1+1 H and N1HfN 1 H. 
Detection of one-bond heteronuclear coupling 
Detection of multiple-bond heteronuclear coupling 
NOESY/R 
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DQF COSY or TOCSY connectivity patterns and 
NOESY or ROESY connectivity patterns along the polypeptide 
backbone 
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The overwhelming majority of sequence-specific assignments obtained to date have 
been achieved by detection of NOE connectivities between the NH of residue i and the 
adjacent NH of residue i+1. In most cases, one or more of the interresidue distances 
(a 1IT!N +1 H, 1HfN +1 H and N1HfN +1 H) can be inferred from NOESY cross peaks. 
Information about the amino acid sequence and the spin system types to which these 
resonances belong (COSY, DQF COSY and TOCSY data) is used to distinguish nearest 
neighbour NOE connectivities from longer range ones. 
Starting points for sequential assignments are provided by unique single residues or 
unique di- and tripeptides whose identities can be deduced from spin system analysis 
plus interresidue NOE connectivities. Once starting points have been identified, they 
can be extended by combining COSY/TOCSY and NOESY data. 
Protein chemists usually divide the 20 common amino acid building blocks of 
polypeptides into 8 groups such as neutral (A, G, I, L and V), basic (H, K and R), acidic 
(D and E), hydroxy (S and T), sulphur containing (C and M) and aromatic (F, W and Y) 
amino acids, amides (Q and N) and imino acids (P). For each amino acid residue, the 
non-labile protons constitute one or several spin systems which are connected by scalar 
(through-bond) spin-spin couplings J. 
Several amino acids have the same categories of spin system. For example Asn, Asp, 
Cys, His, Phe, Ser, Trp and Tyr all show an AMX spin system and Glu, Gin and Met 
show an AM(PT)X spin system. Further complications arise from the same amino acid 
residues occurring more than once. The spin systems of the nonlabile hydrogen atoms 
(Figures 2.8 and 2.9) and the chemical shifts for the 20 common amino acid residues in 
"random coil" polypeptide provide a reference 
61  for a qualitative understanding of the 
general features of a polypeptide spectrum. 
The recognition of particular geometric patterns in the TOCSY spectrum are 
characteristic of the different spin systems encountered in the 20 common amino acid 
residues. For all amino acid residues, the completion of the spin system by delineation 
of the NH/aH connectivity in the H 20 solution of the polypeptide is a very important 
part of resonance identifications. 
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R 	 Figure 2.8 
H I Amino acid residue. 
/ 	
R is the side chain. 
The circle identifies 
C 	the labile amide 
6 11 	proton. 
In addition, the TOCSY experiment can in principle delineate almost all spin-spin 
coupling connectivities between protons in a macromolecular structure and it is thus 
much more efficient than the use of 1D decoupling experiments. 
The fingerprint part (ca 7-10 ppm) of the DQF COSY spectrum of a polypeptide is a 
most useful guide for unambiguously distinguishing NH/aH cross peaks from NH/PH 
cross peaks of AMX spin systems which lie in the same region of the TOCSY spectrum. 
In the spectrum analysis, the 2J and 3 J coupled resonances all of which arise from the 
same amino acid residue can be identified. In situations of degeneracy or near 
degeneracy of two resonances, the DQF COSY spectrum may be helpful, since there is 
no interference with the diagonal. Using the DQF COSY and the TOCSY spectra, 
essentially complete identification of the NHIaH COSY cross peaks can be obtained 
prior to the sequential assignments. 
62,63  The 20 common amino acid residues give rise 
to 10 different COSY connectivity patterns for aliphatic protons and 4 patterns for the 
aromatic ring protons (Figure 2.10). 
The fingerprint part of the NOESY connectivities can be used for obtaining the NH/aH 
sequential assignments. In addition to the sequential connectivities, through space 
connectivities of almost all the amino acids could be obtained from the NOESY 
spectrum. In addition to the NOESY spectrum, NH/PH and NH/NH etc. could also be 
obtained from the ROESY spectrum. 
In a sequential assignment procedure, connectivities between the 1 H spin systems of 
sequentially neighbouring monomeric units can be established by the NOESY spectrum. 
The identification that is missing in incomplete spin system identifications can be 
obtained in connection with the sequence-specific assignments. Different amino acid 
types with the same spin-spin patterns can be identified once their sequence positions 
are determined. 
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Figure 2.9 	: Side chains R (See Figure 2.8) and three-letter symbols for the 20 
common amino acids and the spin systems of the non-labile hydrogen atoms in the 
molecular fragments HaCR. 
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NMR in aqueous solution and italics indicate the labile protons which are not usually 
observed by NMR 
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Figure 2.10 : COSY, relayed-COSY and double-relayed-COSY connectivities for the 
spin systems of non-labile protons in the common amino acid residues 
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2.11 Determination of Secondary Structure. 
Once extensive sequence specific 1 H NMR peak assignments have been obtained, 
NOESY cross peaks that represent longer range proton-proton connectivities can be 
catalogued. Patterns of these NOE's are used in identifying 13 and 7-turns, 13-sheets and 
helical regions (Table 2.1). 
64 
The a-helix is characterised by close approach between residues i/1+3 and i/i+4. The 
a 1 HfN 3H NOESY cross peaks are stronger than aHIN 1+4H NOESY cross peaks. In 
the 3 10-helix, short distances prevail between residues ili+3 and i/i+2 and the NOESY 
cross peak between a 1 HIN1+2H is weaker than a 1 H/N1+3H. The prevalence on an a- 
helix may further be obtained from observation of rather strong a 1HJ[3 +3H NOESY 
cross peaks. 
The 3J coupling constant values (3NHa)  are higher than 7Hz for 13-sheets. The long 
range NOE's between cxH/aH have a pivotal role in antiparallel 13-sheets. More details 
of identification of secondary conformations have been discussed elsewhere. 
Table 2.1: Survey of the sequential and medium range 'H- 1 H NOE's and (3NH(,,)  spin -
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CHAPTER 3 
3D STRUCTURE CALCULATION OF PROTEINS 
3.1 Introduction 
NMR spectroscopy is currently the only method for obtaining detailed information 
about the spatial arrangement of proteins in solution. During the last decade, there has 
been a dramatic increase in the use of NMR to study protein structures in solution. 
65 
Computational tools have been developed in the last few years, which facilitate direct 
determination of protein structures from NMR data. Numerical calculations with 
simulated and experimental NMR constraints for distances and torsional angles show 
that data sets obtainable with current NMR techniques carry sufficient information to 
determine the global fold of a small protein. 
The overall geometry of a protein molecule is partially defined by the primary structure 
and the basic structural parameters such as bond lengths and bond angles. In addition to 
these distances and angles, additional distance and angle constraints are used to define 
the final tertiary structure of the molecule. Structure calculation of biological 
macromolecules from constraints upon the possible values of their interatomic 
distances, together with additional constraints have become an important tool in 
structural biomolecular chemistry. 
66-69
These calculations have successfully been used 
to solve problems in drug design, 
70,71 
 structural interpretation of NMR data, 
10 
 and 
protein structure predictions. 
72 
 The first determination of the structure of a complete 
protein, the Bull Seminal Inhibitor, was made by Williamson et al. 
73 
 using the DISGEO 
distance geometry program described by Havel. 
74 
Different methods for the determination of protein structures from NMR data exist and 
new algorithms and software are still being developed. Among them distance geometry 
(DG), molecular dynamics (MD), restrained molecular dynamics (rMD) and dynamical 
simulated annealing (DSA) are commonly used by molecular modellers according to 
their requirement. Currently mathematical models such as DG which deal with atomic 
coordinates are commonly used for deriving protein structures from NMR data. 
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3.2 Use of NOESY in Structure Calculations 
The use of 2D NOESY in the structural analysis of macromolecules has become 
widespread during last decades. 65  The data for a protein structure determination are 
collected using one-, two-, or three-dimensional NMR techniques. 8,10  Typically, the 
NOESY spectra of proteins contain hundreds of cross-peaks arising from the three 
dimensional fold of the polypeptide chain. Each NOESY cross peak shows that two 
protons in known locations along the polypeptide chain are separated by a distance of 
less than approximately 5A in the three dimensional protein structure. For the structural 
interpretation of NMR data, mathematical techniques are available to identify those 
three-dimensional arrangements of the linear polypeptide chain which satisfy all the 
experimental constraints. Each individual structure calculation may find a protein 
conformation that is compatible with all the experimental constraints collected from the 
NOESY data and possibly supplementary experiments. 
To evaluate the effects of spin diffusion, the profile of the NOE build-up is usually 
investigated. The build-up rates of the nuclear Overhauser effect can be measured by 
acquiring NOESY spectra with different mixing times. The prominent substantially 
well resolved short- and long-range inter-residue cross peaks such as a jHIN, 1 FI, 
N1H/N11H, a1ll/N +3H, a1HIaH and a 1H/3 +3H are usually studied for this purposes. 
The build-up rates of first-order Overhauser effects which arise from direct dipole-
dipole coupling between closely spaced protons and the second-order Overhauser 
effects due to spin diffusion by cross-relaxation between more distant protons can be 
discriminated to carry out further analysis of the NOESY data. 
To investigate further whether a given set of NMR based input data defines a unique 
conformation, a family of structures is obtained by repeating the calculation with the 
same NMR data but with different, randomly generated starting conditions. In NMR, 
the data which are used for molecular modelling come mainly from the distances 
between atoms in structure. Since each distance constraint describes an allowed 
distance range rather than a precise value for the distance, 10  the individual structures are 
similar but not identical. The result of a structure determination from NMR data is 
therefore commonly represented by a group of conformers, each of which represents a 
solution to the geometric problem of fitting the polypeptide chain to the ensemble of all 
experimental constraints. 
When assignment of signals to protons has been achieved by a combination of NMR 
techniques, NOEs between proton pairs can be identified and translated into the proton-
proton distance constraints. There are three common methods of translating NOE cross 
peak intensities into distances found in the literature. 
Method 1: The most important quantity derived from NOB cross peaks is the cross-
relaxation rate cr ij between protons i and j. The cross-relaxation rates can be measured 
from build-up rates of cross peaks in 2D NOESY spectra at several mixing times. 
Assuming a rigid protein and no indirect magnetisation transfer, the build-up rates or 
NOB intensities are calibrated empirically by comparing values of unknown distances to 







This approach, also known as two-spin approximation, is used to translate NOE 
intensities or build-up rates into a set of approximate distance constraints. This 
translation does not indicate the distribution of NOE distances from different 
conformations at the given NMR time scale. The derived set of distance constraints, 
therefore, does not necessarily represent the average structure, and there may be no 
single conformation that is consistent with the data set. The weakest N,H/a 1H-type 
NOEs = 2.9A), the strongest a 114IN1+1 H-type NOEs (dmin = 2.2A) orPH/PH-type 
NOEs (d = 1 .75A) are normally used as reference points for calibrating. 
Method 2: Another approach for calibration NOEs to analyse the cross peak integrals in 
a histogram. Two integral thresholds are defmed for designating three distance ranges 
such as "strong" (1.8 - 2.49), "medium" (2.5 - 3.29) and "weak" (3.3 - 5.0), thus 
allowing more restrictive bounds. If the maximum NOE distance seen is near 5A, about 
10% of the NOEs will be in the strong range, 20% will be in the medium range and the 
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rest will be in the weak range. These choices can lead to better defined structures, since 
they contain more information. Too restrictive a set of bounds would result in structures 
that explore an incorrect part of conformational space. 
Method 3: Because NOE cross peak intensities cannot be translated into precise 
distances owing to correlated motions, anisotropic motions, flexibility and spin 
diffusion, two major limits can be introduced; upper limit and lower limit. In this 
method, NOE cross peak intensities are categorised into either three or four approximate 
upper limit constraints; strong (2.5-2.8A), medium (3.3-3.6A), weak (4.OA) and/or very 
weak (5 .OA). Translating NOEs into reliable lower limit constraints is difficult and it is 




Two or three intensity thresholds are defined to designate strong, medium, weak and 
very weak intensity cross peaks and three or four distance range limits are specified. 
Thresholds are determined by comparing known distances to experiment NOE integral 
values. The inter-residue a 1HIN 1, 1 distances {(2.3A in n-sheets and 3.6A in cc-helices)) 
and N 1HfN +1 distances {(4.3A in n-sheets and 2.8A in cx-helices)} are generally used as 
reference cross peaks for obtaining threshold values. This approach works well for 
obtaining a crude structure and it is less sensitive to errors such as spin diffusion and/or 
local correlation times. This method is commonly used for generating constraints to 
obtain starting structures for further calculations. 
3.2.1 Additional dihedral angle and distance terms 
In order to optimise a structure simultaneously with respect to the atomic interaction 
function and the experimental data set, additional terms can be added which represent 
the atom-atom distance and torsional angle constraints. The use of vicinal proton-
proton couplings is another source of useful geometric information for studies of 
molecular modelling. Coupling parameters of vicinal protons (NHJaH (xH1H in 
proteins) can be obtained from 1D proton and DQF COSY experiments. The 
dependence of the vicinal coupling constant between two protons Ha  and  Hb  on the 




where J is the coupling constant and 8 is the intervening dihedral angle between two 
atoms (0 = N' - 6O° . The parameters A(6.4), B(-1.4), and C(l .9) for the vicinal 
coupling constant 	for the polypeptides have been determined by Pardi et al.. 
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The formation of hydrogen bonds between CO and amide NH can be seen in the 
common polypeptide secondary structures; cc-helix (CO 1 - NH1+4), 3 10-helix (CO - 
NH +3) also in n-sheets. The individual NH proton exchange rates can provide valuable 
information in regular secondary structures. The amide protons which are hydrogen 
bonded show slow exchanging process but exposed amide protons exchange rapidly. 
This information can be added as additional constraints in structure calculations. 
Information from loop regions such as disulphide bridges and cyclic peptide rings can 
also be included as constraints. 
3.2.2 Constraints 
There are two common ways to express constraints. The first method assigns a target 
value for the parameter of interest and the objective function measures the deviations 
from the optimum value. The second method for handling constraints is that the upper 
and lower bounds on a particular parameter can be specified. A penalty is added when 
the boundary conditions are violated. 
Most of the distance constraints that are available for use in calculations are obtained 
from the nuclear Overhauser experiments. In addition to the distances derived from the 
NOE measurements, additional structural information can be obtained from many types 
of experiments such as coupling constants, hydrogen bond information, NH exchange 
rates, distance from spin labels, chiral information, specific distances from fluorescence 
energy transfer experiments and chemical cross-linking. 
3.2.3 Atom definitions 
The basic unit of the force field is the atom which is considered as a spherical and non-
polarizable "point" mass with no directional properties and no internal degrees of 
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freedom. There are two common types of atom representations; an 'all-atom' 
representation where every atom is considered explicitly and an 'united-atom' 
representation where all hydrogen atoms are collapsed into their heavy atom. The 
advantage of the united-atom representation is that the number of atoms in the system is 
reduced and the larger systems can easily be modelled. As an united-atom is always 
spherical and the direction of the hydrogen is not available, a loss of steric effects and 
inability to represent directional hydrogen bonds are disadvantages. 
Most of the algorithms used in structure calculations only deal with distances between 
points. These points can be real atoms or united-atoms. In NMR studies, atom 
representations are of real atoms and pseudoatoms. The real atoms represent all the 
heavy atoms including those hydrogens that can be resolved. A pesudoatom is placed 
where no real atom exists. Unresolved resonances associated with methylene groups, 
the aH of glycines, methyl groups, NH 2 groups and various ring hydrogens, can be 
represented as pseudoatoms. 
The pseudoatom is positioned at the geometric centre of the unresolved group of 
resonances and the distance constraint can be assigned to the pseudoatom. In these 
cases boundary conditions are loosened to permit the pseudoatom to meet the 
constraints properly. The pseudoatom is treated as a point and has no van der Waals 
radius. In order to compensate, the van der Waals radius is given to the pseudoatom. 
3.3 Strategies for Conformational Search 
It is important to realise that it is not always possible to construct a single algorithm that 
can simultaneously enforce all these types of constraints. Most of the programs 
available at present can easily deal only with distances, angle, and chiral constraints. 
The programs DISGEO,74 ' 79 DGEOM,80 DSPACE, 8 ' PROTEAN, 
82-84 
 and the DG-II 
68 	 85 	 86 
program use atomic coordinates, while the DISMAN, DIANA and the 
FANTOM87 programs use angular coordinates as independent variables. Basic 
requirements of these programs are 
Data input procedures are needed 
A way of generating an initial structure or set of structures must be available 
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(3). An optimisation routine is needed to bring the constraints and the structures into 
closer harmony 
Data input procedures normally allow descriptions of geometry taken from electron 
diffraction data, X-ray data, NMR data or other structural measurements. The choices 
for generating starting structures include random starting conformations, model-built 
starting conformations, or starting conformations calculated from another program such 
as distance geometry. The DISMAN, DGEOM, DISGEO and DSPACE programs 
randomly generate initial structures. Modifications of molecular dynamics routines 
88,89 
or more complex mathematical search procedures 
82,85 
 begin with model-built 
structures. Thus the constraints can be applied directly. Currently available 
minimisation methods can be used to optimise the penalty function of the constraints. 
3.4 The Force Field 
The combination of all potential energy functions is the force field. The potential 
energy can directly be used to determine the relative stabilities of the different possible 
structures of the system. The mechanical forces acting on the atoms of the systems can 
be used to calculate dynamic properties of the system by solving Newton's equations of 
90,91 
motion. 	In the force field, the molecule is viewed as a collection of points (atoms) 
connected by springs (bonds) with different elasticities (force constants). The force 
holding the atoms together can be described by potential energy functions of structural 
features like bond lengths, bond angles and non-bonded interactions. In addition to 
these, steric, electrostatic and other strain forces must also be included. The force field 
can be modified in order to constrain interproton distances when a NOE between them 
has been measured by NMR. 
The energy (B) of the molecule in the force field arises from deviations of ideal 
structural features, and can be approximated by a sum of energy contributions. The set 
of potential functions contains adjustable parameters that can be optimised to obtain the 
best fit of calculated and experimental properties of the molecule such as 
conformational energies, geometries and other thermodynamic properties. The force 




only be valid for small deformations from the natural structural features such as lengths 
and angles. 
E = {Estr + Ebend + EOOp  + Etors + Evdw 
[F Eeie + Edist c + Eang c + ''tor_c ± Erange_c + E x I optional energy terms } ........ 33 
B str energy of a bond stretched from its natural bond length 
E bend energy of bending bond angles from their natural values 
E oop energy of bending planar atoms out of plane 
B tors energy of torsional due to twisting about bonds 
E vdw energy due to van der Waals non-bonded interactions 
E ele energy due to electrostatic interactions 
E dist_c energy associated with distance constraints 
E ang_c energy associated with angle constraints 
E tor _c energy associated with torsion angle constraints 
E range_c  energy associated with range constraints 
E x energy associated with other possible constraints 
Numerous force fields have been developed for simulation and modelling of 
polypeptides and nucleic acids. Among them AMBER, 
93 
 CHARMM,94 GROMOS95 
and Tripos92 force fields are commonly used. 
3.5 Distance Geometry (DG) 
The DG calculations have been playing an important role in the initial stages of the 
overall structure determination process. The name distance geometry has come to refer 
to the computer programs that convert geometric constraints into molecular coordinates. 
The DG program includes random start approach. The mathematical algorithm 
guarantees that the initial coordinates are the best multidimensional fit to the trial 
distances. The randomisation is associated with the trial distances, which are chosen as 
randomly distributed between upper and lower boundary conditions. When additional 
constraints are available, DO attempts to produce structures that meet both the basic 
constraints described above and these additional constraints. 
Ca 
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The distance geometry approach can be used to search conformational space subject to a 
wide variety of constraints beyond those obtainable by NMR. The final target of the 
distance geometry calculation is to produce one or more molecular structures that meet a 
set of constraints. As a general rule, DG calculations do not yield a unique structure. 
Two different methods are used to convert distance constraints; the metric matrix 
79 66,74, 	
i approach 	which operates n distance space and the variable target function 
approach 
85,86 
 which operates in real space. These are called DG algorithms but their 
approach is fundamentally different. 
3.5.1 Metric Matrix approach 
66,74,79 
 
The metric matrix approach consists of the following steps. First, upper and lower 
distance-bound matrices are set up for all atom distances in the molecule. The NMR 
information is complemented with distance information following from allowed van der 
Waals atom-atom distances, standard bond lengths, and bond angles. For pairs of atoms 
separated by one rotable bond, upper and lower bounds can be calculated from the 
corresponding trans and cis configurations. 
The DG algorithm then proceeds with an iterative bound smoothing procedure using 
triangle inequalities. This is achieved by increasing the lower bounds and reducing the 
upper bounds in those cases where the bounds are not geometrically self consistent. 
Triangle smoothing treats all atom triples to derive narrower bounds when possible. 
This process can derive distance information between atoms where no constraint has 
been entered. Distance matrices are then randomly selected between the upper and 
lower bound matrices and subsequently embedded in 3D coordinate space. Only 
bounds matrices that have been smoothed can be embedded with reasonable results. 
As the distances, however, do not defme the chirality of the structures because the 
embedding procedure is dependent only on distances in matric matrix method, mirror 
images (local or global) of the correct structure can occur. These can be rejected as the 
chirality of single amino acids (L) and helices (right handed) is known. 
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Because, in the embedded structures, many distances usually fall outside their bounds, 
optimisation is needed to minimise the remaining atom-atom distance violations and to 
impose the known chirality to the various asymmetric centres in the protein molecule. 
Therefore the chiral constraints are used only during optimisation. The metric metrix 
79 




3.5.2 Variable Target Function method 
85,86 
 
This method involves the minimisation of a distance constraint error function (target 
function) in variable dihedral angle space. The target function (T) is similar to the error 
function in matric matrix approach. During the minimisation of T, only x and  4 
variable dihedral angles are used as independent values, instead of Cartesian 
coordinates. Bond lengths, bond angles and co dihedral angles are kept at fixed values. 
The minimisation of the target function is performed at different levels to reach the 
global minimum T=O of the target function as closely as possible. 
This procedure normally starts with a number of different initial conformations obtained 
by taking random values for the dihedral angles. From conformations obtained after a 
series of low-level optimisations the best conformations are selected for higher level 
optimisations. The quality of conformations can be improved by repeating a series of 
function optimisations. This approach is implemented in the DISM 
85 
AN and DIANA 
86 
programs. 
Independent methods (such as metric matrix approach and the variable target function 
approach) for deducing spatial structures may sometimes obtain compatible families of 
solutions but it does not necessarily indicate that these methods are sufficient, or the 
families of possible solutions even contain the correct ones. 
Although all DG methods have been used on macromolecules containing a large number 
of atoms, they all suffer from one or more shortcomings. DG algorithms are useful 
techniques to derive crude, widely diverse tertiary structures consistent with the 
experimental data. Ideally a structure obtained by a distance geometry calculation 
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should have no violations of the distance constraints imposed by the experimental data. 
In practice, finding these structures involves several optimisations, error calculations 
and therefore each solution includes a certain number of small distance violations. 
The structures generated by DG calculations can be improved by combining DG with 
the refinement method. The success of a combination of DG with other refinement 
methods is dependent on the accuracy of the experimental data, the quality of the initial 
structures generated by the DG algorithm, and the accuracy of the force field and the 
simulation adopted. 
3.6 Molecular Dynamics (MD) 
The molecular dynamics simulation provides information about the dynamic behaviour 
of a system. The presence of motional freedom in the model simulation implies the 
possibility of passing over energy barriers, and a range of protein conformations is 
sampled. Therefore MD searches a larger part of conformational space and generally 
finds a lower energy minimum than regular energy minimisation techniques. By 
numerically integrating the Newtonian equations of motion with a sufficiently small 
time step during which the forces can be regarded as constants, a trajectory (atomic 
positions as a function of time), can be obtained. 
To begin the dynamic simulation, an initial set of atomic coordinates and velocities is 
needed. Initial velocities for all atoms are taken either from a random distribution or 
from a previous distribution corresponding to the desired temperature. During the 
simulation, the temperature is held constant by scaling the velocities after each time 
step. Newtonian equations of motion are solved by integration over very small time 
steps in which the forces can be regarded as constants. 
The method used in the constant temperature simulations incorporates a damping 
function to avoid systematic oscillations and rapid changes. The damping function 
which is achieved by coupling the system using an adjustable time constant, avoids 
sharp changes in the temperature when heating and cooling. This eliminates artefacts 
that may arise during simulations. Simulations under constant temperature conditions 
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correspond to operating in the NVT (N - constant number of particles, V - constant 
volume and T - constant temperature) or canonical ensemble. 
97 
 In this type of 
simulation, the velocities of the atoms are scaled at each step so that the kinetic energy 
of the system corresponds to a set temperature. 
The major use of molecular dynamics in protein NMR is conformational sampling and it 
has been a great interest in conformations of lowest energy. The obvious way to sample 
more conformations is to raise the temperature of the simulation. This type of dynamics 
simulation which is called Molecular Quenched Dynamics, is performed continuously at 
a high temperature and snapshots are taken for subsequent minimisation. 
When the MD simulations are carried out without including the effects of solvent, this 
may cause amino acid side chains at the surface to collapse onto the core of the protein, 
thus biasing the sampling behaviour of the protocol. Other disadvantages in vacuo 
simulation are details on hydrogen bond formation and breaking and amplitudes of 
motions involving solvent accessible parts of the molecule. This problem is felt with 
MD simulations of solvent accessible molecules such as small peptides. 
Molecular dynamics is not capable of generating initial structures, but it can simulate 
the dynamic behaviour of molecules while including the average character of the NMR 
data. In most cases poorly defined parts of the molecules were seen to adopt a wider 
range of conformations after the MD refinement. There have been several excellent 
surveys of applications of MD to the study of protein structure 
98-100
and several reviews 
on conformational searching. 
101,102 
3.7 Restrained Molecular Dynamics (rMID) 
88,89,103 
Restrained molecular dynamics has been shown to be an additional valuable tool in 
elucidating the molecular conformations compatible with NMR data. Existing computer 
programs of MD calculations have been modified to allow inclusion of the NMR data. 
This is done by adding a pseudo pair potential energy term to the potential function used 
in the free dynamics simulation. These additional harmonic pseudo forces act like 
strings between those atom pairs constrained by the NMR data and drive the molecular 
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conformations towards conformations compatible with the NMR data. The energy 
represented by a distance penalty will then be lost to the surroundings as the dynamics 
simulation moves the atoms towards an energy minimum. 
Restrained molecular dynamics calculations of protein conformations using NMR data 
have been done with two different aims. One aim was the refinement of a model built 
structure that crudely satisfies the NOE distance constraints and the other aim was to 
decrease both the potential energy and the atom pair pseudo energy arising from the 
NOE distance constraints. Restrained molecular dynamics should be used only to 
search for low energy conformations within the allowed parts of conformational space. 
Solvent molecules can also be included for rMD calculations. Refinement by rMD 
improves the quality of the structures in terms of energy. One disadvantage of rMD is 
that structural information obtained from NMR experiments is mixed with the force 
field parameters used. 
3.8 Dynamical Simulated Annealing (DSA) 
104-106 
A common use of the constant temperature simulation is to explore the conformational 
space available at the given temperature. This is done by simulating the motions at a 
very high temperature. All conformations are then energetically accessible. The final 
step is lowering the temperature. In simulated annealing calculations, an integration 
algorithm is used to solve Newton's equations of motion in an analogous fashion to that 
used in MD. This method which is known as Simulated Annealing has been used in 
other fields as a technique for global optimisation of multi dimensional surfaces. 
107,108 
 
It has recently been introduced to molecular modelling of proteins using NMR data. 
106 
In DSA, geometric restraints and the non bonded interactions are represented by a 
simple repulsion term. The non bonded interactions replace the dihedral, van der Waals, 
electrostatic and hydrogen bonding potentials of the empirical energy function in 
conventional molecular dynamics. NOE distance constraint data can be included in the 
energy potential to provide a driving force term in the dynamics simulation. A penalty 
function can be included to satisfy the violated distance constraints. In addition, 
dihedral angle constraints and hydrogen bond restraints can also be added in a similar 
manner. 
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The method describe in the DSA circumvents the folding problem, by starting from a 
completely random array of atoms and introducing the force constants for the covalent, 
interproton distance, torsion angle, and repulsion van der Waals terms in the target 
function appropriately. The system is simulated at high temperature by solving 
Newton's equations of motion. As the values of all force constants are very low during 
the early stages of the simulation, energy barriers between different folds of the protein 
can be overcome, and the global minimum of the target function is really located. 
Because the atoms are initially only weakly coupled, they can move independently to 
satisfy the applied restraints, thereby avoiding problems associated with folding. 
The total target function Ftotai  for which the global minimum region is searched 
comprises the following terms. F0i  represents the effective potential energy in the 
dynamics calculation which involves the integration of Newton's equations of motion. 
Ftotai = Fcovaient + Frepei + FNOE  + Ftor 	 ..................................3.4 
The Fcovaient  term is employed to drive the system towards the correct covalent 
geometry such as bond lengths, bond angles, planes and chirality. 
Fcovaient = 	kb (r-r0)2 + I k9 (e-e0)2 + k (40)2  +Z k, (o)a0)2 ......... 3.5 
bonds 	angles 	impropers 
The force constants of the energy terms are described as bonds (k b), angles (k0), 
improper torsions (k) which define planarity and peptide bond dihedral angles (k m). 
The correct bond lengths, angles, improper angles and peptide dihedral angles are 
defined as r0 , e0, 4, and coo respectively. 
The non bonded van der Waals interactions are represented by Frepei  which employs a 
purely repulsive term and is defined in Equation 3.6 where r is the inter-atomic distance. 
0 
Frepei 
= 	 2 [kVdW  (s 	mm - r ) 
2 22 
,ifr ~!s S rmjn 
,ifr<s • rmjn  ..........................3.6 
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The associated force constant kdW  may be varied during the calculation and the values 
of the inter atomic distance (rmjn)  are the standard values of the van der Waals radii 
represented by the Lennard-Jones potential. 
109 
 Alteration of the van der Waals radius 
scale factor s allows for manipulation of the degree of van der Waals repulsion so as to 
maintain a soft repulsion term during the initial structure determining steps of the 
protocol allowing atoms to pass closer to each other. 
The NOE distance restraints are represented by a square-well potential with the variable 
force constant (kNoE) where nj " and n j 1 are values of upper and lower limits of the 
applied distance constraint respectively and nj represents the actual calculated inter 
atomic distance. The torsion angle restraints are also represented by a square-well 
potential with the force constant ktor  where pj" and 
Ti 
  are upper and lower limits 
respectively. 





L k NOE (nj - nj) 1 2 
Ek tor  ((pi(pjU)
2 
Ftor = 	0 
12 
Lk tor (Ti p i ) 
, if nj < nj < r ju  
	
,if rij 	rjj 1 .................................................3.7 
if cpj 	
U 
if Ti<(nj < (p 
U 
5 if Ti < (Pi ' .................................................3.8 
The strategies involving the application of simulated annealing for protein structure 
determination from NMR data have recently been proposed. 
105,110  The DSA 
calculation which is commonly used in protein structure calculation, describe a real 
space method based on the principles of simulated annealing which circumvents the 
folding problem completely and the starting structures are generated from a completely 
105 
random array of atoms. 
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Practically, the DSA process is begun at the maximum temperature specified (starting 
temperature), and the system is held at that temperature for a certain amount of time 
(Plateau time). During this period, the system can rearrange itself into a different 
conformation. During the annealing time, the temperature is reduced until the minimum 
temperature is reached. At this point, the first cycle is completed and the process may 
be continued for the specified number of cycles. The conformations obtained by 
simulated annealing are further minimised to ensure that the system is truly in a low 
energy state. In addition to available molecular dynamic programs, DSA can be used 
not only to refine an initial set of approximate coordinates but also to introduce major 
structural changes. 
Advantages of the DSA calculations 
A higher starting temperature can be used to surpass torsional barriers. 
A longer plateau time can be introduced to reach dissimilar previous 
conformations. 
More stable systems can be reached by lowering the finishing temperature. 
A longer annealing time can be introduced to avoid bad structures. 
Higher number of cycles can be used to discover important conformations. 
Different annealing methods such as stepwise, exponential and linear can be 
introduced during cooling step. 
3.9 Energy Minimisation (EM) 
Energy is a function of the atomic coordinates and the energy minimisation (EM) 
program attempts to generate the coordinates which correspond to a minimum of 
energy. All the minimisation methods currently used are descent series methods. They 
are iterative methods in which the atomic coordinates are modified from one iteration to 
the next in order to decrease energy. The minimisation procedure consists of moving 
the atoms of a molecule in such a way as to always reduce the total energy of the system 
based on an empirical representation of the interaction energy of the atoms of a 
molecule. The EM methods are generally unable to find the global energy minimum 
and most of the time, only a local minimum is found. The only way to find the global 
minimum is to explore different sets of starting coordinates. 
M. 
In highly distorted structures the potential energy surface and its derivatives are often 
discontinuous. Simplex minimisation can handle these areas while a derivative based 
procedure can not. Five common optimisation procedures are provided for finding a 
local minimum of the energy function. 
Powell minimisation 
Conjugate Gradient minimisation 
Newton Raphson minimisation 
Steepest Descent minimisation 
Broyden, Fletcher, Goldfarb and Shanno minimisation 
The results obtained with energy minimisation depend on the starting coordinates. It is 
necessary to perform minimisation calculations with different sets of starting 
conformations. Energy minimisation covers only a small part of the configuration space 
but is capable of relaxing the strain in a molecule by small local positional adjustments. 
Optimisation of conformational energy is often a convenient way of obtaining 
reasonable geometry for molecular models. Good covalent geometry, energetically 
acceptable hydrogen bonds and total absence of steric overlaps are certainly expected as 
the output of a carefully conducted energy minimisation study. In every minimisation 
procedure, overall translation and rotation of a molecule is never observed. 
3.10 Back Calculation 
111-114 
A quantitative comparison of the experimental and back-calculated NOESY spectra is 
the basis of fitting NOE data with an iterative full relaxation matrix refinement. Once a 
final structure or family of structures is obtained, it is fairly straight forward to back-




These can be used to qualitatively investigate the reliability of 
the structure, and significant discrepancies should be addressed. 
In addition to its use in evaluating the accuracy of structures, NOESY back-calculation 
can be used for the further refinement of previous structures in order to obtain 
consistency with experimental NOESY data. Since distances estimated directly from 
61 
NOE data which is done by forward calculation are prone to errors, the back-calculation 
of NOESY spectra from structures provides the user with a means of adjusting those 
structures to better agree with the experimental data. If one identifies simulated cross 
peaks that are too big or too small compared to their experimental intensities at any 
mixing time, the corresponding distance bounds can then be adjusted in the proper 
direction. Another advantage of the back-calculation lies in the fact that all spins, not 
only those that have been assigned and measured, are considered in the NOESY 
simulation. Agreement with experimental NOESY data is an essential requirement for 
NMR based structure determination, but because one can reproduce experimental data, 
one can not assume that an accurate structure has been determined. 
3.11 Evaluation of Structures 
It is clear that the computational methods to generate structures from NMR data can 
have an important impact on the accuracy and reliability of the obtained structural 
results. The precision of a conformation obtained by structure calculations strongly 
depend on the relative and absolute magnitudes of the weights placed on the constraints, 
for example, the weighting factors in the DG objective function, 65 '68 or target function 86 
or the force constants used in the DSA or MD. 
110,115 
The precision of conformation is typically expressed using root mean square deviations 
(RMSD) of the atomic coordinates of an ensemble of structures obtained by executing 
repeated, independent fits of the same constraints. Therefore, these structures have to be 
obtained by unbiased random sampling of the accessible conformational space. The 
average displacement among equally reliable structures represents the minimum 
diversity of conformers that meet the constraints. Typical results for globular proteins 
with upto 6-12 NOEs per residue are 1 A RMSD for all backbone hydrogens and 2 A 
RMSD for side chain hydrogens. The other way to estimate the quality of the structures 
determined is evaluation of the proximity between simulated NMR data from the 
structures built and the analogous real experimental NMR data from which these 
structures were determined. 
62 
The procedures and parameters used for achieving a structure from a given set of 
distance constraints are often not usable with another structure and data set. The quality 
of structures and the best convergence are often a matter of luck; with significant 
interaction between the user and the parameters used for some protocols. 
3.12 Conclusion 
Molecular dynamics programs search the thermally accessible vicinity of a particular 
starting conformation. 
116 
 It is expected that MD refinements do not converge to a 
global minimum. The sampling of the MD algorithm can be improved by increasing the 
temperature and using a soft nonbonded repulsion term that allows atoms to pass 
through each other. During EM and MD refinement the electrostatic interactions are 
significantly improved for all structures, whereas bad atomic overlap is relaxed. The 
lower internal energies for MD refined structures compared to only EM refined 
structures clearly reflect the ability of MD to explore a much larger part of the 
conformational space than EM. 
Distance geometry can be used to derive initial three dimensional structures consistent 
with the NMR data but in all cases have very high potential energy terms. The DG 
structures satisfy distance constraints reasonably well, but owing to crude geometric 
terms used to describe the atomic interactions in a molecule, the physical reliability is 
poor. MD refinement of DG structures normally leads to a considerable decrease of the 
internal energy while the consistency of the structures with the NMR data is maintained 
or even improved. Application of molecular dynamics was shown to enhance variety in 
a set of DG structures, the lac repressor headpiece, 
117 
 BSPI 2, 
118 
 and the phoratoxin. 
119 
 
Powerful strategies on high-temperature dynamics have been introduced by Nilges et 
al.. 
110  These methods are capable of sampling a larger region of the conformational 
space than MD using a physical force field. Adequate sampling of a MD simulation is 
dependent on the length of the simulation and the possibility of crossing large energy 
barriers. Crossing large barriers is unnecessary if starting from DSA structures. As 
noted by researchers, distance geometry calculations followed by DSA then MJT)/rMD 
generates equally plausible structures consistent with the NMR data. 
CHAPTER 4 
SOLUTION STRUCTURES OF LINEAR ENDOTHELIN 
DERIVATIVES 
4.1 Introduction 
4.1.1 Literature Review of Endothelins 
Endogenous vasoactive peptides such as angiotensin II, vasopressin, neuropeptide Y and 
endothelin are potent vasoconstrictors acting on smooth muscle and in the central 
nervous system. 
120  Endogenous peptidic vasodilators presumably act in concert with 
the vasoconstrictor peptides to maintain homeostasis. It is interesting that the 
vasoconstrictor substances are usually mitogenic, while the vasodilatory peptides inhibit 
cell growth. Endothelial cells are known to be capable of releasing vasoactive 
substances that regulate smooth muscle tone and platelet function. 121 
ET-1, now known to belong to a new peptide class, is some ten fold more potent than 
the vasoconstritor angiotensin II, and has extremely long lasting pressor effects. The 
discovery of ET-1, a potent vasoconstrictor peptide released from endothelial cells, has 
attracted great interest as one possible candidate for (endothelium derived 
vasoconstrictor factors) EDCF.' 22 The endothelin has been proposed to mediate 
vasoconstriction via production of EDCF in response to various chemical and physical 
stimuli. Indeed the expression of this peptide has been highly conserved during the 
course of vertebrate evolution and may perform similar homeostatic functions in a 
variety of mammalian and nonmammalian species. 
Over the last 6 years this peptide has drawn the attention of many investigators because 
of its unique structure and numerous biological actions (Table 4.1). Some of the 
biological actions of the ET's (Table 4.1) are described and the evidence for a possible 
involvement in a variety of diseases are reported (Table 4.2). 
The development of selective receptor antagonists and/or processing inhibitors is 
eagerly awaited and may provide novel therapeutic agents for the treatment of a variety 
of human diseases. 
64 
4.1.1 Identification and Characterisation 
The term "endothelin" refers to a family of 21 amino acid peptides found in four distinct 
isoforms, 123124 ET-1, ET-2, ET-3 and ET-P or mouse vasoactive intestinal contractor 
(VIC) (Figure 4. 
1).125 
 ET-1 was originally discovered in the supernatant liquid of 
cultured bovine aortic endothelial cells and subsequently isolated from the culture 
supernatant liquid of porcine aortic endothelial cells. 
123 
 The primary sequence of 
human endothelin has been deduced from a human placental cDNA library and found to 
be identical to that of porcine endothelin, now referred to as endothelin-1 (ET-1).' 24 
Common three forms of endothelins, ET-1, ET-2 and ET-3 appear to be distinct gene 
products. Two endothelin related genes were identified by cloning and sequence 
analysis of the mouse genome. 125 One encoded the peptide ET-1, while the other 
encoded a new peptide differing by three amino acid residues. The gene for this novel 





As illustrated in Figure 4.1, the endothelin isopeptides have significant structural 
homology including two disulphide bonds, a cluster of polar charged side chains on the 
hairpin loop and a hydrophobic C-terminus (residues 16-21). These features show 
remarkable similarity to another group of cardiotoxic peptides, known as sarafotoxins 
(SRTX 6a-d, Figure 4.1) isolated from the venom of the Egyptian burrowing asp, 
Atractaspis engaddensis.'26 Relation between endothelins and sarafotoxins suggests an 
ancient and common evolutionary origin. A new members of the ET/SRTX peptide 
family named Bibrotoxin was isolated from the snake venom of the South African 
burrowing asp Atractaspis bibroni. 127 
ET-1 is the most potent vasoconstrictor discovered to date. It is some ten-fold more 
potent than angiotensm II, and the duration of pressor effects is extremely long. 
128 
Sarafotoxins also share similar biological activities to the ETs 129 suggesting that ET 
genes have evolved under strong pressure to conserve the structure and function of 
mature ET peptides. 
65 
Figure 4.1: Sequence homology between the Endothelin and Endothelin-like 
peptides; underlined residues are sites of differences from human ET- 1 





1 	4 	7 	10 	13 	16 	19 
SRTX-6a C-S-C-K-1-M-I-D-K-E-C-L-N-F-C-H-Q-D-Y-I-W 
SRTX-6b C-S-C-K-1-M-I-D-K-E-C-L-Y-F-C-H-Q-D-1-I-W 
SRTX-6c C-I-C-N--M-I-D-E-E-C-L-N-F-C-H-Q-D -Y-I-W 
SRTX-6d C-I-C-K--M-I-D-K-E-C-L-Y-F-C-H-Q-D-I--I -W 
BBTX 	C-S-C-A-fl-M-I-D-K-E-C-L-Y-F-C-H-Q-D-1-I-W 
Apamin C-N-C-K-A-E-E-I-A-L-C-A-R-R-C-Q -Q-ll 
1 	4 	7 	10 	13 	16 	19 	22 
MCD 	I- K-C-N-C-K-R-H-V-I-K-P-H-I-C-R-K-I-C-G-K-N 
Tertiapin A-L-C-N-C-N-R-I-I-P-H-M-C-W-K-K-C-G-K-K 
ET-1 	: Human, Porcine, Canine, Rat, Mouse, Bovine 
ET-2 	: Human, Dog 
ET-3 	: Human, Porcine, Rabbit, Rat, Mouse 
ET- (VIC) : Rat, Mouse 
SRT)(s 	: Egyptian burrowing asp, Atractaspis engaddensis 
BBTX 	: South African burrowing asp, Atractaspis bibroni 
MCD 	: Mast Cell Degranulating peptide 
C'—C' 5 and C3—C 11 
C'—C" and C3—C'5 
Disulphide bonds: 1-10 
11-12 
The sequence of ET-1 from human was shown to be the same as that from porcine, rat, 
mouse and bovine. There is also no difference between the sequence of human and rat, 
mouse, rabbit and porcine ET-3. The sequence of ET-2 from human was shown to be 
the same as that from dogs. The VIC, with only one amino acid difference from human 
ET-2 (Asn-4 verses Ser-4), is the mouse ET-2. The sequence of bibrotoxin is highly 
homologous to that of SRT)(-6b with the only difference being the substitution of Ala-4 
for Lys-4. 
4.1.3 Biosynthesis of Endothelin 
The synthesis and secretion of endothelin (ET5) is analogous to several other bioactive 
peptides. They arise from post-translational processing of large isopeptide specific 
prohormones. Yanagisawa et al. 
123 
 cloned the procine El gene and based on cDNA 
sequencing, predicted the amino acid sequence for preproendothelin. Since then several 
eDNA and genomeric clones for preproETs (ET-1, ET-2 and El-3) have been isolated 
from various species, namely human, murine, canine, porcine, rat, rabbit and bovine. 
124- 
 
125, 130 The genomeric DNA blotting shows that each El isopeptide is encoded by a 
distinct gene. 
Figure 4.2 : Biosynthesis of Endothehn 
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Figure 4.3 : Sequences of Big Endothelins 
7 	4 	1 
M-L-S-S-C-S-C 	 ECE 	 Human big-ET-1 
I /\ 
D-K-E-C-V-Y-F-C-H-L-D-I-I-W-V-N-T-P-E-H-V-V-P-Y-G-L-G-S-P-R-S 
8 	11 	14 	17 	20 	24 	27 	30 	33 	36 
7 	4 	1 
M-L-S-S-C-S-C 	 ECE 	 Bovine big-ET-1 
I 1. 
D-K-E--V-Y-F-C-H-L-D-I-I-W-V-N-T-P-E-H-V-V-P-Y-G-L-G-S-P--R- 
8 	11 	14 	17 	20 	24 	27 	30 	33 	36 	39 
7 	4 	1 
M-L-S-S-C-S-C 	 ECE 	 Porcine big-ET-1 
D-K-E-C-V-Y-F-C-H-L-D-I-I-W-V-N-T-P-E-H-I-V-P-Y-G-L-G-S-P--R- 
8 	11 	14 	17 	20 	24 	27 	30 	33 	37 
7 	4 	1 
M-L-S-S-C-S-C 	 ECE 	 Rat big-ET-1 
/\ 
D-K-E-C-V-Y-F-C-H-L-D-I-I-W-V-N-T-P-E-R-V-V-P-Y-G-L-G-S-P-S- 
8 	11 	14 	17 	20 	24 	27 	30 	33 	36 	39 
7 	4 	1 
L--S-S-C-S-C 	 ECE 	 Human big-ET-2 
I /\ 
D-K-E-C-V-Y-F-C-H-L-D-I-I-W-V-N-T-P-E-Q-I-A-P-Y-G-L-G-N-P- 
8 	11 	14 	17 	20 	24 	27 	30 	33 	36 
7 	4 	1 
K-X-I-E-C-I-C 	 ECE 	 Human big-ET-3 
/\ 
8 	11 	14 	17 	20 	24 	27 	30 	33 	36 	39 
ECE : Endothelin Converting Enzyme 
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The predicted amino acid sequence for preproETs are proteins (ca 200 amino acids) 
with specific species and isopeptide differences. ET-1 is derived from a 203 amino acid 
peptide precursor known as preproendothelin, which is cleaved after translation by 
endopeptidases specific for the paired dibasic residues to form a 38 (human) or 39 
(porcine) amino acid peptide, proendothelin or big-ET (Figure 4.2).'' 
The three isoforms of big-ET have several different features (Figure 4.3) including; 
Length of the peptide chain; big-ET-1, -2, and -3 contain 38, 37 and 41 amino 
acids respectively. 
Big-ET-3 has Ile-22 instead of Val-22 at the scissile bond. 
Residues 27-29 in big-El-i are His-Val-Val, in big-ET-2 are Gln-Thr-Ala and in 
big-ET-3 are Gln-Thr-Val. 
The C-terminal regions of big-ET- 1 and big-ET-3 are somewhat dissimilar while 
those of big-ET- 1 and big-ET-2 are moderately conserved. 
No glutamines are present in big-ET-1 and unique methionine and alanine residues 
are present in big-El-i and big-ET-2 respectively. 
The amino acid homology of Tyr and Thr are higher in big-ET-3 while Ser is higher 
in big-El-1. 
Big-ETs undergo a proteolytic cleavage at an unusual processing site, Trp-2 1 -Val-22, 
by a putative endothelin converting enzyme (ECE) to give mature ETs and the 
128 
corresponding C-terminal fragments (Figure 4.3). 
123, Due to much lower 
vasoconstricting potency of big-ETs than ETs the conversion of big-ET to ET appears 
essential for physiological activity. 
132  The physiological importance of cleavage of 
ET(I-39) is indicated by the reported 140-fold increase in vasoconstrictor activity upon 
cleavage to ET-1. 
132 
Recently in vivo expression of synthetic RNA encoding human preproET-1 in xenopus 
oocytes' 33  resulted in the secretion of ET-1 and big-ET-1. In the subsequent study 
134 
 a 
set of preproET- 1 mutants were designed and expressed. This study demonstrated that 
big-ET-1 is a necessary intermediate in the formation of ET and the peptide segment 
after the C-terminus of big-El-i in preproEl was not necessary for the synthesis of ET -
1 or big-El-1. 
Additionally it was shown that different preproETs mutated (4 mutants) at the Trp-Val 
site (Trp-21 was replaced with Phe and Tyr and Val-22 by Asp and the most conserved 
residue in all ET related sarafotoxins Ile-20 with Ala) are processed into their 
corresponding mature 21 amino acid peptides, indicating the absence of a strict 
sequence specificity. Recently it was shown that amino acids 91-212 were not 
necessary for the synthesis and secretion of big-ET-1 and ET-1 by using Stop9i 
mutant. 
134  The exact site of the conversion of big-ET to ET in the presence of ECE is 
still not known as big-ET and ET have been found in the supernatant of endothelial cells 
and in the plasma. 
135 
4.1.4 Tissue Distribution of Endothelin 
ET-1 mRNA is widely expressed in rat, porcine, guinea pig, and human tissues. The 
distribution of the propeptide, big-ET and immunoreactive ET-1, has been compared in 
porcine tissues. 
136  The concentration of immunoreactive big-ET was highest in the 
aortic intima and lung, while the highest concentration of immunoreactive ET-1 was 
found in the kidney inner medulla. The broad range of binding sites indicates that ET 
may function in the regulation of a variety of organ systems. In addition to endothelial 
cells, from which endothelin obviously derives it name, ET-1 is produced by mesangial, 
kidney, and epithelial cells and also by various human cancer cell lines and human 
macrophages. 
131  ET gene transcription occurs in a variety of functional regions in the 
human brain, especially the hypothalamus. Evidence for transcription and expression of 
the ET-3 gene in the human placenta and the ET-2 gene in human tumour cells has only 
recently been reported. 
137 
4.1.5 Physiological and Pathological roles of Endothelin 
The ET's elicit a long lasting vasoconstriction in almost all arteries and veins. 
138 
Numerous reports have described the effects of ET on the cardiovascular system in vitro 
and in vivo. Some of these actions are summarised in Table 4.1 and have been reviewed 
recently. 
139  There have been several reports describing the initial transient but potent 
vasodilatation of ET that appears to be selective for certainarterial
140  
arterial beds. Intravenous 
infusions of ET-1 to humans (1, 2.5 and 5.0 ngfkg per mm) caused increases in mean 
blood pressure and serum potassium concentration. 
141 
70 
The many potent effects of the ET's on the cardiovascular system have implicated this 
peptide class in a variety of human diseases (Table 4.2). There have been several 
reports implicating ET in the pathogenesis of congestive heart failure and myocardial 
ischaemia. 
142-143 
Table 4.1 : Biological Actions of Endotheirn 
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Tissue/Organ 	Effect 
Vascular 	 long-lived constriction of isolated vascular muscle 
smooth muscle 	mitogenic actions in cultured smooth muscle cells 
release of endothelium-derived relaxing factor 
coronary arterial vasoconstriction, increased perfusion pressure 
Nonvascular 	constriction of intestinal, tracheal and uterine smooth muscle 
smooth muscle 
Heart 	 increased contractility 
increased heart rate 
stimulation of ANP release 
Nervous tissue 	enhanced neurotransmitter release 
Kidney 	 inhibition of renin release 
decrease in renal blood flow 
decrease in glomerular filtration rate 
urinary Na+  and  K+  excretion 
Adrenal glands 	stimulation of aldosterone biosynthesis 
release of catecholamines 
71 
Table 4.2 : Possible physiological roles and beneficial actions ofET 131 
Cardiovascular diseases 	myocardial ischaemia 




Bronchoconstriction 	 pulmonary hypertension 
asthma 
Neuronal action 	 cerebral vasospasm 
subaracimoid haemorrhage 
Renal disease 	 acute/chronic renal failure 
Gastric mucosal damage 	gastrointestinal disorders 
Vascular disorders 	 artheosclerosis 
complications in diabetes 
complicated vascular disorders 
Cancer 	 pulmonary cancer 
carcinoma cancer 
Other 	 endotoxic shock 
septicaemia 
Beneficial actions 	 physiological regulation of blood pressure 
neuroendocrine regulation 
closure of umbilical vessels 
wound healing 
control of menstruation 
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4.1.6 Receptor Studies of Endothelin 
ET has multiple specific binding sites on various kinds of cell membranes including 
smooth muscle, epithelial and endothelial cells. 
144-146 
 Two ET receptor subtypes, 
termed ETA and ETB, were first identified, cloned and expressed from bovine and rat 
lung respectively. 
147-149
Both are G-protein coupled and belong to the rhodopsin 
family, with seven transmembrane domains. One, isolated from bovine lung, highly 
specific for ET-1 and ET-2 is located in the periphery and CNS, and has been suggested 
to be the vascular smooth muscle type. 
148 
 The proposed nomenclature, based on the 
relative affinity of the agonists for the receptors, has termed this receptor as the ET A 
type. The other is a "nonselective" subtype that binds ET-1, ET-2 and ET-3 with 
similar affinity 
149-150and 
 has been termed the ET B receptor. 
There is some evidence for an ET-3 specific receptor subtype that is located primarily in 
brain and in endothelial cells. 
151  Recently, an ET-3 specific receptor, named ET C was 
cloned and characterised from Xenopus laevis dermal melanophores. 152 It is not known 
whether this receptor subtype is present in mammalian species. 
Recently ET receptors have been cloned and expressed from a variety of human 
128,132,136 
tissues. 	The bovine ETA receptor consists of 427 amino acid residues and is 
highly specific to ET- 1. The rat and human ET B receptors consist of 441 and 442 amino 
acid residues respectively and show equal affinity towards ET-1, ET-2 and ET-3. The 
ETB receptor was first found on endothelial cells and it has been identified in many 
types of tissues including brain, vascular smooth muscle, lung, kidney and heart. 
151-153 
It was first thought that the ET B receptor was associated with vasodilator activity 
149 
partially due to the release of the EDRF. However, numerous recent reports have shown 
that ETB receptor also mediates vasoconstriction in certain tissues and species. 
154-155 




The distribution of ET receptor subtypes in human tissues is of importance due to the 
species differences that are emerging and for the design of relevant receptor antagonists. 
The literature to date on this subject is summarised in Table 4.3. 
158 
There are many studies ongoing in a variety of animal tissues attempting to elucidate the 
existence and distribution of ET receptor subtypes. Comparison of the receptor 
affinities of various ET's and SRTX's in rat aorta and atria (ET A) or cerebellum and 
hippocampus (ETB) indicates that SRTX-6c is a selective agonists for the 
cerebellumlhippocampus receptors. 159 A further study indicated that this ligand exerted 
only vasodialation in the rat aortic ring, possibly through the release of EDRF from the 
endothelium. 
160 
Other selective ET B ligands, for example, the linear analogue ET[1,3,1 1,15-Ala] and 
truncated analogous ET[6-21, 11,15-Ala], ET[8-21, 11,15-Ala] and N-acetyl-ET[10-21], 
have been reported to cause vasorelaxation in isolated, endothelium-intact porcine 
pulmonary arteries. 
161  Some of these analogues, ET[1,3,1 1,15-Ala] and ET[8-21, 
11,15-Ala], are potent ET B agonists causing vasoconstriction in the rabbit pulmonary 
artery. 
162  The present evidence available indicates that the physiological response 
mediated by the ETB receptor in certain tissue beds cannot be sorely described by 
vasodialation. Indeed it appears that vascular smooth muscle can possess an ET B-like or 
nonselective receptor subtype. It will be important to determine the relevance of these 
reports to the distribution of receptor subtypes in the human. The use of specific 
antibodies to the ETA and ETB receptors should enable useful receptor localisation 
studies to be performed. 
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Table 4.3 : Distribution of ET receptor subtypes in human tissues 
158 
Tissue 	 Predominant subtype 
Placenta ETB 
Umbilical vessels ETA 
Renal cortex, medulla ETB > ETA 
Parathyroid gland ETA, ETB 
Myometrium ETA 
Bronchus ETA , ETB 
Pulmonary artery ETA 
Skin ETA  >ETB 
Giraldi heart cells ETB 
Liver ET8 > ETA 
Myocardium ETA , ETB 
Atrioventricular conducting system ETA , ETB 
Coronary artery ETA , ETB 
Ulterus ETA 
Hippocampus ETB 
Brain (cortex, cerebelium, brain stem, ETA, ETB 
basal ganglia, hypothalmus) 
Spinal cord ETB 
Kidney ETB > ETA 
Adrenal ETB > ETA 
Atria, Aorta ETA > ETB 
Lung ETA > ETB 
Stomach ETA > ETB 
75 
4.1.7 Aim of the Study 
Numerous studies have been reported on the pharmacological evaluation of ET 
analogues and fragments. Structure activity relationship studies of ET analogues have 
been reviewed extensively. 
158,163-164 
 After careful consideration of the literature 
reports published on biological and pharmacological evaluation of endothelins, protein 
and peptide research group in our department decided to concentrate on the ET B 
selective analogues. 
So far none of the ET B selective analogues has been found through the structure activity 
relationship studies. In order to find the requirements for the ET B receptor recognition, 
a series of linear analogues of ET-1 have been synthesised and biological activity tested. 
The synthesis of the peptides were carried out by Dr. Lu Jiang in our laboratory. Some 
of the linear endothelin analogues (Figure 4.4) which showed promising biological 
activity are tabulated in Table 4.4. 
Linear endothelin analogues were synthesised by protecting all the cysteines with -CH 2- 
NI1-CO-CH3 group. Methionine is liable to oxidation and it is commonly replaced by 
norleucine or leucine without loss of biological activity. 
165
It can be seen that both the 
norleucine and leucine are well tolerated at position seven since similar biological 
activities were observed for both of the analogues. Therefore methionine at position 
seven was replaced by leucine for all the analogues except UP lB. 
To improve the stability, solubility and the helicity of the analogues, some of the 
cysteine residues were replaced by cx-aminoisobutyric acid. Replacing cysteine at 
814 
position 3 and/or 11 didn 't alter the biological activity. The amino acid residues D , F 
i and C-terminal H 
16_W -W were suggested as important residues n the biological 
assay. 
158  Stereochemistry of these residues were changed to study the importance of 
individual amino acids. Replacing one of the crucial amino acids, histidine, by 
phenylalanine showed completely loss of ET B activity. Truncated analogues were also 
included for biological evaluation. 
To understand the basic structural requirements for biological activity, endothelin-1 was 
subjected to solution structure determination. It is well known that the truncated and 
reduced ET-! analogues didn't produce promising biological activity results. 
Out of 100 of linear ET-1 analogues tested, LW! showed both the highest ET B activity 
and the ETA/ETB selectivity. Most of the linear ET-1 peptides which have alanine at 
position 3 and d-aspartic acid at position 8 show quite low ET B activity and ETA/ETB 
selectivity (Table 4.4). Therefore these two peptides, LIP! and LJP26, along with ET-
1, were selected for solution structure studies. 
Most peptides are normally found in aqueous environments and H 20 would therefore 
seem an obvious choice. However, peptides act at protein surfaces or in membranes, 
which are less polar, and therefore less polar solvents may give a more relevant result. 
Less polar solvents also tend to induce more structure in peptides because of the weak 
character of the solvent for hydrogen bonding. 
Either methanol or TFE is often added to aqueous solutions to induce helix formation, 
the assumption being that the helices seen in such solvent systems are representative of 
the helices formed in their native environment, especially in membranes. 
Most of the linear ET-1 analogues were partially dissolved in H 20 and some of them did 
not dissolve at all, especially with more alanine residues. To alleviate this problem, 
peptide samples were dissolved in methanolI14 20 mixture and minimum amount of 
methanol (50%) was used. 
In this thesis 1 H NMR studies of ET-1 and two endothelin analogues, LJP1 and LJP26, 
are presented and possible 3D structures derived from NOESY data using molecular 
modelling techniques are discussed. 
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Figure 4.4: Sequences of ET-1 and modified linear ET-1 derivatives 
1 	5 	 10 	15 	 20 
I 	 I 
ET-1 CSCSSLMD KECVYFCH LDIIW 
I 
LJP1 CS1SSLL D KE4.VYFCH LDIIW 
LJP1B CS4.SSLLD KESj.VYFCH L D I I W 
LJP1C 4S4SSLL D KE4VYF4H L D I I W 
LJP2 C S A S S L L D KE4VYFCH L D I I W 
LJP2B CSASSLL.  D KEAVYFCH L D I I W 
LJP24 C S A S S L L D KE4.VYFCE'LDIIW 
LJP25 C S A S S L L DdKE4.VYFCFdLDIIW 
LJP26 C S A S S L L Ld KEVYFCH L D I I W 
LJP7-21 j D KEVYFCH L D I I W 
- cc-aminoisobutyric acid; L - norleucine; X" - D amino acid 
All the cysteine side chains are protected by -CH 2-NFI-CO-CH3 group. 
Underlined residues are sites of differences from ET- 1. 
Table 4.4: Biological Activity of Endothelin Peptide Analogues 
Peptide 1C50(j.tM) IC50M) Selectivity EC50QiM) 
ETA ' ETB2 ETAIETB ETB3 
ET-1 0.0002 0.0016 0.13 0.0003 
LJP1 9.1 0.00006 151,667 0.00059 
LJP1B 4.5 0.0009 5,000 0.00048 
LJP1C 0.77 0.0003 2,567 0.0013 
LJP2 6.2 0.0001 62,000 0.00053 
LJP2B 16 0.0007 22,857 0.0021 
LJP24 17 0.56 31 0.48 
LJP25 13 1.8 7 0.54 
LJP26 16 0.002 8,000 0.00032 
LJP7-21 2.8 0.0009 3,111 0.0013 
1 	: Tested in rabbit renal artery vascular smooth muscle cells 
2 : Tested in rat cerebellum 
3 	: Tested in Chinese Hamster ovary cells 
IC50 : Concentration of drug giving 50% displacement of specific binding 
to the receptor 
EC50 Concentration of drug giving 50% of the maximum response 
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Figure 4.5 Fingerprint region of the TOCSY spectrum of ET-1. Each vertical line 
shows the individual spin system. 
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4.2 Results and Discussion 
4.2.1 The Endothelin-1 
4.2.1.1 Interpretation of NMR data of Endothelin-1 
The importance of the biologically active structure of a peptide in determining the 
specific receptor interactions and eliciting its pharmacological properties has made the 
three dimensional structure of the ET's a subject of intense interest. 
The endothelins (Figure 4.1) are a family of bicyclic, 21 amino acid peptides whose first 
member is identified as ET-1. The sequence of 21 (Figure 4.1) residues in ET-1 
includes 8 unique amino acid members, Met-7, Lys-9, Glu-10, Val-12, Tyr-13, Phe-14, 
His-16 and Trp-2 1. The two disulphide bridges which make the bicyclic core at the N-
terminus region are formed at positions 1-15 and 3-11. The proton 1D, DQF COSY, 
TOCSY and NOESY spectra have been acquired for ET-1 and the experimental 
conditions are given elsewhere. The DQF COSY and TOCSY spectra were obtained in 
50:45:5 = CD30H:H20:D20 and all exchangeable and non exchangeable protons give 
signals under these conditions. The fingerprint region of the DQF COSY spectrum 
showed 20 cross peaks for NH/aH connectivities except the N-terminus residue, Cys- 1, 
because of the rapid exchange of the amide proton. 
The TOCSY spectrum is useful guide for the identification of individual spin systems. 
Figure 4.5 shows the NH region of the TOCSY spectrum of ET-1. The high frequency 
region of the TOCSY spectrum clearly showed the complete side chain proton 
connectivities with the NH proton but some missing side chain connectivities for Leu-6 
and Lys-9. The two serine residues, Ser-4 and Ser-5, were clearly identified on the basis 
of their distinctive chemical shift values of the two n—proton resonances in the 
fingerprint region of the TOCSY spectrum. Ser-2 showed only a single peak for P- 
protons. The two isoleucines, Ile-19 and Ile-20 showed complete side chain 
connectivities through the NH proton in the TOCSY spectrum. The unique Lysine, Lys-
9, was identified on the basis of its distinctive aHIcH cross peak in the aH region of the 
TOCSY spectrum. The complete spin patterns for unique Val-12 was observed in the 
DQF COSY and TOCSY spectra. 
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Figure 4.6 :Fingerprint region of the NOES  spectrum of El-i. Complete walk along 
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One of the two leucines, Leu-6 and Leu-17, were clearly identified on the basis of its 
distinctive chemical shifts of methyl resonances appeared in the aH region in the 
TOCSY spectrum. The TOCSY cross peaks corresponding to magnetisation transfer 
from aHIyH through the entire spin system were clearly visible for both unique amino 
acid residues Met-7 and Glu-10. The chemical shift value for ECH 3 of Met-7 was 
obtained from a 1 D proton spectrum. 
Aromatic proton connectivities for Tyr-13 and Trp-2 1 were clearly visible near the 
diagonal in the aromatic region of the TOCSY spectrum. At this stage, the AMX spin 
patterns for the adjacent NH/13H and 3HIj3H cross peaks appeared in the TOCSY and 
the DQF COSY spectra respectively, could not be assigned. These include the two Asp 
residues, four Cys residues and four unique aromatic residues. 
Four unique aromatic amino acid residues, Tyr-13, Phe-14, His-16 and C-terminal end 
Trp-21, were clearly discriminated from the others by the aromatic protons/3H 
resonance connectivities in the NOESY spectrum. Then the individual identification 
and the positions of the residues are determined by direct comparison of the TOCSY 
and NOESY spectra. 
The high frequency region of the NOESY spectrum is specially useful guide for 
sequence specific resonance assignments, secondary structure determination and finally 
for tertiary structure calculation of the polypeptide. Since Lys-9 is an unique residue, it 
is possible to identify Glu-lO thus resolving the Met-7 and Glu-lO ambiguity. Although 
Asp-8 NH/a 
6_





 clear and hence L and D are identified. The unique C-terminal aromatic 
residue Trp-2 1 showed a clear aromatic 411JaH and 4H/PH cross peaks in the NOESY 
18 19
i 
17 18 19 
spectrum. The D -I sequential connectivity s clear and the sequence L -D -I - 
20 21 i 
I -w s then identified. 
Since Val-l2 is unique, it is possible to identify neighbours Cys-il and Tyr-13. Strong 
sequential connectivity between His- 16 and Leu- 17 identify the His- 16 and thence the 







Figure 4.7 : Part of the NOIESY spectrum of ET-1 showing J3 1H/N1+ 1H connectivities 
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F2 (ppm) 
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Although the sequential connectivity between Tyr-13 and the remaining Phe-14 could 
not be observed due to the almost same aH chemical shift values (Table 4.5), Phe-14 
was easily discriminated from the other three aromatic residues which have already 
assigned with the aid of aromatic protons/3H cross peaks in the NOESY spectrum. 
The cross peak from the terminal C 1 aH/S2NH was clearly visible in the NOESY 
spectrum thence the Cys-3 is clearly identified. Strong sequential cross peak between 
Cys-3 to Ser-4 thence Ser-5 complete the entire sequential connectivity of ET-l. The 
complete walk along the backbone sequential connectivities and are shown in Figure 4.6 
and the chemical shift values are given in Table 4.5. 
After completion of sequence specific resonance assignments, the individual resonance 
identifications of particular amino acid residues were confirmed. Almost all the side 
chain spin connectivities through aH were clearly observed in the DQF COSY and 
TOCSY spectra for all the amino acid residues. A broader resonance was observed for 
side chain NH3 of Lys-9 at 7.76-7.79. Although two yH resonances were observed for 
Met-7, only a single 7H resonance was previously reported for methionine in a random 
coil peptides. 
61 
 In contrast, two separate overlapping 3H and yH resonances were 
observed for Glu-10. Two degenerate PH resonances were observed for Cys-1 and Cys-
11. Although two PH resonances were observed for Ser-4 and Ser-5, only a single 
resonance was observed for Ser-2. 
The unique amino acid residue Tyr-13 showed complete spin pattern connectivities in 
the TOCSY spectrum with a single overlapped PH resonance. Although the NOESY 
spectrum showed strong prominent spin patterns from NH resonance to the entire side 
chain for Leu-6 and Lys-9, the TOCSY spectrum showed only few cross peaks, 
NH/PH(s) for Leu-6 and Lys-9. The high reliability of the resonance assignments was 
supported by the dpN(i,i+l) (Figure 4.7) and d(i,i+l) (Figure 4.8) connectivities for 
neighbouring amino acid residues. 
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Figure 4.8 : Part of the NOESY spectrum of ET-1 showing N 1HJN + 1H connectivities 
9.0 	8.8 	8.6 	8.4 	8.2 	8.0 	7.8 	7.6 	7.4 
F2 (ppm) 
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Figure 4.9: Summary of interresidue NOESY connectivities observed for ET-1. 
The thickness of the columns and bars is propotional to the NOE 
intensity 
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4.2.1.2 Secondary Structure Determination 
Once the complete sequential assignment had been completed, the reminder of the 
NOESY spectrum was examined for the evidence of secondary structural details. In 
addition to the neighbouring amino acid connectivities, three long connectivities, 
daN(i,i+3) K9/V 12, V 12/C 15 and Y' 31H 16 (Figure 4.6) and one medium range dN(i,i+2) 
S5/ivi7  (Figure 4.7) were observed in the fingerprint region of the NOESY spectrum. 
These dN(i,i+3) cross peaks indicates the possibility of forming a helix between K 9- 
16 9 12 H . The observation of a cross peak K N indicates that the helical structure in this 
3 	11 
segment of the peptide encompasses the disulphide bridge between 
High reliability of the formation of the helix was confirmed by the strong d a (i,i+3) 
cross peaks which appeared in the aH region of the NOESY spectrum. Although 
10 	13 	11 14 E /Y and C IF long range daN(i,i+3) cross peaks would not be distinguished 
owing to spectral overlap, dc p (i,i+3) strong cross peaks indicated the formation of an 
a-helix. In addition to the above connectivities, weak duN(i,i+l) and strong d(i,i+1) 
connectivities observed in the segment of K
9 16 -H suggested the existence of an a-helix. 
Figure 4.9 shows the summary of the inter residue NOESY connectivity patterns of 
ET-1. 
4.2.1.3 D20 Exchange Experiment 
The ET-1 sample was dissolved in 1:1 = CD 30D:D20 and the 1D proton spectra were 
acquired soon after the preparation of the sample at 298K. The H-D exchange rate of 
amide protons provide information concerning the hydrogen bonds in the secondary 
structure. Although both the terminal amide protons and some surface protons 
7 9 	12 	13 	14 	15 
disappeared quickly, those of M , K , V , Y , F and C amide protons were still 
clearly observed after 8 minutes. Twenty five minutes later, all the above amide protons 
were still observed except K9 and E10 but completely disappeared after 6hrs. These 
observations support the conclusion that a strongly hydrogen bonded segment exists in 
	
9 	16 
the region between K and H 
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4.2.1.4 Variable Temperature Studies 
The dependence of the chemical shifts of backbone amide protons on temperature was 
measured over the range of 290-313K. A structured state is indicated by the very small 
temperature gradient of D 8 A8/AT = -0.7 ppb/C. Smaller temperature coefficients -1.7 
ppb/C for Y 
13 
 and -3.5 ppb/C for K
9 	16 and H indicate shielding from solvent exchange 
of the amide protons of residues 9-16 and also suggests that these protons may be 
involved in hydrogen bonding. Figure 4.10 shows the amide proton shielding of some 
amino acids of Endothelin- 1. Other NOB connectivities indicating another regular 
5 8 7 8 
structure was observed in the region between S -D . The strong d NN M /D , very weak 
dNN D8/K9 (can be seen at lower thresholds), medium dN S5/M7 and the slow M7 
amide proton exchange could arise from a turn structure in the S 5 -D8. In the remaining 
parts of the ET-1, especially the C-terminal region beyond H 
16 
 showed a series of strong 
31920 	21 	 3 
daN NOEs and higher 	coupling constants for I , I and W . The 7 Hz JNHa 
couplings are probably not very useful due to conformational averaging. 
4.2.1.5 Solution Structure of Endothelin-1 
Notably dissimilar NMR structures have been proposed for ET-1 by different research 
groups and the description of the characteristic features of ET-1 and endothelin-like 
peptides derived from previous NMR results are tabulated in Table 4.6. Despite the 
general similarity of all structures reported for peptides of the endothelin family, 
including ET-3 and sarafotoxin-6b, significant differences include the number of amino 
acid residues involved in the helix, the nature of the helix, the presence or absence of a 
turn at residues 5-8 and the conformation and degree of disorder reported for the C-
terminus. 
Figure 4.11 shows the comparison of documented literature and experimental values of 
NH and ctH chemical shift variations. The experimental shift values of ET-1 lie in 
between the literature listed shift values. 
A full list of structural constraints (NOE, torsional angle, hydrogen bond, disulphide 
linkage) and 
3 
ja coupling constants may be found in Appendix I (pages 177-184). 
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Figure 4.10: Amide proton shielding of some amino acids of Endothelin-1 
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Figure 4.11: Comparison of experimental ET-1 NH and ctH chemical shift 
variations with documented literature 
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Figure 4.12 : Solution structure of ET- 1. Two disulphide bridges are shown 
in ball and stick presentation 
KE 
The results obtained from CD 30H!H20 solution data for ET-1 are in good agreement 
with those published by other research groups. Molecular modelling of ET-1 suggests 
that the disulphide constraints (1-15 and 3-11) are insufficient to restrict the formation 
of helical conformation in the middle of the sequence. It is interesting to see that the 
two disulphide bridges are on one side of the helix, while the other side of the helix 
forms a contiguous area containing most of the biologically active residues. Figure 4.12 
shows one of the calculated structures (see section 4.3.6) of ET-1. Although some 
research groups (Table 4.6) reported that the C-terminal is associated with the bicyclic 
core of the molecule, no indication of this was observed in the present studies. 
14 
The 3D structure through the c -s segment of the polypeptide is ill-defined from the 
NOE and molecular modelling data. The N-terminal portion of the molecule is 
probably in rapid equilibrium among various conformational states. Anderson et al. 174 
have also reported that the C-terminus is not the most mobile portion of the structure but 
motional averaging is in fact more evident in an N-terminal region. 
The slow deuterium exchange of the NH protons of both 1 
19 
 and 1 with higher 
coupling constants confirmed the ordered structure of the C-terminal region. Important 
long-range interactions between the C-terminal part of the molecule and the helix were 
also detected. 	In particular, the V12aH/L17PH, Y13aromatics,lL17CH3  and 
14 	17 
F aromaticsfL CH3 showed intense cross-peaks. This results are in good agreements 
with the recently published solution structure of ET-1 in water 
179 
 in which the C-
terminal of the peptide folds back towards the helical segment. 
It can be seen that the local RMSD values (Table 4.7) for the backbone conformation 
between K9-H 16 show small variations while the N- and C- termini show larger 
variations. Small global RMSD variations were also observed for helical residues. The 
structure within the C-terminus and its orientation to the bicyclic core were completely 
indetermmant in all the studies, including g our studies, except Saudek and 
Bortmann. 181 The present evidence for a helical structure (K 9-H' 6) and a turn at S 5-D8 
was noted in few cases (Table 4.6). 
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The structures obtained for ET-1 are in good agreement with the experimentally derived 
constraints. The structural statistics for the family of structures of ET-1 are given in 
Table 4.8. 
Table 4.5: Chemical shifts of ET-1 obtained in the 50:45:5 = CD30H:H20:D20 
Residue NH ctHI 
aCH3 13CH3 yCH3  
CH2/ 
8CH3 
CH2/ 	Aromatics & Others 
4CH3  
1 	C 4.29 3.29, 3.29 
2 S 8.91 4.69 3.81, 3.81 
3 C 8.15 4.99 2.59, 3.23 
4 S 8.97 4.32 3.87, 3.96 
5 S 7.71 4.55 3.66, 3.96 
6 L 8.68 4.14 1.62, 1.62 1.62 0.85, 0.92 
7 M 8.01 4.44 1.91, 2.17 2.45, 2.61 
8 D 7.43 4.76 2.80, 3.24 
9 K 8.32 3.91 1.57, 1.85 1.48 1.69 2.98 	+NH3 -7.76 - 7.79 
10 E 8.44 4.17 2.15, 2.15 2.48, 2.48 
11C 7.62 4.26 3.18,3.18 
12 V 8.08 3.53 2.04 0.84, 0.99 
13 Y 7.87 4.20 2.96, 2.96 2/6 - 6.80, 3/5 - 6.62 
14F 8.19 4.21 3.13,3.18 2/6-7.30,3/5-7.35 
4H - 7.32 
15 C 8.60 4.60 3.03, 3.27 
16 H 7.97 4.48 3.30, 3.34 2H - 8.57, 4H - 7.28 
17L 7.89 4.23 1.63, 1.63 1.52 0.79, 0.79 
18 D 8.23 4.61 2.70, 2.86 
191 7.68 4.12 1.73 0.75 0.64 
1.03, 1.35 
201 7.84 4.15 1.77 0.79 0.79 
1.07, 1.39 
21 W 8.03 4.65 3.17, 3.29 2H - 7.16,4H - 7.55 
5H -7.03, 6H -7.11 
7H-7.36,NH- 10.14 
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Table 4.6: Summary of the solution conformations of the Endothelin and Endothelin-
like peptides derived from previous NMR studies 
Peptide 	Helical Region N-terminus 	C-terminus 	Solvent 	References 
ET- 1 	undefined 	undefined 
ET-1 K9-C' 5 structured 
ET-1 C"-C' 5 undefined 
opposite handed 
[N1e7]-ET-1 K9-H' 6 S5-D8 
(quasi turn) 
ET- 1 L6-C" undefined 
ET-1 K9-L' 7 S5-D8 
ET-1 K9-C' 5 S5-D8  (13-bend) 
ET-1 K9-C' 5 S5-D8 
ET-1 K9-F' 4/C' 5 
(reverse turn) 
[1,15Aba]- K9-H' 6 S5-D8 (13-turn) 
ET- 1 
ET-1 K9-C' 5 S5-D8 (13-turn) 
ET-1 K9-H'6 S5-K9  (13-turn) 
ET-1 K9-H'6 S5-D 8 (13-turn) 
[A1a7]ET- 1 K9-H'6 S5-D8 (13-turn) 
[A1a8]ET- 1 K9-H'6 S5-A8 (13-turn) 
ET-1 K9-H'6 S5-K9 (13-turn) 
ET-3 	K9-C' 5 	 - 
ET-3 K9-C' 5 13 strand 
opposite handed 
Big-ET-1 K9-C 15 S5-D8 (13-turn) 
Apamin A9-Q' 7 N2-A5 (13-turn) 
Apamin P6-Q 16 N2-A5 
(reverse turn) 
Apamin C3-A51P6 A9-H' 8 
(reverse turn) 
SRTX-6b D8-C' 5 C3-M6  (13-turn) 
SRTX-6b D8-H' 6 C3-M6 (13-turn) 
SRTX-6b K9-Q 17  undefined 
SRTX-6c E9-C' 5 undefined 
associated with d6-DMSO 
bicyclic core 
undefined d6-DMSO 
associated with d6-DMSO/TFE 
bicyclic core 
- d6-DMSO and 
50% CD3CNIH20 
undefined d6-DMSO 
undefined ethylene glycolIH20 
(60:40) with TFA 
undefined 10% d4-AcOHJ H20 
undefined 30% CD3CNIH20 
averaging ethylene glycoIIH20 
(60:40) with TFA 
structured 10% CD3CNIH20 
with 1.5% AcOH 





folds back H20 
towards the helix 
opposed to the H20 
bicyclic core 





































It should be noted that whatever medium is used, the ET-1 molecule seems to adopt 
roughly a similar structure. All the results suggest that the endothelin assumes an 
ordered conformation in solution. 
The crystal structure of ET-l' 9° has been described as having an N-terminal extended - 
strand with a bulge between residues 5 and 7 followed by a hydrogen bonded loop 
between the carbonyl oxygen of residue 7 and the amide proton of residue 11. The 
residues 12-15 of endothelin form an irregular a-helix while C-terminal tail (residues 
16-21) forms an ordered a-helical structure. In addition, the crystal structure of the tail 
portion is neither more flexible nor more disordered than the globular head region 
(residues 1-15). Thus the X-ray and NMR structures do have common features but also 
differ significantly in detail, especially the C-terminal residues (16-21). There is little 
basis for assuming that either the solution structure or the crystal structure would bear a 
close resemblance to that observed in receptor associated conformation. 
Table 4.7: RMSD values obtained from DIANA calculations. 
Three residues were used as a segment length and both termini residues, 
Cys- 1 and Trp-2 1, were not included for calculation. 
Residue Local RMSD/Segment 
Backbone 	Heavy atoms 
Global RMSDIResidue 
Backbone 	Heavy atoms 
1 0.00 0.00 4.39 4.19 
2 0.85 1.63 3.31 3.86 
3 0.83 1.62 1.93 2.48 
4 0.64 1.44 3.26 4.12 
5 0.57 1.38 3.60 4.20 
6 0.56 1.86 3.67 5.50 
7 0.87 2.05 2.05 4.31 
8 0.78 2.66 2.69 4.87 
9 0.60 2.08 1.90 3.21 
10 0.21 1.61 1.64 2.85 
11 0.06 1.21 1.69 2.00 
12 0.02 0.76 1.49 1.81 
13 0.01 0.84 1.10 2.12 
14 0.01 0.86 1.37 2.62 
15 0.01 0.59 1.79 2.09 
16 0.01 0.05 1.80 2.68 
17 0.39 1.21 1.59 1.92 
18 0.82 1.91 1.94 3.38 
19 0.57 1.72 2.60 4.31 
20 0.35 2.34 5.08 5.99 
____ 21 0.00 0.00 8.28 10.01 
Table 4.8 : Structural statistics for the family of structures of ET-1 
Number of DIANA calculated structures 
	
300 
Number of structures obtained from DIANA calculation 
	
15 
Number of selected structures for final calculation 
	
10 
DIANA structures 	FINAL structures 
Number of NOE constraints used 
	
230 131 
Number of NOE violations> 0.2 A ° 25 	 8 




Intra residue constraints 
Sequential constraints 
Medium and long range constraints 
Total NOE constraints 
Hydrogen bond constraints 
Disulphide constraints 
Van der Waal violations 
Torsional angle constraints> S deg 
DIANA 	> 0.2 A° FINAL structures 
Mean SD Mean SD 
0.409 - 0.112 0.043 0.0021 
0.716 0.218 0.073 0.0042 
0.433 0.213 0.055 0.0032 
0.5 19 0.184 0.058 0.0037 
0.340 0.127 0.058 0.0053 
0.423 0.163 0.065 0.0021 
0.286 0.083 0.044 0.0023 
34.60 16.300 
FINAL structures 
Atomic nns differences (A°) 





Backbone (1-21) 2.601 0.453 
Total helical region (9-16) 1.781 0.425 
Helical backbone (9-16) 0.672 0.151 
Helical heavy atoms (9-16) 1.410 0.217 
Total turn (5-8) 1.386 0.322 
Turn backbone (5-8) 1.418 0.245 
N-terminus (1-4) 1.150 0.274 
C-terminus (17-21) 2.953 0.660 
Energy (k cals/ mol) Mean SD 
Bond stretching 7.595 0.451 
Angle bending 65.326 3.751 
Torsional 38.736 3.247 
Out of plane bending 0.673 0.161 
1-4 van der Waals 20.964 0.968 
van der Waals -90.869 5.323 
Total 42.425 8.758 
4.2.1.6 Biological Assay of Endothelin-1 
Characteristic of the ET-1 is the conserved two disulphide bridges and the hydrophobic 
C-terminal amino acid residues, which are considered to be important for the expression 
of its biological activities. 
191 
Kimura et al. 
191 
 reported that the vasoconstrictor activity of ET is considerably 
decreased by the removal of the C-terminal W 21 residue. In the models obtained from 
this study, a biologically active W 21 residue which is located at the end of the C- 
terminal tail is isolated and separated from all the other residues. It is unlikely that the 
removal of W21 causes a considerable conformational change over the molecule leading 
to loss in activity. Therefore rather W 21 itself would be recognised by the receptor(s). 
It is well known 
191,192  that the two disulphide bridges are required for receptor binding 
and vasoconstrictor activity. Synthetic truncated analogues of ET such as porcine ET1- 
15 or ET 16-21 do not show vasoconstrictor activities 
193 
 nor receptor binding 
activities. 
194 These observations suggest that the receptor(s) for ET-1 recognise(s) an 
active conformation consisting both the helical core and the tail region. The results 
obtained from this study did not show the interaction between the core and the tail 
portions in solution. It seems likely that the receptor bound conformation of ET-1 is 
different from that in solution. 
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Figure 4.13 Part of the TOCSY spectrum of UP  showing individual spin systems 
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4.2.2 The UP! 
4.2.2.1 Interpretation of NMR data of UP! 
The sequence of 21 amino acid building blocks in LIP 1 includes 7 unique residues, Lys-
9, Glu-lO, Val-12, Tyr-13, Phe-14, His-16 and Trp-21. The primary structure of UP! is 
shown in Figure 4.1. The proton 1 D, DQF COSY, TOCSY and NOESY spectra were 
acquired (298K) in mixture of aqueous methanol described before. 
Each vertical line in the part of the TOCSY spectrum shown in Figure 4.13 showed all 
the signals of a particular spin system. It was possible to observe TOCSY cross peaks 
corresponding to magnetisation transfer from aH through the complete side chain to cH 
for the unique amino acid residue Lys-9. The cH resonance was clearly assigned on the 
basis of its distinctive chemical shift of 2.93 ppm and the broader resonance for the side 
chain NH3 at 7.71-7.73. 
The unique amino acid Glu-10 was clearly identified in the TOCSY spectrum and two 
yE! resonances and a single resonance for degenerate PH protons were observed. The 
TOCSY spectrum showed complete spin system for the unique Val-12. Four unique 
aromatic amino acid residues, Tyr-13, Phe-14, His-16 and C-terminal Trp-21 could not 
be discriminated individually in the TOCSY spectrum due to other AMX spin patterns. 
One of the three serine residues, later identified as Ser-2, was clearly identified on the 
basis of its distinctive chemical shift values of PH protons. The spin patterns for other 
two serine residues, Ser-4 and Ser-5, were discriminated from the remaining spin 
systems with the aid of the DQF COSY spectrum. Degenerate PH resonances were 
observed for both Ser-4 and Ser-5. 
Three leucine residues, Leu-6, Leu-7 and Leu- 17, were identified on the basis of their 
chemical shifts of 6CH 3 resonances. Two isoleucine residues, Ile-19 and Ile-20, which 
showed complete spin patterns and distinctive methyl resonances were clearly identified 
from other amino acid residues. At this stage, two aspartic acid residues, Asp-8 and 
Asp-18, and two cysteine residues, N-terminal Cys-1 and Cys-15 could not be assigned 
due to complexity of AIvIX spin patterns. 
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Figure 4.14 : Fingerprint region of the NOESY spectrum of LIP 1. Partial walk along 
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The AMX spin systems, aromatics and multiple copies of the same amino acids were 
carefully sorted out using the NOESY spectrum. The four aromatic residues were 
identified using the NOESY connectivities of H's to their aromatic ring protons. The 
individual identification of spin patterns of aromatics were then determined by direct 
comparison of the TOCSY and NOESY spectra. 
The prominent cross peak from the N-terminal C 1 aHIS2NH was clearly visible in the 
NOESY spectrum. The S 2aH/4 3NH cross peak is clear and the Aib-3 spin pattern is 
then identified. Since Lys-9 and Glu-1 0 are an unique residues, it is possible to identify 
the neighbours Asp-8 and Aib- 11 thus resolving the Asp- 18 ambiguity. The unique 
Trp-2 1 showed PH to aromatic proton 4H connectivity confirm the spin patterns of W 21 . 
18 19 i 18_,19_,21_W21   
The cross peak D aHJI NH s clear and the sequence D    is identified. 
Strong backbone connectivity of D 18 confirmed the spin system of L 17. The backbone 
16 17 	 16 
i connectivity of H /L s clear and the above sequence extends back to H 
The backbone connectivity a 1H!N11H is clearly visible for two adjacent leucine 
residues, Leu-6 and Leu-7, and the sequence L 
6 7 8 9 10 
-L -D -K -E 
- 11 
is identified. Two 
adjacent serine residues, Ser-4 and Ser-5, which showed a aH/N 1H backbone 
connectivity extends the above sequence up to the Ser-4. 
The unique Val-12 showed strong backbone connectivity to Tyr-13. The remaining 
aromatic residue Phe- 14 and Cys- 15 were then identified. The sequence-specific 
resonance assignments were completed and all the individual spin systems were then 
identified. The finger print region of the NOESY spectrum is shown in Figure 4.14. 
Although two PH resonances were observed for each of Phe- 14, His-16 and Trp-2 1, 
only a single PH resonance was observed for Tyr- 13. A single 13H resonance was also 
observed for Glu-10, Cys-15 and two serine residues, Ser-4 and Ser-5. The two yH 
resonances were observed for Ile- i 9 and in contrast a single yH resonance was observed 
for Ile-20. All the side chain spin connectivities through ctH were clearly observed in 
the DQF COSY and TOCSY spectra for all the amino acid residues. Although weak 
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Figure 4.15 : Summary of interresidue NOESY coimectivities observed for UP I. 
The thickness of the columns and bars is propotional to the NOE 
intensity. (X = Aib) 
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cross peaks were observed for methyl resonances of isobutyric acids, Aib-3 and Aib- 11, 
in the TOCSY spectrum, strong methyl resonances were appeared in the NOESY 
spectrum. The 1H/N11H and N1HIN11H connectivities of neighbouring amino acid 
residues supported the reliability of the resonance assignments. Figure 4.15 shows the 
summary of the inter residue NOESY connectivity patterns of LW I. 
4.2.2.2 Secondary Structure Details of UP! 
Evidence of the secondary structure was obtained from the long-range connectivities 
observed in the NOESY spectrum. The finger print region of the NOESY spectrum 
	
6 96 10 	8 11 	9 12 
showed clear strong daN(1,1+fl) connectivities for L /K, L /E , D /4) , K /V , and 
12 15 	 5 8 	14 17 








13  could not be discriminated due to overlapping 
cross peaks. The methyl resonances of two isobutyric acid residues, Aib-3 and Aib- 11, 
also showed strong long range connectivities to L 6NH and F 14NH respectively. A weak 
long-range connectivity was observed for methyls of Aib-3 to Leu-7 amide proton. 





The aH region of the NOESY spectrum showed strong da (i,i+3) cross peaks 
confirming the a-helical segment in the middle of the sequence. Among them, S 5/D8 , 
6 9 	7 10 	8 11 	9 12 	10 13 	12 15 
L /K, L /E , D /4) , K AT , E /Y and V IC long-range connectivities are 
clearly indicated the formation of an a-helix. The strong backbone connectivities of the 
d(i,i+ 1) observed in the segment 4)
3 
 IC
15  also confirmed the helical character of LW I. 
The LW! sample was subjected to the H-D exchange experiment and series of 1D 
proton spectra were acquired. The spectrum acquired soon after the preparation of the 
sample showed most of the NH protons except residues 1 to 3. The amide protons of S 4 
and S 5  had clearly disappeared after the 12 minutes. The amide protons of N-terminal 
residues i19  and W21 were still observed even after 25mm. The observation of amide 
protons in the helical region strongly supports the hydrogen bonded segment. 
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Figure 4.16 : H-D exchange profile of the amide protons of UP  as a function of 
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Figure 4.16 shows some of the ID spectra of the H-D exchange experiment. All the 
observed amide protons except L 7 and 
(j)11 
 were exchanged with D 20 after 6hrs and no 
protons were observed after lOhrs. 
4.2.2.3 Solution Structure of LJP1 
The set of 300 starting structures was calculated using DIANA and a set of 19 structures 
was finally obtained (see section 4.3.6). The root mean square deviation of the 
structures on the basis of backbone atoms, calculated as the average of all possible 
pairwise comparisons, was 2.1A. Although the rms deviation of the global 
superimposition is high (2.8A), the level of agreement obtained between structures is 
demonstrated if the LW 1 is considered as consisting of several segments. One of the 
calculated structures of LJP1 is shown in Figure 4.17. A full list of structural 
constraints (NOE, torsional angle, hydrogen bond) and 3 JNHa coupling constants may 
be found in Appendix II (pages 185-193). 
The dominant structural features of LJP1 is a well-defined ct-helix (Figure 4.17). The 
structure calculations reveal a highly ordered conformation in which a helical region 
extending from S 5 to H 16. Relaxed stereo-view of the ten backbone conformations of 
the helical region of LW 1 is shown in Figure 4.18. It is clearly seen that 4) and  w angles 
of residues S
5 _H 16 show fairly good convergence (Table 4.10). On the other hand 4) and 
'i' angles of C-terminal residues are poorly converged. This is why the C-terminal tail 
did not show a defined orientation relative to the core portion. 
The ordered side chain groups adopt a stable conformation as evidenced by numerous 
interresidue NOE constraints observed for this region. Figure 4.19 shows the side chain 
conformations of the helical region of LJP1. Although X1 dihedral angle is well defined 
26 	7 	10 	12 	16 	20 	
i for some residues (S , L , L , E , V , H and I ), especially n the helical region, 
beyond X1 are poorly defined throughout the molecule (data not shown). This is 
because quite a few NOEs involve side chain protons and the side chain prochiral 
groups are not stereospecifically assigned. Similarly, the wide variance in 4) and XV at 
Leu- 17 suggests that this residue acts as a hinge facilitating different orientations of the 
tail with respect to the rest of the molecule. 
105 
5 	16 
Figure 4.18 :Relaxed stereo-view of the backbone of the a-helix in LJPI; S -H 
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Figure 4.17 : Three dimensional solution structure of LJP1 
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The structures obtained for UP I remain within one family of conformations. The 
and X1  values of the averaged ten structures are summarised in Table 4.10. 
The N-terminal tail region is the least well-defined portion of the family of calculated 
solution structures, possibly indicating that it is more conformationally flexible than the 
rest of the molecule. The C-terminal region (residues 17-21) of the calculated structures 
also shows no preferred conformation, as demonstrated by the significant variations of 
the and '.i torsion angles in this region. 
Table 4.9: Chemical shifts of LJP1 obtained in the 50:45:5 = CD30H:H20:D20 








E,CH2/ 	Aromatics & Others 
CH3 
1 	C 4.28 3.00, 3.15 
2 S 8.81 4.49 3.93, 4.06 
3 	4) 8.90 1.50, 1.50 
4 S 8.15 4.09 3.89, 3.89 
5 	S 7.99 4.26 3.99, 3.99 
6 L 7.63 4.22 1.70, 1.73 1.60 0.86, 0.90 
7 L 7.97 4.12 1.73, 1.75, 1.60 0.87, 0.89 
8 D 8.23 4.48 2.85, 2.93 
9 K 7.80 4.07 1.59, 1.94 1.44 1.66 2.93 	+NH3 -7.71 -7.73 
WE 8.11 4.05 2.19, 2.19 2.38, 2.59 
11 4) 8.16 1.55, 1.55 
12 V 7.56 3.72 2.07 0.82, 0.98 
13 Y 7.86 4.21 2.90, 2.90 2/6 - 6.73, 3/5 - 6.61 
14 F 8.23 4.39 3.00, 3.25 2/6 - 7.28, 3/5 - 7.34 
4H - 7.32 
15C 8.11 4.48 3.04,3.04 
16 H 8.10 4.57 3.26, 3.33 2H - 8.58, 4H - 7.27 
17 L 7.87 4.26 1.59, 1.61 1.53 0.80, 0.81 
18 D 8.30 4.63 2.75, 2.91 
191 7.68 4.10 1.71 0.74 0.62 
1.03, 1.36 
201 7.86 4.15 1.76 0.79 0.79 
1.08, 1.39 
21W 8.02 4.64 3.17, 3.28 2H-7.15,4H-7.54 
5H -7.03, 6H -7.10 
7H - 7.35, NH - 10.10 
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Figure 4.19 Sidechain conformations of the helical region of UPI 
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The side chain conformations of the helical region of LJP1 is shown in Figure 4.19. 
The structures obtained for LW 1 are in good agreement with the experimentally derived 
constraints and the structural statistics for the family of structures of LW 1 are given in 
Table 4.11. 
The slow exchange of amide protons of i19  and i20  protons proves the poor accessibility 
of water in the C-terminal region. This suggests the presence of hydrogen bonding 
character which might be responsible for the C-terminal tail. Prior to this work 
however, the effect of disulphide replacements on the solution conformation of the 
resulting peptides relative to that of native El- 1 was largely unknown. 
Table 4.10 : Average Dihedral Angles of Ten Conformations of UP 1 
Residue 	Phi 	Psi 	Chi 1 
CYS1 -14±121 86±35 -33±182 
SER2 66±4 162±9 -48±3 
AIB3 -138±109 55±3 
SER4 -164±27 -55±3 35±181 
SER5 -50±6 -43 ±2 -1± 187 
LEU6 -64±4 -44±2 -57±2 
LEU7 -63±2 -41±4 -55±3 
ASP  -62±2 -45±2 2±161 
LYS9 -56±3 -44±2 -70± 172 
GLU1O -62±3 -54±2 -68±3 
A1B11 -50±2 -49±2 
VAL12 -62±6 -49±3 170±2 
TYR13 -52±5 -51±4 119±116 
PHE14 -71±7 -49±8 -70±99 
CYS15 -37±12 -41±7 -2±161 
HID 16 -57±8 -50±4 -58±6 
LEU17 51±9 33±32 -66±19 
ASP 18 48±23 -52 ±93 18± 137 
ILE19 -58±52 -28±43 -24±66 
ILE2O -72 ±27 -50±68 -59±6 
TRP21 -109±20 7±107 -55±89 
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Table 4.11: Structural statistics for the family of structures ofLJP1 
Number of DIANA calculated structures 
	
300 
Number of structures obtained from DIANA calculation 
	
19 
Number of selected structures for final calculation 
	
10 
DIANA structures 	FINAL structures 
Number of NOE constraints used 
	
278 173 
Number of NOB violations> 0.2 A° 45 	 8 




Intra residue constraints 
Sequential constraints 
Medium and long range constraints 
Total NOB constraints 
Hydrogen bond constraints 
Van der Waal violations 
Torsional angle constraints> 5 deg 
Atomic nns differences (A °) 
Total residues (1-21) 
Backbone (1-21) 
Total helical region (5-16) 
Helical backbone (5-16) 
Helical side chain (5-16) 
Helical heavy atoms (5-16) 
N-terminus (1-4) 
C-terminus (17-21) 
DIANA > 0.2 A° IF1NAL structures 
Mean SD Mean SD 
0.339 0.105 0.041 0.0011 
0.439 0.140 0.037 0.0032 
0.476 0.229 0.032 0.0053 
0.418 0.162 0.021 0.0043 
0.400 0.180 0.029 0.0031 
0.300 0.095 0.021 0.0024 
11.470 6.725 6.657 3.3240 
FINAL structures 















Angle bending 64.689 1.166 
Torsional 34.386 2.180 
Out of plane bending 0.510 0.128 
1-4 van der Waals 23.589 0.753 
van der Waals -98.120 5.113 
Total 34.492 2.974 
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Figure 4.20 Part of the TOCSY spectrum of LJP26 showing individual spin systems 
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4.2.3 The LJP26 
4.2.3.1 Interpretation of NMR data of LJP26 
The amino acid sequence of 21 residue in LJP26 includes 11 unique residues, Ala-3, 
Asp d_8, Lys-9, Glu-10, Aib-1 1, Val-12, Tyr-13, Phe-14, His-16, Asp-18 and Trp-21. 
The differences between LJP1 and LJP26 are third and eighth residues (Figure 4.4). 
The proton 1D, DQF COSY, TOCSY and NOESY spectra were acquired for LJP26. 
The NH region of the TOCSY spectrum (Figure 4.20) shows the resonances of 
individual spin systems. The backbone region showed 19 resonances for NWaH and 2 
extra resonances for side chain protecting groups. No NH/aH cross peak appeared for 
the N-terminal Cys- 1. The magnetisation transfer from NH through the complete side 
chain protons were observed where possible for all amino acid residues in the TOCSY 
spectrum. The three serine residues were clearly identified on the basis of their 
distinctive chemical shifts of two PH resonances in the TOCSY spectrum. 
The unique amino acid residues, Ala-3, Lys-9, Glu-10 and Val-12 were clearly 
identified on the basis of their individual signals that appeared in the TOCSY spectrum. 
The chemical shifts of methyl resonances were used to identify the two isoleucines and 
three leucines. The four aromatic residues, two cysteine residues and two aspartic acid 
residues could not be distinguished due to the similarity of the AMX spin system. 
The DQF COSY spectrum also showed the spin connectivities for all the amino acid 
residues. Discrimination of the aromatic and non-aromatic residues which show the 
same AIVIX spin pattern was assigned by the PH to aromatic proton resonance 
connectivities appeared in the NOESY spectrum. The positions of the residues which 
occur more than once were determined by the direct comparison of the TOCSY and 
NOESY spectra. The unique amino acid residues were used as a starting point for the 
identification of the sequence-specific resonance assignments. The backbone finger 
print region of the NOESY spectrum is shown in Figure 4.21. 
The NOESY spectrum showed cross peaks from the ring hydrogen resonances of Trp-2 1 
to the ctH and 3H allowing the confirmation of unique C-terminal residue. The unique 
residue Val- 12 to Tyr- 13 thence to Phe- 14 backbone connectivities are clear thus 
112 
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distinguishing the remaining aromatic residue His- 16. The backbone connectivities of 
16 17 	17 	18 	18 
H IL , L 
19 
ID and D /1 are also clear and this completes the C-terminal part of the 
sequence His-16 to Trp-21. 
Since Ala-3 is unique it is possible to identify the neighbour Ser-4 and thence Ser-5. 
The backbone connectivity of C 1 /S2 and are clearly visible in the finger print 
region on the NOESY spectrum. This completes the N-terminal part of the sequence 
Cys-1 to Ser-5. 
The unique residue Lys-9 showed connectivities to both neighbouring residues, Asp-8 
and Glu-lO. The backbone connectivities of L 7/D8 and two adjacent leucine residues, 
Leu-6 and Leu-7, were distinguished clearly in the NOESY finger print region. 
Identification of these spin patterns clearly discriminated the remaining cysteine residue, 
Cys- 15, in the finger print region. 
4.2.3.2 Chemical Shift Index 
The Chemical Shift Index technique (CSI)(CS!) 	can be used to obtain the secondary 
structural details using only the chemical shifts. This method is strongly depend on the 
character and nature of the protein secondary structure. Random coil chemical shift 
values and experimental shift values are categorised according to the procedure given 
below and +1, 0 or -1 indices are then grouped. Any grouping of four (not necessarily 
consecutive) or more -Is not interrupted by a +1 is a helix and any grouping of three or 
more +ls not interrupted by a -1 is a n-strand. The first appearance of opposite (+1/-i 
or -1/+I) or two consecutive zero CSIs marks the termination point. Although the 
random coil shifts pertain to chemical shifts in aqueous solution were used in this study, 
residues between D 8-C' 5 clearly show the cc-helical character (Figure 4.23). 
random coil chemical shift value ± 0.1 > experimental value = 	-1 
random coil chemical shift value ± 0.1 <experimental value = 	+1 
random coil chemical shift value ± 0.1 = experimental value => 	0 
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Figure 4.22: Summary of interresidue NOESY connectivities observed for LJP26. 
The thickness of the columns and bars is propotional to the NOE 
intensity. (X = Aib) 
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Figure 4.23: Chemical Shift Indices of aHs of LJP26; X-Aib 
4.2.3.3 Secondary Structure Details of LJP26 
After completing the assignments of sequence-specific resonances, the NOESY 
spectrum was searched for secondary structure correlations. The strong long range 
9 1210 	13 	12 15 
daN(i,i+3) connectivities of K N , E /Y and V IC and a weak connectivity of 
L61K9 was clearly identified in the finger print region of the NOESY spectrum. The 
L7/E
10 , D
8 I " and 1 iP correlations could not be identified due to overlapping cross 
peaks. 
The strong N 1HfN 1 H backbone connectivities between L 6-F' 4 and weak aH/N 1+1 H 
connectivities confirmed the a-helical pattern between L 6 and C' 5 . The C-terminal 
1720 
amino acid residues L -I also showed strong NI-IIN +,H backbone connectivities. 
9 




 K N 
12 
 and 
V 12 /C11 
 appeared in the aH 
region of the NOESY spectrum also confirmed the a-helical structure. Figure 4.22 
shows the summary of the interresidue NOESY connectivity patterns of LJP26. 
The H-D exchange experiment was carried out and a series of 1D proton spectra were 
15 
collected. The amide protons C -S were exchanged soon after the preparation of the 




fH . The C-terminal residues i - w21  also showed slowly 
exchanging amide protons and completely disappeared after 30min except I' (50mm). 
All the protons were disappeared completely after 8hrs. 
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Figure 4.24 : NB Region of the 1D spectra of LJP26 acquired at different temperatures 
8.8 8.7 8.6 8.5 8.4 8.3 8.2 8.1 8.0 7.9 7.8 7.7 7.6 7.5 	ppm 
117 
Variable temperature studies of amide protons were also confirmed the shielding 
protons. Small temperature coefficients were observed for amino acid residues in the 
helical region from K
9 	16 
to H except 
V12. 
In addition, NH of 1 19  also showed shielding 
properties. Figure 4.24 shows some of the 1D spectra of the NH region at different 
temperatures. 
Table 4.12: Chemical Shifts of LJP26 obtained in the 50:45:5 = CD30H:H20:D20 
Residue NH aFT] PH/ yHI 8CH2/ CH2/ 	Aromatics & Others 
aCH3  PCH3 yCH3 6CH3 CH3 
1 	C 4.29 3.16, 2.99 
2 S 8.73 4.53 3.89, 3.96 
3 A 8.64 4.29 1.40 
4 S 8.24 4.34 3.84, 3.91 
5 	S 8.17 4.40 3.92, 4.03 
6 L 8.14 4.18 1.67, 1.67 1.65 0.86, 0.91 
7 L 7.93 4.09 1.65, 1.65 1.59 0.87, 0.91 
8 D  8.36 4.37 2.72, 3.09 
9 K 8.04 4.03 1.58, 1.90 1.44 1.65 2.92 	- 7.66 - 7.69 
10E 8.21 4.04 2.17,2.19 2.37,2.58 
11 4 8.13 1.53, 1.53 
12 V 7.53 3.70 2.06 0.80, 0.94 
13 Y 7.92 4.21 2.89, 2.89 2/6 - 6.72, 3/5 - 6.61 
14F 8.19 4.39 2.99,3.25 2/6-7.31,3/5-7.34 
4H-7.33 
15 C 8.12 4.48 3.04, 3.04 
16H 8.11 4.57 3.25,3.32 2H-8.57,4H-7.32 
17 L 7.87 4.26 1.60, 1.60 1.53 	0.80, 0.80 
18 D 8.30 4.63 2.73, 2.89 
191 7.69 4.09 1.71 0.74 	0.61 
1.02, 1.36 
201 7.85 4.14 1.75 0.79 	0.78 
1.07, 1.37 
21 W 7.97 4.63 3.16, 3.27 2H -7.15, 4H - 7.54 
5H - 7.03,6H - 7.10 
7H-7.35,NH- 10.08 
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Figure 4.25 Three dimensional solution structure of LJP26 
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Fizure 4.26Backbone conformations of ten structurec of TJP26 
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4.2.3.4 Solution Structure of LJP26 
The differences of amino acids between LW! and LJP26 are positions 3 and 8; LJP1 
(Aib and Asp) and LJP26 (Ala and d-Asp). Replacement of the third residue Aib—*Ala 
makes the significant change to the biological activity and the formation of the helix 
which starts from the residue at 8 position. This is probably due to the loosening 
behaviour of Aib which induces the helical character in peptides and proteins and also 
the D-configuration of the aspartic acid at 8 position. 
However a few interresidue NOESY connectivities were observed for L 6 and L7, and 
structure calculations showed residue 8 as the starting point of the helical region. A 
right handed helix in the region D 8-H' 6 is a consistent feature of the obtained 
conformers. Figure 4.25 shows one of the conformations of LJP26. It can be seen that 
the backbone conformation between residues 8-16 is almost identical while the N- and 
C- termini show larger variations. Under these experimental conditions, that the region 
8 	16  from D -H has essentially the same structure in all contributing conformers. The 
complete backbones for ten final conformations are shown in Figure 4.26. A full list of 
structural constraints (NOE, torsional angle, hydrogen bond) and 3NHa  coupling 
constants may be found in Appendix III (pages 194-20!). 
The N-terminus (residues 1-6) appears to undergo conformational averaging and no 
single structure consistent with the NMR constraints could be found in this region. The 
poor fit outside the helical region suggests that some form of conformational averaging 
or structural randomisation applies. Summary of 4 and  w angles for the ten 
conformations of LJP26 are given in Figure 4.27. 
It should be noted that the high level of structure definition was obtained without 
prochirality assignments for CH 2 and CH3 units. This may be due to small size of the 
peptide and at least five NOE constraints per residue were used for the structure 
calculations. If stereochemical assignments had been introduced, final conformations 
may have been further refined especially the details of side chain conformations. 
The structures obtained for LJP26 are in good agreement with the experimentally 
derived constraints and the structural statistics for the family of structures of LJP26 are 
given in Table 4.13. 
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Figure 4.27: Summary of 4) and  'i  angles for the fiani ten conformations. Good 
convergence is observed for both 4) and  w angles in the helical region D 8 - C' 5 
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Table 4.13 Structural statistics for the family of structures of LJP26 
Number of DIANA calculated structures 
	
300 
Number of structures obtained from DIANA calculation 
	
10 
Number of selected structures for final calculation 
	
10 
DIANA structures FINAL structures 
Number of NOE constraints used 245 155 
Number of NOB violations > 0.2 A° 34 11 
Violations of NOB constraints > 0.5 A° 14 4 
DIANA > 0.2 A° FINAL structures 
Constraint violations Mean SD Mean SD 
Intra residue constraints 0.463 0.266 0.031 0.0021 
Sequential constraints 0.503 0.227 0.042 0.0032 
Medium and long range constraints 0.488 0.234 0.032 0.0053 
Total NOE constraints 0.486 0.233 0.021 0.0040 
Hydrogen bond constraints 0.323 0.032 0.019 0.0021 
Van der Waal violations 0.414 0.177 0.035 0.0024 
Torsional angle constraints> 5 deg 6.660 1.725 7.557 3.2540 
FINAL structures 
Atomic rms differences (A°) Mean SD 
Total residues (1-21) 3.612 0.447 
Backbone (1-21) 2.475 0.377 
Total helical region (8-16) 1.622 0.424 
Helical backbone (8-16) 0.762 0.394 
Helical heavy atoms (8-16) 1.399 0.378 
N-terminus (1-4) 3.249 0.528 
C-terminus (17-21) 3.804 0.756 
Energy (k cals/ mol) Mean SD 
Bond stretching 8.942 0.501 
Angle bending 82.754 14.075 
Torsional 38.752 2.536 
Out of plane bending 0.700 0.276 
1-4 van der Waals 25.037 2.062 
van der Waals -95.853 5.930 
Total 60.333 13.392 
1 23 L. 
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4.2.3.5 Back-Calculated Spectra of LJP26 
The level of similarity between the experimental and calculated NOESY data were 
determined by visual inspection. Almost all the experimental and calculated NOESY 
data were similar in appearance and intensity except for strong intensity of cross-peaks 





 NH, is missing in the calculated data. These is probably due to the 
parameters related to the motional behaviour of the both termini residues specially in the 
N-terminal region. 
In addition, the calculated NOESY data showed some of the cross-peaks which didn't 
appear in the experimental NOESY data (Figure 4.28). The 2H proton of aromatic 
amino acid His-16 showed NOESY connectivities to aH proton of itself and aH proton 
of Leu-17. Although a very weak cross-peak observed for Y 13aHIH 16NH in the 
experimental NOESY data, calculated NOESY data showed a quite prominent cross-
peak confirming the termination point of cc-helix at position 16. Long range correlation 
of D8aH/V 12NH was also observed as a additional cross-peak in the calculated data. 
Although the cross-peak C 15cxH/L 17NH didn't appear in the experimental NOESY data, 
a strong clear cross-peak was observed in the calculated data. Calculated structures of 
LJP26 showed the 2.5-3.5A distance between C 15aH and L' 7NH suggesting that the cc-
helix may probably a extended helix. Some of the documented literature (Table 4.6) of 
endothelin and endothelin-like peptides also showed that the termination of the helix at 
position 17 of the peptide sequence. 
If the back-calculated NOESY spectra and the experimental spectra match well, it is 
possible to conclude that the structure not only satisfies the proton-proton distance 
constraints but is also consistent with the entire proton relaxation network that generates 
the time-dependant NOESY spectrum. 
The overall match between the experimental NOESY data and the back-calculated 
NOESY data is quite good. In particular, the calculated spectrum produced both the 
strong and weak cross-peaks observed in the experimental data. This also confirmed 
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that the NOESY peak assignments and distance constraints measurements had been 
carried out as accurately as possible with the data. It may therefore be concluded that 
the LJP26 structure has been determined as precisely as possible with the NOESY 
distance data and the structure must be close to the actual solution structure. 
4.2.4 Differences of NMR data of ET-1, UP! and LJP26 
Although chemical shifts of NHs between residues L
6 
_C
15 for ET-1 and modified 
analogues are remarkably different (M = 0.05ppm) except Y 13 and F 14, the chemical 
shifts of C-terminal residues, 
L17_W21  ,  are almost same. This clearly indicates the 
characteristics of cyclic and linear features of ET-1 and modified analogues. The 
chemical shifts of NHs of LJP1 and LJP26 are also different (Áö> 0.Olppm) between 
residues 3-10 and remaining shifts of NHs lie between A8 ± 0.05ppm. 
Quite remarkable differences in chemical shifts are also observed for aH of S 4, S5 and 
D8 of UP  and LJP26. A single 13H resonance was observed for both S 4 and S 5 in LJP1 
but well separated signals were observed for LJP26. The Asp-8 PH resonances of 
LJP26 showed a significant chemical shift differences (6 = 0.37ppm) indicating the D-
configuration character of the residue. Significant ctH and PH chemical shift 
differences of S 
4 
 and S 5 residues of LJP1 and LJP26 are indeed due to the variation of 
the amino acid at position 3. 
Although the weak N 1HfN +2H cross-peaks 4) 3/S5 , L6/D8, K9!' 1 , E10 N 12 and V12  /F 14  
were observed for UPI, LJP26 showed only E 101V' 2 and V' 2/F' 4 weak cross-peaks. 
The cross peaks of S 5aH/D 8NH (weak), L6aH/K9NH (medium), L7aH/E 10NH (strong), 
D8aH/'NH (weak), S 5aHfD8 H (medium) and D 8aW 11 CH3 (strong) confirmed the 
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helical character of the UP  between S -D which is not the case for LJP26. 
In general, N-terminus is the least structured region of all the peptides and the length of 
ct-helix changes with the behaviour of the individual amino acids. The C-terminus 
shows the ordered structure in all cases while ET-1 shows some additional long-range 
interactions between the helix and the C-terminus. 
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4.3 Materials and Methods 
4.3.1 Sample Preparation and NMR Experiments of ET-1 and its Derivatives 
The ET-1 and modified linear ET-1 derivatives were supplied by the peptide synthesis 
group in our department. Identification of ET-1 was done by comparing with an 
authentic sample obtained from Parke Davis Pharmaceutical Ltd. All NMR 
experiments were performed using 5mm proton (inverse) probe on a Varian VXR 600S 
spectrometer operating at 599.945 MHz for proton. The peptide samples were stored at 
280K between experiments. The 1 H NMR signal from CD30H was used as an internal 
reference and defined as 3.30 ppm. The CD 30H present in the sample provided the 
lock signal for the NMR spectrometer lock channel. The spectrometer was controlled 
with a Sun 4/110 host computer using the VNMR system software version 4.1. The 
white solid peptide samples (5mg), ET-1, LJP1 and LJP26 were dissolved separately in 
50:45:5 = CD30H:H20:D20 in 5mm diameter Wilmad 528PP NMR tubes except for 
amide proton exchange studies. The peptide samples dissolved in 1:1 = CD 30D:D20 
were used for amide proton exchange studies. All the NMR experiments were 
performed on the sample at pH 3.6 and 298K except for variable temperature studies. 
Sample temperature was controlled using the spectrometer variable temperature control 
units. General methods for data acquisition and manipulation were optimised for all 
peptide samples. 
Single pulse proton NMR spectra were recorded using the pulse sequence shown in 
Figure 2.4. A saturation delay 1.5s was used with zero saturation power. 256 
Transients were acquired over a 7KHz spectral width and 35K data points were 
collected. The data were zero filled to 65536 data points and was multiplied by an 
optimised shifted sinebell squared function prior to Fourier transformation. After 
Fourier transformation the final spectra were drift and baseline corrected. 
The 2D phase-sensitive DQF COSY spectra were obtained using the pulse sequence 
shown in Figure 2.4. An eight step phase cycle (hypercomplex acquisition) was used 
with a relaxation delay D1=1.5s and acquisition time AQ=0.146s. 32 Scans were 
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performed for each t 1 value and 512 FIDs were acquired. Other parameters were 
SW=7KHz; 2048 data points and 64 dummy scans. Prior to Fourier transformation, the 
data set was zero filled to 1024 data points only in F 1 dimension and was multiplied by 
shifted sinebell squared function in both dimensions. Phase constants were introduced 
after the Fourier transformation and the negative and positive levels were incorporated 
into contour plots of the resulting data. 
The 2D phase-sensitive TOCSY spectra were obtained using the pulse sequence shown 
in Figure 2.4. An eight step phase cycle (hypercomplex acquisition) was used with a 
relaxation delay Dl =1. 5s and acquisition time AQ=0. 1 46s. The MLEV- 17 spin-lock 
pulse was used with a 80ms mixing time cycle and two trim pulses of 2ms each. 16 
Transients were performed for each t1 value and 512 FIDs were acquired. Other 
parameters were SW=7K1-Iz and 2048 data points. The data set was zero filled to 1024 
data points only in F 1 dimension. Prior to Fourier transformation the data set was 
multiplied by an optimised shifted sinebell squared function in both dimensions. Phase 
corrections were done in both dimensions after the Fourier transformation. Final 
spectrum was baseline was corrected. 
The 2D phase-sensitive NOESY spectra were obtained using the pulse sequence shown 
in Figure 2.4. 32 Scans were performed for each t1 value and 512 FIDs were acquired. 
An eight step phase cycle was used with a relaxation delay Dl=1.5s and the acquisition 
time AQ=0. 146s. Other acquisition parameters were SW=7KHz, 2048 data points and 
64 dummy scans. Water signal was saturated during preparation and mixing periods 
with saturation power —0 dB. Fourier transformation in F 2 was carried out without zero 
filling whereas data points in F 1 were zero filled to 1024 data points prior to Fourier 
transformation. The data were apodized in both dimensions using a shifted sinebell 
squared window function prior to Fourier transformation. The real Fourier 
transformation was carried out on 1024x2048 data points. Phase corrections were 
applied in both dimensions and baseline was corrected only in F 2 dimension. To 
evaluate the effects of spin diffusion, the LJP26 NOESY data sets at mixing times 40, 
80, 150, 200 and 300ms were acquired consecutively without removing the sample from 
the magnet. Most of the NOEs were however clearly detectable at mixing time of 
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lSOms or higher. Hence the ET-1 and LJP1 NOESY data were acquired only with 
150ms mixing time. All the 2D spectra were acquired on a non-spinning sample. 
4.3.2 Variable Temperature Experiments 
Variable temperature studies of the peptide samples were carried out using standard ID 
proton NMR pulse sequence and 1mg of the peptide sample was used. The peptide 
sample was allowed to equilibrate for 10- 1 5min in the magnet and Z 1 and Z2 shim coils 
were readjusted to establish maximum field homogeneity. At each temperature, the 
transmitter offset frequency was adjusted to coincide with the alteration of the resonance 
frequency of the HOD protons. Spectra were recorded at four degree intervals from 
290-298K and five degree intervals from 298-318K continuously. A relaxation delay 
D1=1 .5s and zero saturation power were used to eliminate the residual HOD solvent 
resonance. The data were acquired into 35K data points and zero filled to 65K. Other 
parameters were SW=7KHz, 256 scans and acquisition time AQ=2.5s. Prior to Fourier 
transformation, the data set was multified by an optimised shifted sinebell squared 
function. 
4.3.3 Amide Proton Exchange Experiments 
Amide proton exchange experiments were carried out using 1mg of the peptide sample 
and standard ID proton NMR spectra were acquired. The NMR tube only with the 
mixed solvent alone was allowed to settle in the magnet and all shim coils were adjusted 
to gain the field homogeneity from the solvent. The peptide sample was then added to 
the solvent tube and only Z 1 and Z2 shim coils were readjusted to establish the 
maximum field homogeneity. A relaxation delay Dl=1 .Ss and saturation power —0 dB 
were used only during preparation period to eliminate the residual HOD solvent 
resonance. 64 Transients were acquired over a 7KHz spectral width and 35K data 
points were collected. The data were zero filled to 65K and was multified by a shifted 
sinebell squared function prior to Fourier transformation. Spectra were recorded at 
5min intervals (15-20mm), 10min intervals (20-50mm), 15min intervals (50-80mm), 
30min intervals (80-140mm), lhr intervals (140-260mm) and 2hr intervals (260-
740min) consecutively 2mm (adjustment of Z 1 and Z shim coils) after the submission 
of the sample into the magnet. 
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4.3.4 NOESY Peak Calibrations 
To evaluate the effects of spin diffusion, the build-up of NOESY cross-peak intensity 
was studied by acquiring NOESY spectra with mixing times 40, 80, 150, 200 and 
300ms for LJP26. The NOESY cross peaks D8aHIK9NH, 4)' 1NH/V' 2NH and 
V 12aH/C 15 H which were sufficiently well-resolved from all other peaks were used to 
measure the cross peak intensities. The height at the centre of the cross peak was 
measured in different NOESY spectra and the peak heights were plotted against the 
mixing time. A smooth curve was drawn through the points in the intensity vs mixing 
time graph. The build-up of NOESY cross peak intensity was assumed to be linear up 
to 1 5Oms and the data sets acquired with 1 5Oms were used for structure calculations. 
The ET-1 and UP  NOESY data were only acquired with 150ms mixing time. 
NOESY data which were normally deposited inthe NMR data station were transferred 
to the Silicon Graphics work station through the ethernet. The data sets were processed 
using the same recipes as data were manipulated for structure determination. 2D 
NOESY spectrum was calibrated to the CH 30H internal reference peak (3.3ppm) and 
the 2D contour plot was stored for further studies. 
One side of the diagonal of the 2D contour plot was used for picking of NOESY cross 
peaks. The threshold value of the contour plot was set to zero and only the positive 
cross peaks which were not extensively overlapped were picked manually. Physical 
characteristics, the peak number, peak position (F 2, F 1 ), peak height and half height, 
intensity and volume integrals, were obtained in a table for the manually picked cross 
peaks. The assignments of the NOESY connectivity details of cross peaks were then 
added to the table. 
The volume integrals and NOESY connectivity assignment columns were then used for 
generating lower and upper distance constraints. Dipolar couplings were classified into 
three categories of upper distance bounds according to their volume integral values 2.5A 
(strong), 33A (medium), and 5.OA (weak). The lower distance bound was in all cases 
set to the van der Waals distance of 1.8A. The threshold values of upper distance 
bounds were established using the known sequential distances of d NN and daN. '96 
Pseudoatoms with appropriate distance corrections were employed for protons which 
could not be stereospecifically assigned. 
197 
130 
4.3.5 Identification of Endothelin-1 
There are three different possibilities of disulphide linkages that may be formed in ET- 1 
synthesis and only a single major product was observed in our synthesis. 
(1) C' - C 3 and C " - C' 5 	(2) C 1 - C" and C3 - C' 5 	(3) C 1 - C 15 and C3 - C 11 
Possibility of linkage (1) neither been observed in literature of ET- 1 synthesis nor in our 
synthesis and the linkage (2) was not observed in the peptide folding conditions used in 
our laboratory. Therefore only ET-1 peptide was obtained and purified. The co-
injection of purified ET-1 with native ET-1, which was obtained from the Parke Davis 
Pharmaceutical research, confirmed the correct disulphide linkage (3) of the synthesised 
peptide. Purified ET-1 peptide was further identified by the amino acid analysis. 165 
Figure 4.29: FIPLC traces; Purification and identification of ET-1 165 










20 	25 	min 
(a) (b) (c) (d) (e) 
Gradient (time, acetonitrile %): 
Flow rate: 1 ml/min, 214nm 
Columns used: (a), (b), and (e) 
(c) 
(d) 
(2,10), (32,90), (34,10) 
Hichrom C18 	220x4.6 mm 
RP C18 	 110x4.6min 
Vydac C18 220x4.6min 
crude peptide mixture 
purified endothelin- 1 
and (d) 	characterisation of endothelin-1 using different HPLC columns 
(e) 	 co-injection of purified endothelin-1 with native endothelin-1 
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4.3.6 Additional Distance Constraints 




were fixed directly in all structure 
calculations by constraining a2.O-2.1/ on the S 1-S distances and 3.0-3.1A on the C-S jjj 
distances across each bridge. The slow amide proton exchange rates were observed 
for some NHs in the helical region of the peptide backbone. These NH protons and 
relevant backbone carbonyls were constrained by introducing hydrogen bonds a range of 
1 .8-2.OA and 2.7-3.OA for the H-O distance and N-O distance respectively. 
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 The 3HNa 
values were obtained from the 1D proton spectra and these coupling constants were 
used to calculate the 4) torsion angle. The 4) torsion angles were then constrained to a 
range of ±30 ° . 
Facilities for calculating macromolecular structures based on NMR data were installed 
in the department during the course of this project. These facilities were based on 
funding provided by the Wellcome Trust on a grant to Dr. J.A. Parkinson and Prof. T. 
Brown. A considerable amount of time was devoted to setting up and optimising the 
software packages. The results presented in this thesis are the first examples of 
complete peptide structures calculated from NMR data in this department. 
4.3.7 Three Dimensional Structure Calculations 
The suitable peptide structures were generated in the following way. 
Construction of the peptide by sequentially adding amino acid building blocks 
Modify stereochemistry of amino acids and addition of protecting groups 
Adding pseudoatoms for -CH2 , -NH2, -CH3 , -NH3 and aromatic groups if necessary 
Introduce random coil conformation 
Energy minimisation until a reasonable lower energy was obtained. 
The Distance Geometry (DG) program DIANA was used to generate structures from 
random starting conformations. All distance and torsional constraints were included in 
DIANA calculations. DIANA was used to calculate 300 structures and the best 
structures were selected on the basis of their final penalty function values. These 
structures were then subjected to further calculations. 
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Output structures were deposited both in angle coordinate files and in PDB/Sybyl MDB 
files. Default constraint cut-off values were used to obtain the calculation results; upper 
and lower limit 0.2A, van der Waals cut-off 0.2A and angle constraint cut-off 50 
Maximal hydrogen bond length 2.4A and hydrogen bond angle 35° were used as cut-off 
values for reporting hydrogen bonds. RMSD comparisons were reported for total 
structures except for both termini residues and three residues were counted for reporting 
RMSD segment length. 







ET- 1 Intra residue NOE 131 48 
Sequential NOE 64 48 
Long range and medium range NOE 16 16 
Constraints across the disulphide bridges 6 6 
Hydrogen bond 8 8 
Torsional angle 5 5 
Total 230 131 
LW 1 Intra residue NOE 133 44 
Sequential NOB 71 59 
Long range and medium range NOB 45 45 
Hydrogen bond 8 8 
Torsional angle 17 17 
Total 278 173 
LW 26 Intra residue NOB 122 48 
Sequential NOB 65 49 
Long range and medium range NOB 33 33 
Hydrogen bond 8 8 
Torsional angle 17 17 
Total 245 155 
Constraints used for calculation of DIANA structures 
Output constraints obtained from DIANA calculations. These modified constraints 
were used for further calculations. 
During the DIANA calculation, atomic distances were constrained using the force 
constant kNOE = 4.18 kJ moF 1 K2 and torsions were constrained using kDhd = 0.042 
U mof' deg 2. The DIANA calculation produced 10-20 structures depending on the 
final target function value. 
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Distances which are predetermined by the covalent geometry of the molecule or by no 
possible conformation which will violate the constraint are regarded as irrelevant 
constraints in the DIANA program. These constraints are eliminated during the 
calculation and structurally important constraints are produced as modified constraints. 
Out of 300 structures calculated from DIANA, 10, 15 and 19 structures were obtained as 
best structures on the basis of their penalty function values for LJP26, ET-1 and LJP1 
respectively. Bear in mind to compare all the families of final structures of all peptides, 
ten structures were used for further calculations as this was the maximum number of 
structures obtained form LJP26. 
Therefore ten DIANA structures which showed the least number of violated constraints 
were selected for further calculations. These structures were constrained by the 
modified distance and torsional constraints which were obtained as a output from the 
DIANA calculation. In these structures, atomic distances were constrained using a 
higher force constant using kNoE = 41.8 kJ mol' K2 and torsions were constrained 
using the same force constant kDihed = 0.042 kJ mol' deg 2. Structures were then 
subjected to 200 cycles of energy minimisation. 
The conjugate-gradient optimisation method was used for energy minimisation through 
out the structure calculations. The Tripos 5.2 force field with the standard Sybyl energy 
minimiser MAXIMIN 2 were used in the minimisation program. 
198  Higher starting 
energies were minimised using an atom-by-atom Simplex minimisation. Other 
parameters for constraining covalent geometry were kBofld = 2500 kJ mof' K2, kAngle = 
0.084 kJ mol' deg 2 and kTor = 0.836 kJ mof' deg2.92  Further details of force 
constants are discussed by Clark et al. 
92 
 At this stage interatomic distances and 4 
torsions were constrained by experimental energy terms kNOE = 41.8 kJ mof 1 K 2 and 
kDihed c  = 0.042 kcal mof' deg 2. All other conditions were Tripos MAXIMIN 2 
minimiser defaults. 
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Energy minimised structures were then refined using the dynamical simulated annealing 
(DSA) method adapted by Tripos molecular modelling software. 198  The DSA process 
was begun at the maximum temperature 1000K and the system was held at that 
temperature for 5400fs. During the annealing time 900fs, the temperature was reduced 
until the minimum temperature 100K was reached. The Boltzmann scaling of atomic 
velocities were chosen from a random number seed and the "stepwise" annealing 
method was used during the cooling step. This process completed the first cycle and the 
process was continued for 10 cycles. The conformations obtained by DSA were further 
minimised with 200 energy minimisation cycles. The minimisation parameters are 
same as described before for DIANA calculated structures. 
The energy minimised conformations were subjected to final molecular dynamics (MD) 
quenching calculations without changing both distance and torsional force constants. 
The MD calculations were performed in the gas phase. The initial atomic velocities 
were chosen from a random distribution at 1000K and the dynamic trajectory (lOOfs) 
was followed for 20ps in ifs steps. 
These calculations were carried out under NTV ensemble with the 1 Ofs coupling factor 
for the temperature. The molecular dynamics calculations were repeated 3 times for 
each conformation using different initial values for random number seed (20e3, 60e3 
and 100e3) to obtain 3 different conformers for each starting conformations. These 3 
different conformers were then averaged to obtain the averaged conformation and 10 
averaged conformers were finally obtained. After removing all the distance and 
torsional experimental energy barriers, these averaged conformers were finally 
subjected to 500 cycles of energy minimisation as described before. 
4.3.8 Back Calculation of Spectra 
A model structure of LJP26, the NOESY data (1 5Oms), the individual peak characters 
and the cross-peak assignments were used to generate a theoretical 2D NOESY 
spectrum. Only the fingerprint region of the NOESY spectrum of LJP26 was back 
calculated theoretically using the "corma simulation" program supported by Tripos 
molecular modelling software. 
198 
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Modeifree approach was used to calculate the internal motion using the overall 
correlation time (iOns) and the internal correlation time (ins). Both intra- and inter-
residue methyl distances were calculated according to the 3-site jump model which is 
recommended for a good starting model structure. The Gaussian peak shape 3Hz and 
the NOESY mixing time 150ms were used for simulation. Only the experimental 
intensities and their corresponding calculated intensities from fixed distance atom pairs 
were used for normalisation. 
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CHAPTER 5 
STRUCTURE ELUCIDATION OF A GLYCOSIDE 
5.1 History and Usefulness of Medicinal Plants 
The role of biologically active natural products in the developments of drugs used in the 
modern medicine is unsurpassed even today when synthetic chemistry has developed 
beyond expectations. Early knowledge about the use of plants in the treatment of 
diseases came from close observations and experiences. The gradual accumulation of 
knowledge of therapeutical properties of medicinal plants helped the primitive cultures 
to provide themselves with remedies for their basic medical needs. 
The historical use of plants in the treatment of ailments in different civilisations resulted 
in several organised systems of medicine. The thearapeutical properties of a large 
number of medicinal plants were recognised and documented such as Chinese 
Pharmacopoeia, Materia Medica. This may be considered as the first important stage in 
the development of medical science. At the same time medical system were developed 
in various parts of the world, sometimes almost independent of each other. Thus China 
developed the "Bantu system" and India established the "Ayurveda system". These 
systems are very close to each other and are still in practise. Probably the earliest of all 
recorded medicines was the plant "MaHuang". This plant was first described by the 
Chinese emperor Shen Nung in 2760 B.C. as a remedy for coughs and also as a cardiac 
stimulant. The active principle isolated from it called ephedrine was introduced into 
European medicine in 
199 
 
Earlier chemical research work on plants was limited to the isolation and structure 
elucidation of major crystalline compounds. The minor constituents which were often 
non-crystalline and extremely difficult to handle were rejected or ignored. In recent 
years, chemical investigations are linked with screening for biological activity. It is 
estimated that of 300,000 plant species in the world, only a small portion has been 
investigated phytochemically and less so biologically. 
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5.2 Panax Family Plants 
Tenshen, Radix Ginseng, is the dry root of Panax. ginseng C.A.Mey. (Araliaceae), a 
world-wide well known traditional Chinese medicine with the popular name "ginseng". 
Ginseng was formerly a wild plant growing in the north-eastern region of China. Wild 
Ginseng, the mountain ginseng, is called "Shanshen" in Chinese and should be dried in 
the sun. Nowadays, wild ginseng is rarely available, and almost all the commercially 
available ginseng root is cultivated in the north-eastern district and other regions of the 
China, where the growing conditions for ginseng plant are favourable. Cultivated 
ginseng, the garden ginseng, is called "Yuanshen" in Chinese and should be dried either 
in the sun or after steaming. The steamed root has a caramel colour and is also called 
"red ginseng". 
The wild-growing or cultivated ginseng root, which is collected in the autumn, is 
officially listed in the Chinese Pharmacopoeia and used as a tonic. This has carrot-like 
roots which characteristically contain a number of damarrane saponins. The 
ginsenoside content was found to be higher in the root than in the rhizome. The saponin 
and ginsenoside contents were higher in the wild than in the cultivated ginseng. 
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Studies on saponinlsapogenin components of Panax species have been reported as being 
the chemically, biologically and therapeutically active factors. Being biologically 
active, most of the extensive work had been carried out on P. ginseng. The saponin 
content of ginseng tea showed a total ginsenoside content of 1.1%. 
P. japonicus C.A.Mey., P. japonicus C.A.Mey. var. major (Burk.) C.Y. Wu et K.M. 
Feng, P. japonicus C.A.Mey. var. bipinnatfidus (Seem.) C.Y. Wu et K.M. Feng are 
further Panax species officially listed in the Chinese Pharmacopoeia. Most important 
species found in the Panax genus are Panax ginseng (Korean Ginseng), Panax 
quinquefolium (American Ginseng), P. japonicus (Japanese Ginseng), P. pseudo-














5.1-1 panaxadiol H 
5.1-2 panaxatriol OH 
R1 R2 R3 R4 
5.1-3 	protopanaxadiol OR H OH OR 




Oxepane sapogenin (5.1-5) 
5.1-6 Dammar-20(22)-ene-3f3,1213,26-triol 
5.1-7 20(R)-Dammarane-33,12f3,20,25-tetroI 
5.1-8 Sanchmoside B 1 
HO /\ 









5.3 Panax notoginseng 
Sanqi, Radix notoginseng, consists of the dry roots of Panax notoginseng (Burk.) F.H. 
Chen (Araliaceae), another plant of the genus used in traditional Chinese medicine and 
also officially listed in the Chinese Pharmacopoeia. P. notoginseng is taxonomically 
related to P. ginseng. 
Ginseng saponins may be divided into three groups, depending on their aglycones. 
Ginsenosides Rc, Rg 1 and Ro are representatives of the ginseng root saponins of the 
protopanaxadiol, protopanaxatriol and oleanic acid type, respectively. They are used as 
reference substances for qualitative determination of ginseng root in the Chinese 
Pharmacopoeia. Protopanaxadiol (Fig. 5.1-3) and protopanaxatriol (Fig. 5.1-4) are both 
dammarane derivatives. Ginsenosides Rb 1 , Rg 1 , and notoginsenoside R 1 , are 
representatives of protopanaxadiol and protopanaxatriol types which are used in the 
qualitative determination of notoginseng root and in the differentiation of notoginseng 
root from ginseng root in the Chinese Pharmacopoeia. 
The main constituents in notoginseng are saponins especially of the protopanaxadiol and 
protopanaxatriol types. Thus, a number of ginsenosides such as Rb 1 , Rb2, Rb3 , Rc, Rd, 
Re, Rg 1 , R92, Rh 1 , F2, and glucoginsenoside Rf, have been isolated from the 
underground part or above ground part of P. notoginseng.201203 In addition to the 
ginsenosides, a number of new saponins named notoginsenosides (Tables 5.1 and 5.2) 
have been isolated and structurally investigated. 
In addition to the saponins, sanchinoside B 1 (Fig. 5.1-8), panaxadiol (Fig. 5.1-1), 
panaxatriol (Fig. 5.1-2), two dammarane derivatives (Fig. 5.1-6/7) and 20(R)-
protopanaxatriol have also been detected as sapogenins from the rootlets of Panax 
notoginseng. 204 ' 205 The saponin constituents of the aboveground parts of Panax 
notoginseng, stems and leaves, flowers and buds, and fruits have also been investigated. 
Two sapogenins, dammar-20(22)-ene-33,12,26-triol (Fig. 5.1-6) and 20(R)-
dammarane-3a,12f3,20,25-tetrol (Fig. 5.1-7), were isolated from the leaves of 
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P. notoginseng together with panaxadiol and panaxatriol. 209 A oxepane derivative 
(Figure 5.1-5) was also found in the leaves of notoginseng. 21° Sapogenins isolated from 
notoginseng flowers were identified as panaxadiol (Fig. 5.1-1), two dammarane 
derivatives (Fig. 5.1-6/7) and a another sapogenin with a cyclic ether structural feature. 
Furthermore, the notoginseng root contains a number of commercially valuable 
constituents other than saponins. The major components in the essential oil of the root 
of P. notoginseng have been identified as a-guaiene, -guaiene, and octadecane and in 
that of the flower y-elemene, heptacosane, and pentacosane. Saponins from P. 
notoginseng isolated and identified to date are listed in Tables 5.1 and 5.2. 
In the notoginseng saponins eleven different glycosidic groups which are mono-, di- or 
tn- saccharides, are attached to R 1 - R4 , positions at the aglycone part of the saponin. 
These are -O-glc, -O-glc2- 1 glc, -O-glc6- 1 glc, -O-glu6- 1 glc, -O-xyl 2- 1 glc, -O-xyl 6- 1 glc, - 
O-xyl 2- 1 glc2-' glc, -O-xyl 6- 1 glc6- 1 glc, -0-ara(fur) 6- 1 glc, -0-ara(,yr) 6- 1 glc, and -0-
rha(pyr)2-lglc. All the sugar-sugar ring connectivities which are found at positions 
1 —*2 and I—>6 are common in natural saponins. 
5.4 Pharmacology of Ginseng 
Ginseng was used in traditional Chinese medicine for a long time as a general tonic and 
cardiotonic. Systematic pharmacological investigations revealed a multifaceted 
biological activity of ginseng, including effects on the cardiovascular, immune, and 
nervous systems, and activity as an antidote, antitumor agent, or antitumor adjuvant and 
as antidiabetic. 211 
The medicinal use of notoginseng roots is different from that of ginseng roots. 
Notoginseng roots are used mainly as a hemostatic drug in the treatment of different 
types of bleeding. It should be collected in the autumn before the plants bloom. 
Panax notoginseng showed a wide spectrum of pharmacological activities, such as 
hemostatic activity, platelet aggregation inhibitory activity, antiinflammatory activity, 
and therapeutic effects in cardiac infraction, cardiac ischemia, and angina pectoris. 
141 
Table 5.1 :Protopanaxadiol type saponins isolated from P. notoginseng 201-203,206 
RAO Me 
R 1 C 
[A 
Me Me 
Saponin 	 Rl * 	 R4* 	 Origin 
ginsenoside-Rb 1 -0-glc2 - 1 glc -0-glc6J gic 
ginsenoside-Rb2 -0-glc2- 1 gic -0-ara(yr) 6- 1 glc 
ginsenoside-Rb3 -0-glc2- 1 glc -O-xyl 6- 1 glc 
ginsenoside-R -0-g1c2 - 1 glc -0-ara(für) 6- 1 glc 
ginsenoside-R -0-glc2 - 1 glc -O-glc 
ginsenoside-F2 -O-glc -O-glc 
notoginsenoside-R4 -0-glc2- 1 gic -O-xyl 6- 1 glc6- 1 glc roots 
notoginsenoside-R7 -O-glc H roots 
notoginsenoside-Fa -O-xyl 2 - 1 glc2- 1 gte -0-glc6- 1 glc leaves 
seeds 
notoginsenoside-Fc -O-xyl 2- 1 glc2- 1 gic -O-xyl 6- 1 gic leaves 
seeds 
notoginsenoside-Fe -O-glc -0-ara(fur) 6- 1 glc leaves 
gypenoside-XVII -O-glc -0-glc6- 1 glc roots 
gypenoside-IX -O-glc -O-xyl 6- 1 glc leaves 
seeds 
* - see footnote under the Table 5.2 
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Me Me OR2 
Saponin 	 R2 * 	 R4* 	 Origin 
ginsenoside-Re -0-rha(pyr) 2 - 1 gic -O-glc 
ginsenoside-Rg 1 -O-glc -O-glc 
ginsenoside-R92 -0-rha(pyr) 2- 1 glc H 
ginsenoside-Rh, -O-glc H 
glucoginsenoside-Rf -0-glc2- 1 glc -O-glc 
notoginsenoside-R 1 -O-glc -O-xyl 2- 1 glc 	root 
notoginsenoside-RI -O-xyl 2- 1 glc -O-glc 	 roots 
corm 
notoginsenoside-R2 -O-xyl 2- 1 glc 	 H 	 roots 
notoginsenoside-R3 -O-glc 	 -O-glc6- 1 glc 	roots 
notoginsenoside-R6 -O-glc -0-glu6- 1 glc roots 
* - see footnote below 
gic 	: f-D-glucopyranosyl 
glu 	: cL-D-glucopyranosyl 
xyl 	: -D-xylopyranosy1 
ara(fur) 	: a-L-arabinofuranosyl 
ara(pyr) 	: a-L-arabinopyranosyl 
rha(pyr) 	: a-L-rhamnopyranosyl 
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The saponin fraction of notoginseng given intravenously to dogs decreased blood 
pressure and peripheral vascular resistance. The hypotensive effect of the saponins 
appeared to be due primarily to direct dilation of the blood vessels. Intravenous 
injection of the saponins from notoginseng was also found to be effective in protecting 
rabbits against haemorrhagic shock due to the improvement of heart function. 
All of saponins of P. notoginseng were effective against several experimental 
inflammations in mice and rats. The antiinflammatory effect was stronger in normal 
mice than in adrenalectomized rats. The synthesis of protein and DNA in the liver, 
kidney and testis of mice was also significantly increased by oral treatment of 
notoginseng extract. 
Intraperitoneal injection of ginsenoside-Rd into rats increased adrenal intracellar cAMP 
concentrations. The increase was potentiated by ACTH and was prevented by 
hypophysectomy, suggesting that the ACTH-like effect in ginseng saponin is due to the 
direct effect on the hypophysis. Intraperitoneal injection of the total saponins of P. 
notoginseng showed analgesic activity in mice comparable to that of aminopyrine. The 
appearance of the saponin induced analgesia was faster, but shorter than that of 
morphine. The total saponins also induced a sedative effect and inhibited caffeine 
induced locomotive excitation. 
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 The detail physiological properties of ginsenosides 
are described by Fulder. 
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5.5 Chemical constituents of P. notoginseng 
Numerous studies of Japanese and Korean origin of P. ginseng have been reported by 
some Japanese workers since early 1900s. 
213-215
Although ginseng has been used for a 
long time and may be the best known traditional Chinese medicine, isolation and 
characterisation of the chemical constituents only became successful during the 1960s. 
The major constituents of ginseng are the saponins. The first component of ginseng 
saponins isolated and structurally elucidated was oleanic acid. Then another compound 
named panaxadiol (Fig. 5.1-1) was isolated from the crude ginseng saponin mixture. It 
was supposed to be a sapogenin216 but was later shown to be formed as an artefact 
during hydrolysis. 
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The real sapogenin was then identified as protopanaxadiol (Fig. 5.1-3). The 
stereochemistry of the aglycone part of saponins had been assigned from its chemical 
reactions with the aid of literature. 
217 




 The GCMS data on the tnmethylsilyl ethers of ginsenosides have been 
reported by Bombardelli et. al. 
219 
 and Kasai and co-workers reported the mass spectra 
of pertrimethylated products. 
220-221 
Although isolation and structure determination of a number of saponins from ginseng 
(root, rhizome, leaf, bud) 
220-223 
 have been reported, little work has been concentrated 
on structure elucidation by NMR except for some 13 C NMR studies. The application of 
13C NMR spectroscopy to the structure elucidation of ginseng glycosides have been 
achieved by the aid of shift reagents and deuterated compounds. 
224 
 Tanaka and co- 
workers have reported the 13C NMR data for the aglycone and for the sugar 
moieties. 
222-225 
The assignment of the carbon signals of ginseng saponins 226 as well as the 
glycosylation shifts for a variety of glycosides, 
227 
 mannosides, rhamnosides228 and 
arabinosides229 have also been reported by Japanese workers. 
Ginsenoside-Rd is also found in other Panax species; P. japonicus (rhizome), P. 
japonicus var. major (leaves), P. japonicus var bipinnatfldus (rhizome), P. ginseng 
(roots), P. ginseng (flowers), P. ginseng (flower buds), P. ginseng (seeds), and P. 
pseudo-ginseng (leaves). 
It is noteworthy that a cucurbitaceous plant Gynostemms pentaphyllum also contained 
ginsenoside-Rd and number of other ginsenosides including ginsenoside-Rb 1 , Rb2 and 
230 
172- 
Figure 5.2 :One dimensional 1 H NMR spectrum of Ginsenoside-Rd at 14.11; m - methyl singlets; 
a,b and c - three anomeric sugar protons; x - solvent resonances 
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5.6 RESULTS AND DISCUSSION 
A saponin extracted from Panax notoginseng was shown to be responsible for tPA 
release from hemi-pituitary glands in rats in vitro. The work described in this chapter 
has shown that its active principle is ginsenoside-Rd and the 1 H and ' 3C spectra are 
fully assigned for the first time. 
Assignments were obtained by concerted use of one dimensional NMR techniques, 1 11, 
13 C and DEPT and two dimensional NMR techniques, DQF COSY, TOCSY, ROESY, 
HMQC and HMBC. Sugar correlations via oxygen were obtained using the LR COSY 
experiment and the two more useful techniques, 1D TOCSY and 1D ROESY 
experiments were also performed on ginsenoside-Rd to confirm assignments. 
5.6.1 Structure Determination of Ginsenoside-Rd 
The one dimensional proton spectrum of the glycoside in d 4-methanol (Figure 5.2) 
showed a one-proton triplet at 5.10 ppm indicating the presence of a alkene proton and 
clear one-proton doublets at 4.67 (J=7.7 Hz), 4.60 (J=7.9 Hz) and 4.43 (J=7.4 Hz) ppm 
corresponding to three axial anomeric sugar protons. The low frequency region of the 
I  proton spectrum showed six individual methyl singlets at 0.86, 1.02, 1.07, 1.34, 1.62 
and 1.68 ppm and a broad six-proton singlet at 0.92 ppm indicating the presence of a 
total of eight methyl groups. Chemical shifts, multiplicities and coupling constants are 
tabulated in Tables 5.3 and 5.4. 
Classification of 13 C resonances as methyl, methylene and methine groups was obtained 
via spectra obtained by the DEPT technique employing broadband proton decoupling 
during data acquisition. The quaternary carbons were identified with the aid of 'C 
single pulse spectrum. Thus the molecule comprised eight methyl groups, twelve 
methylene groups, twenty-two methine groups and six quaternary carbon atoms. These 
data are consistent with a three-sugar glycoside of protopanaxadiol or its isomer with a 
side chain as found in sanchinoside B 1 (Figure 5.1-8). 
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Figure 5.3 Cross sections through the 2D 'H- 13C one-bond correlation HMQC 
spectrum at carbon frequencies showing proton multiplet structure. 
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The chemical shifts of the protons of aglycone unit were individually obtained from a 
2D proton-detected one-bond 13 C- 1 H correlation (HMQC) experiment carried out at 
14. IT and employing broadband 13C decoupling during data acquisition. Some of the 
1 H cross sections obtained through 2D 13 C- 1 H one-bond correlation HMQC spectrum 
are shown in Figure 5.3. The shifts for the sugar residues showed considerable overlap 
and are discussed later. Except for one methylene group, where the bonded protons 
exhibited similar chemical shifts, each of the methylene carbons correlated with two 
well separated proton chemical shifts. 
Almost all the connectivities of the signals of the spin systems could be obtained from 
the resonances appearing on vertical/horizontal lines in the TOCSY spectrum. Careful 
analysis of the TOCSY and DQF COSY 2D spectra showed the presence of seven 
separate spin systems, four belonging to an aglycone and three belonging to the sugar 
residues. The two separate spin systems that emerged in the TOCSY spectrum at 3.19 
and 3.65 ppm suggested that some of these spins are attached to the carbons which are 
bound to electronegative atoms such as 0, N, S. No evidence of the presence of N and 
S atoms were found. 
5.6.2 Aglycone and sugar spin systems and aglycone ring proton assignments 
5.6.2.1: Five-spinystem A 
The spin connectivities show clearly in the TOCSY spectrum through the diagonal at 
3.19 ppm and showed clear cross peaks in the DQF COSY spectrum. Together with the 
HMQC spectrum these were then identified as a [CH 2-CH2-CH-O] five-spin system at 
1.03 and 1.72 ppm (H-is), 1.72 and 1.99 ppm (H-2s) and 3.19 ppm (H-3). Two of the 
protons each from two methylene groups were also overlapped. These protons are 
consistent with the protons in ring-A of a dammarane type skeleton. 
5.6.2.2: Five-spinystem  B 
The low frequency region of the TOCSY spectrum showed connectivities for a [CH 2-
CH2-CH] five-spin system and the DQF COSY spectrum also showed clear cross peaks. 
Two of the protons each from two methylene groups were also overlapped. The 
possibility of spin systems, A and B arising from an aglycone in which ring-A bears no 
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hydroxyl group and ring-B is hydroxylated at C-6 is excluded by data presented later. 
Figure 5.4 shows the part of the TOCSY spectrum of the saponin showing side chain 
and ring-B proton correlations. 
5.6.2.3: Ten-spin ystem C 
This spin system shows clearly in the TOCSY spectrum at lines through the diagonal 
fully at 3.65 and 2.28 ppm and partially 1.92, 1.74, 1.58, 1.46 and 1.38 ppm (Fig. 5.4). 
The complete spin system connectivity was clearly obtained using the TOCSY and the 
DQF COSY spectra. This spin system corresponds to the protons of ring-C and -D of 
the aglycone with a OH group at C-12 position. Part of the DQF COSY spectrum of the 
saponin revealing side chain and ring-C and -D proton correlations are also shown in 
Figure 5.5. 
5.6.2.4: Five- spjnystem  E 
The alkene proton connected spin system was clearly identified in the high frequency 
region of the TOCSY spectrum at 5.10 ppm. Other resonances connected to the same 
spin system were identified as two methylenes with the aid of the TOCSY (Figure 5.3), 
DQF COSY and the HMQC spectra. The methylene protons next to the olefinic carbon 
showed similar proton chemical shifts. The two methyls appeared as singlets at 1.62 
and 1.68 ppm showed weak connectivities to each other and strong connectivities to the 
alkene proton in the TOCSY spectrum. This indicates the 4J proton connectivities of 
the alkene proton to the geminal methyls which are bound to a olefinic carbon. These 
resonances correspond to the side chain protons of the type in protopanaxadiol and 
excludes an aglycone in which the side chain is of the type in sanchinoside B, (Fig. 5.1-
8). Therefore this data is consistent only with aglycone of protopanaxadiol. The proton 
chemical shifts and coupling constants are given in Table 5.3. 
5.6.2.5: Sugar ring-apinystem: Sugar-a. -b. -c 
Three separate spin connectivities appeared in the TOCSY spectrum at 4.43, 4.60 and 
4.67 ppm laid in the normal resonance region for sugars. Figure 5.6 shows the sugar 
region of the TOCSY spectrum of the saponin. This suggested the presence of three 
monosaccharide units in the saponin molecule. 
Figure 5.7 	ID TOCSY spectra of ginsenoside-Rd; Irradiation positions at aH-1, bH-1 and cH-1 anomeric sugar protons. 
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Complete assignments of the three sugar protons, sugar-a, -b and -c were obtained with 
the aid of the TOCSY and the DQF COSY spectra. 
The proton coupling constants of 2J and 3J, multiplicities of resonances and 
conformation of the protons were obtained using the set of ID TOCSY spectra (Figure 
5.7). One dimensional spectra were acquired using the z-filtered TOCSY sequence with 
low power selective excitation pulses at the positions of the protons H-24, H-17, H-2', 
aH-i,bH-1 and cH-1. 
The confirmations of axial conformation of proton resonances H-3, H-5, H-9, H-12, H-
13 and H-17 were obtained by using the coupling constants observed in the 1D TOCSY 
spectra. The 1D TOCSY spectra were also used to confirm the axial conformations of 
geminal protons H-i/i', H-2/2', H-6/6', H-7/7', H-il/li', H-15/15', and H-16/16'. The 
coupling constants of all the protons except H-6' of all the sugars, sugar-a, -b, and -c, 
were obtained using the 1D TOCSY spectra. The coupling constants of sugar H-6s' 
were obtained from the 1D proton spectrum. All the sugars were then identified as -D-
glucopyranosyls. 
5.6.2.6: HyxxyLgwiip 
An isolated hydroxyl proton resonance shown later to be on C-12 position was 
identified from the broad peak appears on the low frequency edge of the Sugar-b 
anomeric proton resonance at 4.59 ppm in the 1D 1 H spectrum. The sugar ring hydroxyl 
protons appeared to exchange with the solvent and the residual OH resonances appeared 
at 4.85 ppm. 
The basic skeleton was suggested using the 1D proton, ID 13 C, DEPT, 2D TOCSY, 
DQF COSY and the HMQC data and literature. The skeleton in Figure 5.9 was 
numbered using the standard triterpene numbering procedure. The biological pathway 
forming the dammarane type of skeleton has showed that the usual attachment of 
oxygen atoms is at positions C-3, C-6, C-12 and C-20. The data obtained on this 

























At this stage the basic skeleton, the side chain and attachments of the oxygen atoms are 
known and some individual resonance identifications remain to be made. 
HOCH2 
Sugar 





Sugar - a 
	OH 
Hf 
Figure 5.9 : Structure of saponin, ginsenoside-Rd; 20(s)-protopanaxadiol-3-0--D-
glucopyranosyl-( 1 ->2)--D-glucopyranoside- 12-hydroxy-2O-O-3-D-glucopyranoside 
5.6.3 Methyl proton resonance and ring connectivity assignments 
Assignment of the proton resonances of the saponin was confirmed by the connectivities 
appeared in the ROESY spectrum. The alkene proton H-24 showed through space 
connectivities to the protons H-22, H-23, and methyl resonances at 1.62 and 1.68 ppm 
confirmed the identity of methyl-26 and methyl-27 and the presence of a side chain. 
The ring-D proton H-17 and side chain proton H-23 showed strong ROESY 
connectivities to the methyl group at 1.34 ppm. These connectivities confirmed the 
attachment of methyl group at 1.34 ppm to the carbon at C-20 hence methyl group is 
identified as methyl-2 1. The ROESY correlations are shown in Figure 5.8. 
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The methyl group singlets appeared at 0.86 and 1.07 ppm showed DQF COSY cross 
peaks to each other suggesting geminal methyl groups. The methine proton at C-3 
showed the ROESY connectivities to the protons H-l', H-2, H-5 and methyl resonance 
at 1.07 ppm. The methyl groups at 0.86 and 1.07 ppm showed clear connectivities to 
each other in the ROESY spectrum. Low frequency region of the ROESY spectrum 
also showed connectivities of geminal protons themselves and to each other at C-i and 
C-2 positions. The ROESY connectivities of the methyl group at 0.86 ppm to the H-i 
and methyl group at 1.07 ppm to the H-5 confirmed the resonances as geminal methyl 
groups, methyl-30 and methyl-3 1, at C-4. 
The methine proton at C-12 showed the ROESY cross peaks to the protons H-9, H-i 1 
and one of the methyl resonances at 0.92 ppm hence methyl-19 is identified. The 
methylene protons at C-iS and C-16 showed strong ROESY connectivities to their 
geminai partners. The protons H-17, H-16', H- 15', H-13 and H-9 showed clear through 
space ROESY cross peaks to the one of the methyl resonances at 0.92 ppm. Therefore 
methyl-32 is identified. The protons H-2, H-6 and H-i 1 also showed ROESY 
connectivities to one of the methyl resonances appeared at 0.92 ppm in the ROESY 
spectrum. Assignment of the methyl resonances at 0.92 ppm (19 and 32) and the axial 
conformations of the protons H-S. H- 17 and H-9 were therefore confirmed. The methyl 
resonance at 1.02 ppm showed through space ROESY connectivities to the protons H-
11, H-7, H-9, H-15 and H-13 confirmed the assignment of methyl-33 and axial 
conformation of H- 13. 
The geminal protons at C-6 and C-7 showed ROESY connectivities to their coupling 
partners themselves and to each other. The H-S proton showed strong through space 
ROESY connectivities to the protons H-9, H-7' and H-i confirmed the axial 
conformations of H-5 and H-9 protons. 
All the sugars, sugar-a, -b and -c, showed ROESY connectivities to their protons 
themselves. The bH-1 proton of the sugar-b which showed strong ROESY cross peaks 
to protons H-17, H-22, H-23 and methyl-21 confirmed the attachment of the sugar-b at 
C-20. The assignment of the sugar-c which is directly attached to the carbon C-3 was 
Figure 5.10: ID ROESY spectra of ginsenoside-Rd; Irradiation positions at aH-1, bH-1 and cH-1 anomeric sugar protons. 


























confirmed using the strong ROESY cross peaks of the cH-1 proton to the protons H-3, 
H-2 and methyl-31 of the aglycone. 
The sugar-a which did not show any connectivities to the basic skeleton showed a 
strong ROESY cross peak confirming the attachment of sugar-a to sugar-c. At this 
stage linkage position was not clear due to partially overlapping of the sugar-c cH-2 and 
cH-4 resonances. 
In addition to the connectivities obtained from the ROESY spectrum, almost all the 
through space correlations were also confirmed with the aid of 1D ROESY spectra 
(Figure 5.10). One dimensional ROESY spectra were acquired using the 1D version of 
the 2D ROESY sequence with low power selective excitation pulses at the proton 
resonances H-12, aH- 1, bH- 1 and cH- 1. All the connectivities of aglycone-aglycone 
and aglycone-sugar were confirmed except sugar aH-1 to sugar-c connectivity due to 
partially overlapping of cH-2 and cH-4 sugar resonances. 
The COSY experiment was performed to obtain long-range couplings; specially via 
oxygen atoms. Sugar aH-1 showed clear 4J coupling connectivity to sugar cH-2 proton 
confirming the sugar -a/-c linkage position and sugar cH-1 showed 4J through bond 
correlation to aglycone H-3 proton. Sugar-b which showed the bH-1 to methyl-21 5J 
through coupling via oxygen reconfirmed the attachment of sugar-b to aglycone. Part of 
the LR COSY spectrum of ginsenoside-Rd revealing sugar-aglycone correlations is 
shown in Figure 5.11. 
All the 1 C resonances except quaternaries were assigned using the HMQC spectrum. 
All the methyl protons in the HMBC spectrum showed 13C- 1 H couplings and appeared 
as doublets in the proton dimension. The quaternary carbon appeared in the HMBC 
spectrum at 132.24 ppm showed 2J 13C- 1 H connectivities to the methyl protons methyl-
26 and methyl-27 and 3J coupling to the H-23 confirmed the carbon C-25. The 2J 13C-
111 couplings of 11-17, methyl-21 and H-22 and 3J coupling of H-13 to the quaternary 
carbon at 84.92 ppm in the HMBC spectrum confirmed the carbon C-20. 
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The quaternary carbon at 52.48 ppm in the HMBC spectrum showed 2J 13 C- 1 H 
couplings to the protons H-13, methyl-32 and 3J connectivities to the methyl-33 protons 
confirmed the carbon C-14. The observed 2J 1 C- 1 H couplings of the protons H-5, H-9 
and methyl-19 to the quaternary carbon at 37.91 ppm in the HMBC spectrum confirmed 
the assignment of carbon C-10. 
The confirmation of the quaternary carbon C-8 was aided by using the 2J 1 C-'H 
couplings of protons H-9 and methyl-33 and the 3J couplings of the methyl-32 protons 
to the quaternary carbon at 41.00 ppm in the HMBC spectrum. The quaternary carbon 
at 40.58 ppm showed 2J 13 C- 1 H couplings of the protons H-5, methyl-30 and methyl-31 
confirmed the assignment of carbon C-4. 
The structure of the biologically active saponin is then identified as protopanaxadiol 
type saponin, ginsenoside-Rd; {20(s)-protopanaxadiol-3 -O--D-glucopyranosyl-( 1 ->2)-
3-D-glucopyranoside- 1 2-hydroxy-20-O--D-g1ucopyranoside} only by high field NMR 
spectroscopy. 
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Table 5.3: Chemical shifts, Multiplicities and Coupling constants of the aglycone 
part of the glycoside : Ginsenoside-Rd 
Site 8Ha 	
C b 	m 	2J(Hz) 	3 J(Hz) 
1 (a) 1.03 40.25 m 12.4 11.1 (H-2), 3.8 (H-2') 
1'(f) 1.72 m 12.4 
2(p) 1.72 27.21 m 10.6 11.1 (H- 1), 3.2 (H- I') 
2'(a) 1.99 m 10.6 3.8(H-1) 
3 (a) 3.19 91.26 dd 12.4 (H-2), 4.3 (H-2') 
4 - 40.58 
5(a) 0.79 57.54 d 12.7(H-6) 
6 (p) 1.49 19.25 tt 12.3 12.7 (H-5), 2.8 (H-7) 
6'(a) 1.57 m 12.3 2.9(H-7') 
7(a) 1.30 35.86 m 12.6 
7' (13) 1.57 m 12.6 2.9 (H-6') 
8 - 41.00 
9(a) 1.46 51.05 dd 13.3 (H- 11), 3.2 (H-Il') 
10 - 37.91 
11 (P) 1.22 31.03 q 12.4 
11'(a) 1.82 ddd 3.2(H-9) 
12(a) 3.65 71.90 dt 10.4 (H-13), 5.7 (H- 11) 
13(13) 1.74 49.78 t 10.4 (H-12), 10.4 (H-17) 
14 - 52.48 
15 (13) 1.06 31.64 ft 10.2 10.2 (H-16') 
15'(a) 1.58 q 
16(a) 1.38 27.25 dq 10.5 
16'(J3) 1.92 dp 10.5 5.0(H-15') 
17(a) 2.28 53.13 dq 10.4 (H-13), 2.9 (11-16) 
19 0.92 16.75 s 
20 - 84.92 
21 1.34 22.86 s 
22 1.62 36.67 m 14.4 10.6 (H-23) 
22' 1.81 ddd 14.4 10.6 (H-23), 5.8 (H-23') 
23 2.06 24.24 m 
23' 2.06 m 5.8 (H-22) 
24 5.10 125.81 ft 6.9 (H-23), 1.3 (H-22) 
25 - 132.24 
26 1.62 17.95 s 
27 1.68 25.86 s 
30 0.86 16.75 s 
31 1.07 28.40 s 
32 0.92 16.75 s 
33 1.02 16.27 s 
120H 4.59 s 
* - see footnote Table 5.4 
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Table 5.4: Chemical shifts, Multiplicities and Coupling constants of the sugars 
attached to aglycone part of the glycoside : Ginsenoside-Rd 
Site 	8H 	6Cb 	m C 	2J(Hz) 3 J(Hz) 
Sugar-a 	1 4.67 104.5 d 7.7(H-2) 
2 3.19 77.0 t 9.1 (H-i, H-3) 
3 3.35 78.1 t 9.1 (H-2, H-4) 
4 3.21 71.9 dd 8.6 (H-3), 9.7 (H-5) 
5 3.24 78.1 ddd 9.7 (H-4), 2.2 (H-6) 
6 3.60 63.0 dd 11.9 	2.2(H-5) 
6' 3.82 dd 
Sugar-b 	1 4.60 98.3 d 7.9 (H-2) 
2 3.08 75.4 t 8.3 (H-i, H-3) 
3 3.35 78.1 t 9.1 (H-2, H-4) 
4 3.32 71.4 t 9.5 (H-3, H-5) 
5 3.20 78.1 ddd 9.5 (H-4), 2.1 (H-6) 
6 3.63 62.7 dd 12.4 	2.1 (H-5) 
6' 3.76 dd 
Sugar-c 	1 4.43 105.4 d 7.4 (H-2) 
2 3.56 81.3 t 9.0 (H-i, H-3) 
3 3.28 71.6 t 8.2(H-2,H-4) 
4 3.54 78.6 t 9.2 (H-3, H-5) 
5 3.25 78.1 ddd 9.2 (H-4), 1.9 (H-6) 
6 3.65 63.0 dd 11.9 	1.9 (H-5) 
6' 3.85 dd 
a 
- oH is relative to CH30H at 3.3 ppm 
b - 5C is relative to Cfl30D at 49.4 ppm 
c - multiplicities; (s) singlet, (d) doublet, (t) triplet, (q) quartet and (m) multiplet 
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5.7 MATERIALS AND METHODS 
5.7.1 Sample preparation of glycoside; Ginsenoside-Rd 
The glycoside sample was supplied by the Brain Metabolism Unit in our university. 
The white crystalline solid of glycoside (20mg) was examined in d4-methanol solution 
(0.65m1) in a high quality NMR tube (528PP Wilmad). The glycoside sample was 
stored at 280K between experiments. 
5.7.2 NMR experiments of Ginsenoside-Rd 
All NMR experiments were performed using a 5mm proton (inverse) probe on a Varian 
VXR 600S spectrometer operating at 599.945 MHz for proton and 150.869 for 13 C. 
The sample temperature was regulated with a Varian VT temperature controller at 298K 
with 10 litre/min of dry air precooled at 273K by passage through a coil in a refrigerated 
bath. The spectrometer was controlled with a Sun 4/110 host computer using the 
VNMR system software version 4.1. 
1 H single pulse, DQF COSY, LR COSY, TOCSY, ROESY, 1D TOCSY, 1D ROESY 
and 13 C- 1 H heteronuclear correlation NMR spectra (HMQC and HMBC) were carried 
out as described below. Spectra were referenced internally to the CD 30D resonance at 
3.3 ppm. 
Single pulse proton NMR spectra were acquired using the pulse sequence Dl -90 °-AQ 
with a relaxation delay D1=1 .5s and acquisition time AQ=2.5s. 512 Transients were 
acquired over a 3KHz spectral width and 14K data points were collected. The data sets 
were zero filled to 65K data points and was multiplied by optimised shifted sinebell 
squared function prior to Fourier transformation. Fourier transformed data were phase 
and baseline corrected. 
The two dimensional phase-sensitive proton DQF COSY spectrum was obtained using 
the pulse sequence Dl -90 °-t 1 -90°-90°-AQ with a relaxation delay Dl = 1.5s and 
acquisition time AQ0.341s. An eight step phase cycle (hypercomplex acquisition) was 
used. Sixteen scans were performed for each t 1 value and 512 FIDs were acquired. 
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Other parameters were SW=3KHz; 2K data points and 64 dummy scans. Prior to 
Fourier transformation, the data set was zero filled to 1024 data points in F 1 dimension 
and was multiplied by optimised shifted sinebell squared function in both dimensions. 
The pulse sequence used for the 2D TOCSY experiment was Dl-90 °-t 1 -(MLEV-17)-AQ 
with a relaxation delay D1=1.5s, an acquisition time AQ=0.341s. An eight step phase 
cycle (hypercomplex acquisition) was used. The MLEV- 17 spin lock pulse was used 
with a 65ms mixing time cycle and two trim pulses of 2ms each. Sixteen transients 
were performed for each t 1 value and 512 FIDs were acquired. Spectral width was 
3KHz and 2K data points were collected. The data set was zero filled to 1024 data 
points in F 1 dimension. The data set was multiplied by shifted sinebell squared function 
prior to Fourier transformation. After the Fourier transformation, baseline was 
corrected only in F2 dimension and phase corrections were done in both dimensions. 
The 2D proton LR COSY spectrum, set up to observe long-range coupling, was 
obtained using the sequence D1-90 0-t 1 -'r-45 0-AQ with the propagation time 'r=lOOms 
and relaxation delay Dl=2s. 32 Transients were performed for each t 1 value and 512 
FIDs were acquired over a 3KHz spectral width. Other parameters were AQ0.341s; 
2K data points. The data set was zero filled to 1024 data points in F 1 dimension. Prior 
to Fourier transformation, unshifted sinebell squared function was applied in both 
dimensions. 
The 2D ROESY spectrum was obtained using the sequence D1-90 0-t 1 -(spin-lock-30)-
AQ with a relaxation delay D1=1.5s and acquisition time AQ=0.341s. A series of 
pulses of length 3.3ts and delays of length 3.3x7ts were applied to form the spin-lock 
period (lSOms). Sixteen scans were performed for each t 1 value and 512 FIDs were 
acquired. 2K data points were collected over a 3KHz spectral width. The data set was 
transformed by zero filling in F 1 to 1024 data points before apodization. The data set 
was then multiplied by optimised shifted sinebell squared function in both dimensions 
prior to Fourier transformation. 
Wei 
The 1D TOCSY proton spectra were obtained using the 1D version of the 2D TOCSY 
pulse sequence by removing the incremental delay and introducing a low power 
selective pulse (=180) at the beginning of the sequence; D1-4i-90 0-(spin-lock)-90 0-
900-AQ with relaxation delay D1=1.5s. An eight step phase cycle was used. The 
MLEV- 17 spin lock pulse cycle with 1 OOms mixing time and zfilter 1 Oj.is were used. A 
low power shaped selective spin inversion pulse, iburp_4, was applied (1 OOps) on- and 
off-resonance on alternate scans and the FID's alternatively added and subtracted to give 
a "difference" FID which, on transformation, gave spectra showing only TOCSY 
responses. 256 Transients were acquired over a 3KHz spectral width and 14K data 
points were collected. Other parameters were AQ=2.5s and 64 dummy scans. 
1D ROESY spectra were acquired using the pulse sequence Dl sei9O° 90° (spifl4ock) 
900-AQ. An eight step phase cycle was used with a series of pulses of length 3.4.ts. 
Spin-lock field was used during the 150ms mixing period. The selective irradiation was 
achieved using the low power shaped selective pulse (=90 0), tophat_8, for 1 00is 
period. 1024 Transients were performed for each spectrum over a 3KHz spectral width. 
Other parameters were AQ=2.5s and D11.5s. Spectra show ROESY responses as 
positive signals; small negative signals are TOCSY responses. 
The single pulse 13C NMR spectrum was acquired with relaxation delay 700ms and 
acquisition time 0.501s. Broadband proton decoupling was employed throughout with a 
reduced power and 30,000 transients were performed over a 35KHz spectral width. 
The DEPT data were obtained using the sequence Dl-90 0( 1 H)-D2-1800( 1 H); 900(13C) - 
D2-( 1 H); i 80°(' 3C)-D2-AQ with a relaxation delay Di=1 .5s and D2=3.6ms [/2 
(1cH)1• Broadband proton decoupling was employed during the data acquisition with a 
reduced power level. 7K Transients were acquired over a 35KHz spectral width and 
35K data points were collected. 
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The 2D proton detected one-bond 13C- 1 H correlation (HMQC) spectrum was obtained 
using the sequence; Dl -90 °( 1H)..D2... 1800(1  H); 1800(13  C)-D2-90°(' H)-D3-90°( 1 H)-D2-
90°( 1 3 C)-t112- 1 80°(lH)-ti,290°(' 3C)-D2-AQ. The delays used were Dl =1.5s, D2=3 .6ms 
[ 1 /2 (UCH)] and D3=400ms (null period to minimise signals from protons bonded to 
12C nuclei). The experiment was preceded by 256 dummy scans to establish thermal 
equilibrium. A 16 step phase cycle (hypercomplex acquisition) was used with 13 C 
broadband decoupling during acquisition of the proton signals. 128 Scans were 
performed for each t 1 value and 512 FIDs were collected. Other parameters were 
SW( 1 H)=3KHz; SW( 13 C)=35KHz and 2K data points. 
The 2D proton detected multiple-bond 13 C- 1 H correlation (HMBC) spectrum was 
obtained using the sequence; Dl -90 °( 'H)..D2...90°(' 3 C)-D3 -90°( ' 3C)-tii2- 1 80°( 'H)-ti,2-
90°(' 3C)-AQ. The delays used were D1=1.5s, D2=3.6ms [1/2 (1cH)] and D3=60ms 
(optimised for signals from protons with couplings to carbon of ca. 8 Hz). A 16 step 
phase cycle (hypercomplex acquisition) was used with no 13 C broadband decoupling 
during acquisition of the proton signals. 32 Increments with 480 scans for each FID 
were obtained. Others parameters were as for the HMQC experiment. The HMQC and 
HMBC data were both processed using shifted sinebell squared functions in both 
dimensions with zero filling of the F I data to 512W before transformation. 
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Appendix I 
Additional NMR and structure calculation details of ET-1 
Table La: NOE constraints of ET-1 used for DIANA calculation: Peak numbers, peak 
assignments (F2 Fl), lower constraints and upper constraints. 
1 2 3 4 
ASG_POS1 ASG_POS2 LOWER UPPER 
1 P1 SER4.H CYS3.HA 1.80 5.00 
2 P2 SER4.H SER4.HA 1.80 5.00 
3 P3 SER4.H SER4.HB1 1.80 5.00 
4 P4 SER4.H SER4.H82 1.80 5.00 
5 P5 SER4.H CYS3.HB1 1.80 5.00 
6 P6 SER4.H CYS3.HB2 1.80 5.00 
7 P7 SER2.H SER2.HA 1.80 5.00 
8 P8 SER2.H CYS1.HA 1.80 3.30 
9 P9 SER2.H SER2.QB 1.80 5.60 
10 P10 SER2.H CYS1.QB 1.80 5.60 
11 P11 LEU6.H SER5.HA 1.80 5.00 
12 P12 LEU6.H LEU6.HA 1.80 5.00 
13 P13 LEU6.H LEU6.QB 1.80 5.60 
14 P14 LEtJ6.H LEU6.HG 1.80 3.30 
15 P15 LEU6.H LEU6.QQD 1.80 6.56 
16 P16 CYS15.H CYS15.HA 1.80 5.00 
17 P17 CYS15.H PHE14.HA 1.80 5.00 
18 P18 CYS15.N VAL12.HA 1.80 5.00 
1 2 3 4 
ASG_POS1 ASG_POS2 LOWER UPPER 
19 P19 CYS15.H CYS15.HB1 1.80 5.00 
20 P20 CYS15.H PME14.HB1 1.80 5.00 
21 P21 CYS15.H PHE14.HB2 1.80 5.00 
22 P22 CYS15.H CYS15.HB2 1.80 5.00 
23 P23 GLU10.H GLU10.HA 1.80 5.00 
24 P24 GLU10.H LYS9.HA 1.80 5.00 
25 P25 GLU10.H GLU10.QG 1.80 5.60 
26 P26 GLU10.H GLU10.QB 1.80 3.90 
27 P27 GLU10.H LYS9.HB1 1.80 5.00 
28 P28 LYS9.H LYS9.HA 1.80 5.00 
29 P29 LYS9.H LYS9.HB1 1.80 5.00 
30 P30 LYS9.H LYS9.HB2 1.80 5.00 
31 P31 LYS9.H LYS9.QG 1.80 5.60 
32 P32 ASP18.H ASP18.HA 1.80 5.00 
33 P33 ASP18.H LEU17.HA 1.80 2.50 
34 P34 ASP18.H ASP18.HB1 1.80 5.00 
35 P35 ASP18.H ASP18.HB2 1.80 5.00 
36 P36 ASP18.H LEU17.QB 1.80 5.60 
37 P37 ASP18.H LEU17.HG 1.80 5.00 
1 2 3 4 
ASG_POS1 ASG_POS2 LOWER UPPER 
38 P38 ASP18.H LEU17.QQD 1.80 6.56 
39 P39 PHE14.H PHE14.HA 1.80 3.30 
40 P40 PHE14.H TYR13.HA 1.80 2.50 
41 P41 PHE14.H PHE14.HB1 1.80 2.50 
42 P42 PHE14.H PHE14.HB2 1.80 3.30 
43 P43 PHE14.H TYR13.QB 1.80 5.60 
44 P44 CYS3.H CYS3.HA 1.80 5.00 
45 P45 CYS3.H SER2.HA 1.80 5.00 
46 P46 CYS3.H SER2.QB 1.80 5.60 
47 P47 CYS3.H CYS3.HB1 1.80 5.00 
48 P48 CYS3.H CYS3.HB2 1.80 5.00 
49 P49 VAL12.H CYS11.HA 1.80 5.00 
50 P50 VAL12.H LYS9.RA 1.80 5.00 
51 P51 VAL12.H VAL12.HA 1.80 5.00 
52 P52 VAL12.H CYS11.QB 1.80 3.90 
53 P53 VAL12.H VAL12.HB 1.80 3.30 
54 P54 VAL12.H VAL12.QG1 1.80 6.00 
55 P55 VAL12.H VAL12.QG2 1.80 6.00 
56 P56 TRP21.H TRP21.HA 1.80 5.00 
178 
1 2 3 4 
ASG_POS3. ASG_POS2 LOWER UPPER 
57 P57 TRP21.H ILE20.HA 1.80 2.50 
58 P58 TRP21.H TRP21.HB1 1.80 5.00 
59 P59 TRP21.H TRP2]..HB2 1.80 3.30 
60 P60 TRP21.H 1LE20.HB 1.80 5.00 
61 P61 TRP21.H ILE20.QG2 1.80 6.00 
62 P62 MET7.H MET7.HA 1.80 5.00 
63 P63 MET7.H LEU6.HA 1.80 2.50 
64 P64 MET7.H SER5.HB1 1.80 5.00 
65 P65 NET7.H MET7.HG1 1.80 5.00 
66 P66 MET7.H MET7.HG2 1.80 5.00 
67 P67 MET7.H MET7.HB1 1.80 5.00 
68 P68 MET7.H MET7.HB2 1.80 5.00 
69 P69 MET7.H LEU6.HG 1.80 5.00 
70 P70 H1D16.H CYS15.HA 1.80 5.00 
71 P71 HID16.H H1D16.HA 1.80 3.30 
72 P72 HID16.H TYR13.QB 1.80 5.60 
73 P73 HID16.H HID16.HB1 1.80 3.30 
74 P74 HID16.H H1D16.HB2 1.80 2.50 
75 P75 HID16.H CYS15.HB2 1.80 5.00 
1 2 3 4 
ASG_POS1 ASG_POS2 LOWER UPPER 
76 P76 LEU17.H H1D16.HA 1.80 5.00 
77 P77 LEU17.H LEU17.HA 1.80 3.30 
78 P78 LEU17.H H1D16.H81 1.80 5.00 
79 P79 LEU17.H HID16.HB2 1.80 5.00 
80 P80 LEU17.H LEU17.QB 1.80 3.90 
81 P81 LEU17.H LEU17.HG 1.80 3.30 
82 P82 LEU17.H LEU17.QQD 1.80 6.56 
83 P83 TYR13.H TYR13.KA 1.80 2.50 
84 P84 TYR13.H VAL12.HA 1.80 5.00 
85 P85 TYR13.H TYR13.QB 1.80 3.10 
86 P86 TYR13.H VAL12.HB 1.80 5.00 
87 P87 TYR13.H VAL12.QG1 1.80 6.00 
88 P88 TYR13.H VAL12.QG2 1.80 6.00 
89 P89 ILE20.H ILE20.HA 1.80 2.50 
90 P90 ILE20.H ILE19.HA 1.80 2.50 
91 P91 ILE20.H ILE20.HB 1.80 5.00 
92 P92 ILE20.H ILE20.HG1]. 1.80 5.00 
93 P93 ILE20.H ILE20.HG12 1.80 5.00 
94 P94 ILE20.H ILE20.QG2 1.80 6.00 
1 2 3 4 
ASG_POS1 ASG_POS2 LOWER UPPER 
95 P95 ILE20.H ILE19.QD1 1.80 6.00 
96 P96 SER5.H SER5.HA 1.80 5.00 
97 P97 SER5.H SER4.HA 1.80 5.00 
98 P98 SER5.H SER5.HB1 1.80 5.00 
99 P99 SER5.H SER5.HB2 1.80 5.00 
100 P100 1LE19.H ASP18.HA 1.80 5.00 
101 P101 1LE19.H 1LE19.HA 1.80 5.00 
102 P102 1LE19.H 1LE19.HB 1.80 5.00 
103 P103 1LE19.N ILE19.HG11 1.80 5.00 
104 P104 ILE19.H 1LE19.HG12 1.80 5.00 
105 P105 1LE19.H 1LE19.QD1 1.80 6.00 
106 P106 CYS11.H CYS11.HA 1.80 5.00 
107 P107 CYS11.H GLU1O.HA 1.80 5.00 
08 P108 CYS11.H CYS11.QB 1.80 3.10 
:09 P109 CYS11.H GLU10.QB 1.80 5.60 
110 P110 TRP21.HE3 TRP21.HA 1.80 5.00 
111 P113 ASP8.H MET7.HA 1.80 5.00 
112 P114 ASP8.H ASP8.HB1 1.80 5.00 
113 P115 ASP8.H ASP8.HB2 1.80 5.00 
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1 2 3 4 
ASG_POS1 ASG_POS2 LOWER UPPER 
114 P116 PHE14.QR PHE14.HA 1.80 3.30 
115 P117 PHE14.QR CYS15.HB1 1.80 5.00 
116 P118 PHE14.QR PHE14.HB1 1.80 3.30 
117 P119 PHE14.QR PHE14.HB2 1.80 3.30 
118 P120 PHE14.QR TYR13.QB 1.80 5.60 
119 P121 H1D16.HD2 HID16.HA 1.80 5.00 
120 P122 H1D16.HD2 TYR13.HA 1.80 5.00 
121 P125 H1D16.HD2 LEU17.QQD 1.80 6.56 
122 P126 TRP21.HD1 TRP21.HA 1.80 5.00 
123 P129 TYR13.QR TYR13.HA 180 3.30 
124 P130 TYR13.QR TYR13.QB 1.80 3.10 
125 P131 TYR13.QR LEU17.QQD 1.80 6.56 
126 P136 SER4.H SER5.H 1.80 5.00 
127 P137 SER2.H CYS3.H 1.80 5.00 
128 P138 LEU6.H MET7.H 1.80 5.00 
129 P139 CYS15.H PHE14.H 1.80 5.00 
130 P140 CYS15.H HID16.H 1.80 5.00 
131 P141 GLU10.H LYS9.H 1.80 2.50 
132 P142 GLU10.H CYS11.H 1.80 5.00 
1 2 3 4 
ASGPOS1 ASG_POS2 LOWER UPPER 
133 P143 ASP18.H LEU17.H 1.80 3.30 
134 P144 ASP18.H ILE19.H 1.80 5.00 
135 P145 PHE14.H TYR13.H 1.80 2.50 
136 P146 VAL12.H TYR13.N 1.80 3.30 
137 P147 VAL12.H CYS11.H 1.80 5.00 
138 P148 TRP21.H ILE20.H 1.80 2.50 
139 P149 MET7.H SER5.H 1.80 3.30 
140 P150 MET7.H ASP8.H 1.80 5.00 
141 P151 H1D16.H LEU17.H 1.80 2.50 
142 P152 ILE20.H ILE19.H 1.80 3.30 
143 P154 PHE14.H TYR13.QR 1.80 5.00 
144 P155 CYS3.HA CYS3.HB1 1.80 3.30 
145 P156 CYS3.HA CYS3.HB2 1.80 3.30 
146 P157 SER2.HA SER2.QB 1.80 3.10 
147 P158 SER5.HA SER5.HB1 1.80 3.30 
148 P159 SER5.HA SER5.H32 1.80 3.30 
149 P160 SER4.HA SER4.HB1 1.80 3.30 
150 P161 SER4.HA SER4.HB2 1.80 3.30 
151 P164 TRP21.HA TRP21.HB1 1.80 2.50 
1 2 3 4 
ASGPOS1 ASGPOS2 LOWER UPPER 
152 P166 CYS15.HA CYS15.HB1 1.80 2.50 
153 P167 CYS15.HA C1S15.HB2 1.80 3.30 
154 P168 ASP18.HA ASP18.HB1 1.80 3.30 
155 P169 ASP18.HA ASP18.HB2 1.80 3.30 
156 P170 H1D16.HA H1D16.HB1 1.80 2.50 
157 P171 HID16.HA HID16.HB2 1.80 2.50 
158 P172 MET7.HA MET7.HG1 1.80 5.00 
159 P173 MET7.HA MET7.HG2 1.80 5.00 
160 P174 NET7.HA MET7.HB1 1.80 3.30 
161 P175 MET7.HA MET7.HB2 1.80 5.00 
162 P176 CYS1.HA CYS1.QB 1.80 3.10 
163 P177 CYS11.HA CYS11.QB 1.80 3.10 
164 P178 CYS11.HA PHE14.HB2 1.80 2.50 
165 P179 PHE14.HA PHE14.HB1 1.80 2.50 
166 P180 PHE14.HA PHE14.HB2 1.80 2.50 
167 P181 TYR13.HA TYR13.QB 1.80 3.10 
168 P182 GLU10.HA TYR13.QB 1.80 3.10 
169 P183 GLU10.HA GLU10.QG 1.80 5.60 
170 P184 GLU10.HA GLU10.QB 1.80 3.10 
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171 P185 LETJ17.HA 
172 P186 LEU17.HA 
173 P187 LEU17.HA 
174 P188 ILE20.HA 
175 P189 ILE20.HA 
176 P190 1LE20.HA 
177 P191 ILE20.MA 
178 P192 ILE19.HA 
179 P193 ILE19.HA 
180 P194 ILE19.HA 
181 P195 ILE19.HA 
182 P196 ILE19.HA 
183 P197 LEU6.HA 
184 P198 LEU6.HA 
185 P199 LEU6.HA 
186 P200 LYS9.HA 
187 P201 LYS9.HA 
188 P202 LYS9.HA 
189 P204 LYS9.HA 
1 
ASG_POS 1 
190 P205 LYS9.HA 
191 P206 VAL12.HA 
192 P207 VAL12.HA 
193 P208 VAL12.HA 
194 P209 VAL12.HA 
195 P210 VAL12.HA 
196 P211 VAL12.HA 
197 P212 VAL12.HA 
198 P214 ASP8.HB1 
199 P215 CYS3.HB1 
200 P216 ASP18.HB1 
201 P228 MET7.HG2 
202 P229 MET7.HG2 
203 P230 MET7.HB1 
204 P232 VAL12.HB 
205 P233 VAL12.HB 
206 P235 ILE20.HB 
207 P236 ILE20.HB 










ILE19 . HB 
ILE19.HG11 
ILE19 . HG12 
1LE19 . QG2 






LYS9 . QD 
LYS9 . QG 
2 
ASG_POS 2 
VAL12 . QG1 
VAL12.HB 
LEtJ17 . QB 
LEU17.HG 
VAL12 . QG1 
VAL12.QG2 
CYS15 . HB1 
CYS15 .HB2 
ASP8 . HB2 
CYS3 .HB2 
ASP18 .HB2 
MET7 . HB1 
MET7 . HB2 
MET7 . HB2 
VAL12 . QG1 





























































































209 P242 1LE19.HB 	ILE19.HG12 	1.80 
210 P249 SER5.H CYS3.HB1 1.80 
211 P250 LEtJ6.H 	SER5.HB1 	1.80 
Atom definitions can be found in Appendix IV 
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Table Lb : Modified upper distance constraints of ET-1 obtained form DIANA 
calculation. These constraints were used for later calculations (section 4.3). 
1 CYS 
HA 2SER H 3.30 
CB 15 CYS SG 3.10 
QE 2 SER H 5.60 
SG 15 CYS CB 3.10 
SG 15 CYS SG 2.10 
2 SEP 
H 3CYS H 5.00 
3 CYS 
CB 11 CYS SG 3.10 
HB2 4 SER H 5.00 
HB1 4 SER H 5.00 
HB]. 5 SEP H 5.00 
SG 11 CYS CE 3.10 
SG 11 CYS SG 2.10 
4 SEP 
H SSER H 5.00 
5 SEP 
H 7MET H 3.30 
HB1 6 LEU H 5.00 
HB3. 7 MET H 5.00 
6 LEU 
H 6 LEU HG 3.30 
H 6 LEU QQD 6.56 
H 7MET H 5.00 
HA 6 LEU HG 2.50 
HA 7 MET H 2.50 
HG 7MET H 5.00 
7 MET 
H 7 MET HG2 5.00 
H 7 MET HG1 5.00 
H 8ASP H 5.00 
HB1 7 MET HG2 2.50 
9 LYS 
H 9 LYS QG 5.60 
H 10 GLU H 2.50 
HA 9 LYS HB1 2.50 
HA 9 LYS QD 5.60 
HA 12 VAL H 5.00 
HA 12 VAL HE 3.30 
HA 12 VAL QG1 6.00 
HB2 9 LYS QD 3.10 
HB2 9 LYS QE 5.60 
HB1 10 GLU H 5.00 
10 GLU 
H 10 GLU QE 3.90 
H 10 GLU QG 5.60 
H 11 CYS H 5.00 
HA 13 TYR QE 3.10 
11 CYS 
H 11 CYS QE 3.10 
H 12 VAL H 5.00 
HA 14 PHE HB2 2.50 
QB 12 VAL H 3.90 
12 VAL 
H 12 VAL HE 3.30 
H 13 TYR H 3.30 
HA 15 CYS H 5.00 
HA 15 CYS HB2 3.30 
HA 15 CYS HB1 5.00 
HA 17 LEU QB 5.60 
HA 17 LETJ HG 5.00 
HB 13 TYR H 5.00 
QG2 13 TYR H 6.00 
QG1 13 TYR H 6.00 
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13 TYR 
H 13 TYR HA 2.50 
H 13TYR QB 3.10 
H 14 PHE H 2.50 
HA 13 TYR QR 3.30 
HA 14 PHE H 2.50 
HA 16 HID HD2 5.00 
QB 14 PHE H 5.60 
QB 14 PHE QR 5.60 
QB 16 HID H 5.60 
QR 14 PHE H 5.00 
QR 17 LEtY QQD 6.56 
14 PHE 
H 14 PHE HB2 3.30 
H 14 PHE HBJ. 2.50 
H 14 PHE QR 5.00 
H 15 CYS H 5.00 
HA 14 PHE HB2 2.50 
HA 14 PHE HB1 2.50 
HA 14 PHE QR 3.30 
HB2 14 PHE QR 3.30 
HB2 15 CYS H 5.00 
HB1 14 PHE QR 3.30 
HB1 15 CYS H 5.00 
QR 15 CYS HB1 5.00 
15 CYS 
H 16 HID H 5.00 
HA 15 CYS HB1 2.50 
HB2 16 HID I-I 5.00 
16 HID 
H 16 HID HB2 2.50 
H 16 HID HB1 3.30 
H 17LEU H 2.50 
HA 16 HID HB2 2.50 
HA 16 HID HB1 2.50 
HA 16 HID HD2 5.00 
HB2 17 LEU H 5.00 
HB1 17 LEU H 5.00 
HD2 17 LEU QQD 6.56 
17 LEU 
H 17 LEU QB 3.90 
H 17 LEU HG 3.30 
H 17 LEU QQD 6.56 
H 18 ASP H 3.30 
HA 17 LEU HG 2.50 
HA 18 ASP H 2.50 
QB 18 ASP H 5.60 
HG 18 ASP H 5.00 
QQD 18 ASP H 6.56 
18 ASP 
H 19 ILE H 5.00 
19 ILE 
H 19 ILE HG12 5.00 
H 19 ILE HG11 5.00 
H 19 ILE QD1 6.00 
20 ILE H 3.30 
HA 19 ILE HG12 3.30 
HA 20 ILE H 2.50 
HB 19 ILE HG11 2.50 
QD1 20 ILE H 6.00 
20 ILE 
H 20 ILE HA 2.50 
H 20 ILE HG12 5.00 
H 20 ILE HG11 5.00 
H 21TRP H 2.50 
HA 21 TRP H 2.50 
HB 21 TRP H 5.00 
QG2 21 TRP H 6.00 
21 TRP 
H 21 TRP HB2 3.30 
HA 21 TRP HB1 2.50 
HA 21 TRP HD1 5.00 
HA 21 TRP HE3 5.00 	see Appendix IV 
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Table I.c: Modified lower distance constraints of ET-1 obtained form DIANA 
calculation. These constraints were used for later calculations (section 4.3). 
1 CYS 
CB 15 CYS SG 3.00 
QB 2 SER H 1.80 
SG 15 CYS CB 3.00 
SG 15 CYS SG 2.00 
2 SER 
QB 3 CYS H 1.80 
3 CYS 
CB 11 CYS SG 3.00 
SG 11 CYS CB 3.00 
SG 11 CYS SG 2.00 
6 LEU 
H 6 LEU QQD 1.80 
9 LYS 
H 9 LYS QG 1.80 
HA 9 LYS QD 1.80 
HA 12 VAL QG1 1.80 
HB2 9 LYS QE 1.80 
10 GLU 
H 10 GLU QG 1.80 
HA 13 TYR QB 1.80 
QB 11 CYS H 1.80 
11 CYS 
QB 12 VAL H 1.80 
12 VAL 
HA 17 LEU QB 1.80 
QG2 13 TYR H 1.80 
QG1 13 TYR H 1.80 
13 TYR 
QE 14 PHE H 1.80 
QB 14 PHE QR 1.80 
QB 16 HID H 1.80 
QR 14 PHE H 1.80 
QR 17 LEU QQD 1.80 
14 PHE 
H 14 PHE QR 1.80 
QR 15 CYS HB1 1.80 
16 HID 
HD2 17 LEU QQD 1.80 
17 LEU 
H 17 LEU QQD 1.80 
QQD 18 ASP H 1.80 
19 ILE 
H 19 ILE QD1 1.80 
QD1 20 ILE H 1.80 
20 ILE 
QG2 21 TRP H 1.80 
Atom definitions can be found in Appendix IV 
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Table I.d : Torsional angle constraints of ET-1. 
13 Tyr Phi -163.0 -103.0 
15 Cys Phi -160.0 -100.0 
16 His Phi -171.0 -111.1 
19 Ile Phi -167.9 -132.1 
20 Ile Phi -173.4 -126.7 
Table I.e : Hydrogen bond constraints of ET-1. 
lower upper (A) 
4Ser 0 7Met N 	2.7 3.0 
4Ser 0 7Met H 1.8 2.0 
6Leu 0 lOGlu N 	2.7 3.0 
6Leu 0 lOGlu H 1.8 2.0 
9Lys 0 13 Tyr N 	2.7 3.0 
9Lys 0 13 Tyr H 1.8 2.0 
lOGlu 0 14Phe N 	2.7 3.0 
lOGlu 0 14Phe H 1.8 2.0 
Table IS : Constraints across the disulphide bridges of ET- 1. 
lower upper (A) 
1 Cys SG 15 Cys SG 2.0 2.1 
1 Cys SG 15 Cys CB 3.0 3.1 
1 Cys CB 15 Cys SG 3.0 3.1 
3 Cys SG 11 Cys SG 2.0 2.1 
3Cys SG liCys CB 3.0 3.1 
3Cys CB ilCys SG 3.0 3.1 
Table I.g : 3JJa Coupling constants of ET-1. 
Hz 
13 Tyr 5.8 
15 Cys 5.5 
16 His 6.9 
1911e 9.0 
20 lie 8.6 
185 
Appendix II 
Additional NMR and structure calculation details of LIP 1 
Table ll.a: NOE constraints of UP 1 used for DIANA calculation : Peak numbers, peak 
assignments (F2 Fl), lower constraints and upper constraints. 
1 2 3 4 
ASG_POS1 ASG_POS2 LOWER UPPER 
1 P1 aib3.h ser2.ha 1.80 2.50 
2 P2 aib3.h ser2.hb]. 1.80 3.30 
3 P3 aib3.h ser2.hb2 1.80 5.00 
4 P4 ser2.h ser2.ha 1.80 2.50 
5 P5 ser2.h cysl.ha 1.80 2.50 
6 P6 ser2.h ser2.hb]. 1.80 5.00 
7 P7 ser2.h ser2.hb2 1.80 5.00 
8 P8 aspl8.h asp18.ha 1.80 3.30 
9 P9 aspl8.h 1eu17.ha 1.80 3.30 
10 P10 asp8.h asp8.ha 1.80 3.30 
11 P11 phel4.h phel4.ha 1.80 3.30 
12 P12 asp8.h ser5.ha 1.80 5.00 
13 P13 phel4.h tyrl3.ha 1.80 5.00 
14 P14 asp8.h leu7.ha 1.80 5.00 
15 P15 phel4.h glulO.ha 1.80 5.00 
16 P16 a1b11.h asp8.ha 1.80 5.00 
17 P17 hidl6.h h1d16.ha 1.80 5.00 
18 P18 cysl5.h cysl5.ha 1.80 5.00 
1 2 3 4 
ASGPOS1 ASGPOS2 LOWER UPPER 
19 P19 hidl6.h cysls.ha 1.80 2.50 
20 P20 cysl5.h phel4.ha 1.80 5.00 
21 P21 trp2l.h trp2l.ha 1.80 5.00 
22 P22 ser5.h ser2.ha 1.80 5.00 
23 P23 ser4.h ser4.ha 1.80 5.00 
24 P24 aibll.h glulO.ha 1.80 5.00 
25 P25 ser4.h ser2.hbl 1.80 5.00 
26 P26 glulO.h 1eu6.ha 1.80 5.00 
27 P27 glulO.h leu7.ha 1.80 5.00 
28 P28 glulO.h glulO.ha 1.80 3.30 
29 P29 ser4.h ser4.qb 1.80 5.60 
30 P30 cysls.h va112.ha 1.80 5.00 
31 P31 ser5.h ser5.ha 1.80 5.00 
32 P32 leu7.h leu6.ha 1.80 5.00 
33 P33 trp2l.h 11e20.ha 1.80 3.30 
34 P34 ser5.h ser4.ha 1.80 3.30 
35 P35 leu7.h leu7.ha 1.80 3.30 
36 P36 ser5.h ser5.qb 1.80 3.10 
37 P37 ser5.h ser4.qb 1.80 5.60 
1 2 3 4 
ASGPOS1 ASG_POS2 LOWER UPPER 
38 P38 1eu17.h hidl6.ha 1.80 3.30 
39 P39 lys9.h asp8.ha 1.80 3.30 
40 P40 ilel9.h asp18.ha 1.80 5.00 
41 P41 va112.h asp8.ha 1.80 5.00 
42 P42 1eu17.h leul7.ha 1.80 3.30 
43 P43 tyrl3.h tyrl3.ha 1.80 3.30 
44 P44 i1e20.h 11e20.ha 1.80 5.00 
45 P45 i1e20.h 11e19.ha 1.80 3.30 
46 P46 tyrl3.h glulO.ha 1.80 5.00 
47 P47 lys9.h leu6.ha 1.80 5.00 
48 P48 lys9.h lys9.ha 1.80 3.30 
49 P49 tyrl3.h va112.ha 1.80 5.00 
50 P50 11e19.h 11e19.ha 1.80 3.30 
51 P51 1eu6.h ser5.ha 1.80 5.00 
52 P52 leu6.h leu6.ha 1.80 5.00 
53 P54 leu6.h ser5.qb 1.80 5.60 
54 P55 va112.h lys9.ha 1.80 5.00 
55 P56 va112.h va112.ha 1.80 5.00 
56 P59 aib3.h ser4.h 1.80 5.00 
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1 2 3 4 
ASG_POS1 ASG_POS2 LOWER UPPER 
57 P60 aib3.h ser5.h 1.80 5.00 
58 P61 aspl8.h leul7.h 1.80 3.30 
59 P62 phel4.h cysl5.h 1.80 3.30 
60 P63 asp8.h leu7.h 1.80 5.00 
61 P64 phel4.h tyrl3.h 1.80 2.50 
62 P65 asp8.h lys9.h 1.80 3.30 
63 P66 ser4.h ser5.h 1.80 3.30 
64 P67 aibll.h lys9.h 1.80 5.00 
65 P68 hidl6.h leul7.h 1.80 2.50 
66 P69 glulO.h lys9.h 1.80 2.50 
67 P70 trp2l.h ile20.h 1.80 5.00 
68 P71 aspl8.h i1e19.h 1.80 5.00 
69 P72 asp8.h leu6.h 1.80 5.00 
70 P73 phel4.h vall2.h 1.80 5.00 
71 P74 aibll.h vall2.h 1.80 2.50 
72 P75 glulO.h vall2.h 1.80 5.00 
73 P76 ser5.h leu6.h 1.80 5.00 
74 P77 leu7.h leu6.h 1.80 3.30 
75 P78 i1e20.h 11e19.h 1.80 3.30 
1 2 3 4 
ASG_POS1 ASG_POS2 LOWER UPPER 
76 P79 tyrl3.h vall2.h 1.80 3.30 
77 P80 ser2.h cysl.hbl 1.80 5.00 
78 P81 ser2.h cysl.hb2 1.80 5.00 
79 P82 h1d16.hel cysl5.qb 1.80 3.90 
80 P83 aib3.h aib3.qqb 1.80 6.56 
81 P86 hidl6.hel vall2.qg2 1.80 6.00 
82 P87 aspl8.h aspl8.hbl 1.80 2.50 
83 P88 aspl8.h aspl8.hb2 1.80 3.30 
84 P89 phel4.h phel4.hbl 1.80 3.30 
85 P90 phel4.h phel4.hb2 1.80 3.30 
86 P91 asp8.h asp8.hbl 1.80 5.00 
87 P92 phel4.h tyrl3.qb 1.80 3.90 
88 P93 asp8.h asp8.hb2 1.80 2.50 
89 P94 hidl6.h hidl6.hbl 1.80 3.30 
90 P95 hidl6.h hidl6.hb2 1.80 2.50 
91 P96 cysl5.h cysl5.qb 1.80 3.10 
92 P97 cysl5.h phel4.hb2 1.80 5.00 
93 P98 trp2l.h trp2l.hbl 1.80 5.00 
94 P99 trp2l.h trp2l.hb2 1.80 3.30 
1 2 3 4 
ASG_POS1 ASG_POS2 LOWER UPPER 
95 P100 leul7.h hidl6.hbl 1.80 5.00 
96 P101 1eu17.h hidl6.hb2 1.80 5.00 
97 P102 tyrl3.h tyrl3.qb 1.80 3.10 
98 P103 lys9.h asp8.hbl 1.80 3.30 
99 P104 lys9.h asp8.hb2 1.80 5.00 
100 P105 aibll.h glulO.hb2 1.80 3.30 
101 P106 glulO.h glulO.hgl 1.80 2.50 
102 P107 glulO.h g1u10.hg2 1.80 5.00 
103 P108 glulO.h glulO.hbl 1.80 3.30 
104 P109 glulO.h glulO.hb2 1.80 5.00 
105 P110 glulO.h lys9.hbl 1.80 2.50 
106 P111 aspl8.h 1eu17.hg 1.80 5.00 
107 P112 asp8.h leu7.hbl 1.80 3.30 
108 P113 asp8.h leu7.hg 1.80 5.00 
109 P114 asp8.h aibll.qqb 1.80 6.56 
110 P115 aibll.h aibll.qqb 1.80 6.56 
111 P116 ser4.h aib3.gqb 1.80 6.56 
112 P117 glulO.h aibll.qqb 1.80 6.56 
113 P118 trp2l.h 11e20.hb 1.80 5.00 
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1 2 3 4 
ASG_POS1 ASG_POS2 LOWER UPPER 
114 P120 leu7.h leu7.hg 1.80 2.50 
115 P121 ser5.h aib3.qqb 1.80 6.56 
116 P122 leu7.h aib3.qqb 1.80 6.56 
117 P123 tyrl3.h va112.hb 1.80 2.50 
118 P124 1ys9.h lys9.hbl 1.80 2.50 
119 P125 i1e20.h ile20.hb 1.80 2.50 
120 P126 leul.h leu7.hbl 1.80 3.30 
121 P127 1eu7.h leu7.hb2 1.80 3.30 
122 P128 1eu17.h leul7.qb 1.80 3.90 
123 P129 leul7.h leul7.hg 1.80 3.30 
124 P130 11e20.h ile20.hgll 1.80 5.00 
125 P131 lys9.h lys9.gd 1.80 5.60 
126 P132 lys9.h lys9.hb2 1.80 5.00 
127 P133 lys9.h lys9.qg 1.80 5.60 
128 P134 ilel9.h ilel9.hb 1.80 3.30 
129 P135 i1e19.h ilel9.hgll 1.80 3.30 
130 P136 leu6.h leu6.hbl 1.80 3.30 
131 P137 1eu6.h leu6.hb2 1.80 5.00 
132 P138 leu6.h leu6.hg 1.80 3.30 
1 2 3 4 
ASGPOS1 ASGPOS2 LOWER UPPER 
133 P139 leu6.h aib3.qqb 1.80 6.56 
134 P140 vall2.h vall2.hb 1.80 2.50 
135 P141 vall2.h aibll.qqb 1.80 6.56 
136 P143 aspl8.h leul7.qdl 1.80 6.00 
137 P144 aibll.h vall2.qgl 1.80 6.00 
138 P146 glulO.h va112.qg2 1.80 6.00 
139 P147 trp2l.h ile20.qg2 1.80 6.00 
140 P148 leu7.h leu6.gdl 1.80 6.00 
141 P149 ile20.h i1e20.hgl2 1.80 3.30 
142 P150 tyrl3.h vall2.qgl 1.80 6.00 
143 P151 tyrl3.h vall2.qg2 1.80 6.00 
144 P152 1eu17.h leul7.qdl 1.80 6.00 
145 P153 ile20.h 11e20.qg2 1.80 6.00 
146 P154 ile20.h i1e19.qg2 1.80 6.00 
147 P155 ilel9.h ilel9.hg12 1.80 5.00 
148 P156 leu6.h leu6.qdl 1.80 6.00 
149 P157 vall2.h va112.qgl 1.80 6.00 
150 P158 va112.h va112.qg2 1.80 6.00 
151 P159 ilel9.h 11e19.qg2 1.80 6.00 
1 2 3 4 
ASGPOS1 ASGPOS2 LOWER UPPER 
152 P160 hidl6.hd2 hidl6.ha 1.80 5.00 
153 P161 phel4.qr phel4.ha 1.80 5.00 
154 P163 phel4.qr glulO.ha 1.80 5.00 
155 P164 phel4.qr phel4.hbl 1.80 5.00 
156 P170 hidl6.hd2 cysl5.qb 1.80 5.60 
157 P171 phel4.qr phel4.hb2 1.80 3.30 
158 P173 phel4.qr tyrl3.qb 1.80 5.60 
159 P174 phel4.qr glulO.hb2 1.80 5.00 
160 P175 phel4.qr leul7.hg 1.80 5.00 
161 P176 phel4.qr glulO.hg2 1.80 5.00 
162 P177 phel4.qr leul7.qdl 1.80 6.00 
163 P178 hidl6.hd2 leul7.qdl 1.80 6.00 
164 P179 trp2l.hdl ile2O.qdl 1.80 6.00 
165 P180 tyrl3.qr phel4.ha 1.80 5.00 
166 P181 tyrl3.qr tyrl3.ha 1.80 5.00 
167 P182 tyrl3.qr glulO.ha 1.80 5.00 
168 P184 tyrl3.qr tyrl3.qb 1.80 3.90 
169 P186 tyrl3.qr va112.qgl 1.80 6.00 
170 P189 tyrl3.qr vall2.qg2 1.80 6.00 
188 
1 2 3 4 
ASG_POS]. ASG_POS2 LOWER UPPER 
171 P192 phel4.h phel4.qr 1.80 3.30 
172 P193 phel4.h tyrl3.qr 1.80 5.00 
173 P194 hidl6.h hidl6.hd2 1.80 5.00 
174 P195 tyrl3.h tyrl3.qr 1.80 5.00 
175 P200 hidl6.hd2 tyrl3.qr 1.80 3.30 
176 P203 ser2.ha ser2.hb]. 1.80 5.00 
177 P204 ser2.ha ser2.hb2 1.80 5.00 
178 P205 ser5.ha ser5.qb 1.80 5.60 
179 P206 ser4.ha ser4.qb 1.80 5.60 
180 P207 ser2.hbl ser2.hb2 1.80 5.00 
181 P208 hidl6.ha hidl6.hbl 1.80 5.00 
182 P209 cysl5.ha cysl5.qb 1.80 3.90 
183 P210 asp8.ha asp8.hbl 1.80 5.00 
184 P211 asp8.ha asp8.hb2 1.80 3.30 
185 P212 phel4.ha phel4.hbl 1.80 5.00 
186 P213 phel4.ha phel4.hb2 1.80 5.00 
187 P214 cysl.ha cysl.hbl 1.80 3.30 
188 P215 cysl.ha cysl.hb2 1.80 3.30 
189 P216 ser5.ha asp8.hbl 1.80 5.00 
1 2 3 4 
ASGPOS1 ASGPOS2 LOWER UPPER 
190 P217 sers.ha asp8.hb2 1.80 5.00 
191 P218 tyrl3.ha tyrl3.qb 1.80 3.90 
192 P219 glulO.ha tyrl3.qb 1.80 5.60 
193 P220 vall2.ha cysl5.qb 1.80 5.60 
194 P221 glulO.ha glulO.hgl 1.80 5.00 
195 P222 glulO.ha glulO.hg2 1.80 5.00 
196 P223 glulO.ha glulO.hbl 1.80 3.30 
197 P224 lys9.ha vall2.hb 1.80 5.00 
198 P225 lys9.ha lys9.hbl 1.80 5.00 
199 P226 leu7.ha glulO.hbl 1.80 5.00 
200 P227 1eu6.ha lys9.hbl 1.80 5.00 
201 P228 va112.ha vall2.hb 1.80 5.00 
202 P229 asp8.ha aibll.qqb 1.80 6.56 
203 P231 phel4.ha leul7.hg 1.80 5.00 
204 P232 leul7.ha leul7.qb 1.80 5.60 
205 P233 1eu17.ha leul7.hg 1.80 5.00 
206 P234 leu6.ha leu6.hbl 1.80 5.00 
207 P235 leu6.ha leu6.hg 1.80 5.00 
208 P236 ile20.ha ile20.hb 1.80 5.00 
1 2 3 4 
ASG_POS1 ASG_POS2 LOWER UPPER 
209 P237 leu7.ha leu7.hbl 1.80 5.00 
210 P238 leu7.ha leu7.hg 1.80 5.00 
211 P239 i].e20.ha ile20.hb 1.80 5.00 
212 P240 lys9.ha lys9.qg 1.80 5.60 
213 P241 11e19.ha ilel9.hgll 1.80 5.00 
214 P242 ile20.ha ile20.hgll 1.80 5.00 
215 P243 vall2.ha lys9.hb2 1.80 5.00 
216 P244 leul7.ha leul7.qdl 1.80 6.00 
217 P245 leu6.ha leu6.qdl 1.80 6.00 
218 P246 leu6.ha leu6.qd2 1.80 6.00 
219 P247 i1e20.ha i1e20.hgl2 1.80 5.00 
220 P249 i1e19.ha i1e19.hgl2 1.80 5.00 
221 P251 leu7.ha leu7.qdl 1.80 6.00 
222 P252 ilel9.ha ilel9.qdl 1.80 6.00 
223 P253 lys9.ha vall2.qgl 1.80 6.00 
224 P256 hidl6.hbl hidl6.hb2 1.80 5.00 
225 P257 trp2l.hbl trp21.hb2 1.80 5.00 
226 P258 phel4.hbl phel4.hb2 1.80 3.30 
227 P259 cysl.hbl cysl.hb2 1.80 3.30 
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1 2 3 4 
ASG_POS1 ASGPOS2 LOWER UPPER 
228 P260 asp8.hbl asp8.hb2 1.80 3.30 
229 P261 aspl8.hbl aspl8.hb2 1.80 5.00 
230 P262 phe].4.hbl leul7.hg 1.80 5.00 
231 P263 cysl5.gb aibll.qgb 1.80 7.16 
232 P264 cysl5.qb leul7.qdl 1.80 6.60 
233 P265 phel4.hb2 leul7.hg 1.80 5.00 
234 P268 glulO.hgl glulO.hbl 1.80 2.50 
235 P269 glulO.hg2 glulO.hbl 1.80 5.00 
236 P270 vall2.hb vall2.qgl 1.80 6.00 
237 P271 vall2.hb vall2.qg2 1.80 6.00 
238 P272 lys9.hbl lys9.hb2 1.80 5.00 
239 P273 lys9.hbl lys9.qd 1.80 5.60 
240 P275 ile20.hb ile20.hgll 1.80 5.00 
241 P276 ilel9.hb ilel9.hgll 1.80 5.00 
242 P277 lys9.hb2 lys9.qg 1.80 5.60 
243 P281 ilel9.hb ilel9.qdl 1.80 6.00 
244 P282 1eu17.qb leul7.qdl 1.80 6.60 
245 P284 leu7.hbl leu7.cjdl 1.80 6.00 
246 P285 leu6.hbl leu6.qdl 1.80 6.00 
1 2 3 4 
ASG_POS1 ASG_POS2 LOWER UPPER 
247 P286 leu7.hbl leu7.gd2 1.80 6.00 
248 P287 leu6.hbl leu6.qd2 1.80 6.00 
249 P292 i1e19.hgll ilel9.qg2 1.80 6.00 
Atom definitions can be found in Appendix IV 
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Table ll.b : Modified upper distance constraints ofLJP1 obtained form DIANA 
calculation. These constraints were used for later calculations (section 4.3). 
1 CYS 
HA 2SER H 2.50 
HB2 2 SEP H 5.00 
HB]. 2 SEP H 5.00 
2 SEP 
H 2SER HA 2.50 
HA 3AIB H 2.50 
HA 5SER H 5.00 
HB2 3 AIB H 5.00 
HB1 3 AIB H 3.30 
HB1 4 SER H 5.00 
3 AIB 
H 4SER H 5.00 
H 5SER H 5.00 
QQB 5 SER H 6.56 
QQB 6 LEU H 6.56 
QQB 7 LEU H 6.56 
4 SER 
H 5SER H 3.30 
HA 5SER H 3.30 
5 SEP 
H 5 SEP QB 3.10 
H 6LEIJ H 5.00 
HA 8ASP H 5.00 
HA 8 ASP HB2 5.00 
HA S ASP HB1 5.00 
6 LEU 
H 6 LEU HB]. 3.30 
H 6LEU HG 3.30 
H 6 LEtJ QD1 6.00 
H 7LEU H 3.30 
H 8ASP H 5.00 
HA 6 LEU QD]. 6.00 
HA 6 LED QD2 6.00 
HA 9LYS H 5.00 
HA 9 LYS HB1 5.00 
HA 10 GLU H 5.00 
QD1 7 LED H 6.00 
o io GLU N 3.00 
o io GLU H 2.00 
7 LEU 
H 7 LED HB2 3.30 
H 7 LED HE1 3.30 
H 7LEU HG 2.50 
H 8ASP H 5.00 
HA 7 LED QD1 6.00 
HA 10 GLU H 5.00 
HA 10 GLU HB1 5.00 
HB1 8 ASP H 3.30 
HG 8 ASP H 5.00 
o ii AIB N 3.00 
o 11 AIB H 2.00 
8 ASP 
H 8 ASP HB2 2.50 
H 9LYS H 3.30 
H 11 AIB QQB 6.56 
HA 9LYS H 3.30 
HA 11AIB H 5.00 
HA 11 AIB QQB 6.56 
HA 12 VAL H 5.00 
HB2 9 LYS H 5.00 
HB1 9 LYS H 3.30 
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9 LYS 15 CYS 
H 9 LYS HB1 2.50 H 15 CYS QB 3.10 
H 9 LYS QG 5.60 HA 16 HID H 2.50 
H 9 LYS QD 5.60 QB 16 HID HE]. 3.90 
H 10 GLTJ H 2.50 QB 16 HID HD2 5.60 
H 11 AIB H 5.00 QB 17 LEU QD]. 6.60 
HA 12 VAL H 5.00 16 HID 
HA 12 VAL HE 5.00 H 16 HID HB2 2.50 
HA 12 VAL QG1 6.00 H 16 HID HB1 3.30 
HB2 12 VAL HA 5.00 H 16 HID HD2 5.00 
HB1 10 GLU H 2.50 H 17 LEU H 2.50 o 13 TYR N 3.00 HA 16 HID HD2 5.00 o 13 TYR H 2.00 HA 17 LEU H 3.30 
10 GLU HB2 17 LEU H 5.00 
H 10 GLTJ HB1 3.30 HB1 17 LEU H 5.00 
H 10 GLU HG2 5.00 HD2 17 LEU QD1 6.00 
H 10 GLTJ HG]. 2.50 17 LEU 
H 11 AIB QQB 6.56 H 17 LEU QB 3.90 
H 12 VAL H 5.00 H 17 LEU HG 3.30 
H 12 VAL QG2 6.00 H 17 LEtJ QD1 6.00 
HA 13 TYR H 5.00 H 18 ASP H 3.30 
HA 13 TYR QB 5.60 HA 17 LEU QD1 6.00 
HA 13 TYR QR 5.00 HA 18 ASP H 3.30 
HA 14 PHE H 5.00 HG 18 ASP H 5.00 
HA 14 PHE QR 5.00 QD1 18 ASP H 6.00 
HB2 11 AlE H 3.30 18 ASP 
HB2 14 PHE QR 5.00 H 18 ASP HB2 3.30 
HB1 10 GLU HG1 2.50 H 18 ASP HB1 2.50 
HG2 14 PHE QR 5.00 H 19 ILE H 5.00 
0 14 PHE N 3.00 19 ILE 
o 14 PHE H 2.00 H 19 ILE HB 3.30 
11 AIB H 19 ILE HG12 5.00 
H 12 VAL H 2.50 H 19 ILE HG].]. 3.30 
H 12 VAL QG1 6.00 H 20 ILE H 3.30 
QQE 15 CYS QB 7.16 HA 20 ILE H 3.30 
12 VAL QG2 20 ILE H 6.00 
H 12 VAL HE 2.50 20 ILE 
H 13 TYR H 3.30 H 20 ILE HB 2.50 
H 14 PHE H 5.00 H 20 ILE HG12 3.30 
HA 15 CYS H 5.00 H 20 ILE HG].]. 5.00 
HA 15 CYS QB 5.60 H 21 TRP H 5.00 
HE 13 TYR H 2.50 HA 21 TRP H 3.30 
QG2 13 TYR H 6.00 HE 21 TRP H 5.00 
QG2 13 TYR QR 6.00 QG2 21 TRP H 6.00 
QG2 16 HID HE]. 6.00 QD1 21 TRP HD1 6.00 
QG1 13 TYR H 6.00 21 TRP 
QG1 13 TYR QR 6.00 H 21 TRP HB2 3.30 
13 TYR 
H 13 TYR QE 3.10 
H 13 TYR QR 5.00 
H 14 PHE H 2.50 
QB 14 PHE H 3.90 
QB 14 PHE QR 5.60 
QR 14 PHE H 5.00 
QR 14 PHE HA 5.00 
QR 16 HID HD2 5.00 
14 PHE 
H 14 PHE HB2 3.30 
H 14 PHE HB1 3.30 
H 14 PHE QR 3.30 
H 15 CYS H 3.30 
HA 17 LEU HG 5.00 
HB2 14 PHE QR 3.30 
HB2 15 CYS H 5.00 
HB2 17 LED HG 5.00 
HB1 17 LED HG 5.00 
QR 17 LED HG 5.00 
QR 17 LED QD1 6.00 see Appendix IV 
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Table ll.c: Modified lower distance constraints ofLJPI obtained form DIANA 
calculation. These constraints were used for later calculations (section 4.3). 
3 AIB 
QQB 5 SER H 1.80 
QQB 6LEU H 1.80 
QQB 7LEIJ H 1.80 
4SER 
QB 5 SER H 1.80 
5 SER 
QB 6LEU H 1.80 
6 LEU 
H 6 LEU QD1 1.80 
QD1 7LEU H 1.80 
o 10 GLU N 2.70 
o 10 GLU H 1.80 
7 LEU 
o 11 AIB N 2.70 
o 11 AIB H 1.80 
8 ASP 
H 11 AIB QQB 1.80 
HA 11 AIB QQB 1.80 
9 LYS 
H 9LYS QG 1.80 
H 9 LYS QD 1.80 
HA 12 VAL QG]. 1.80 
o 13 TYR N 2.70 
o 13 TYR H 1.80 
10 GLU 
H 11 AIB QQB 1.80 
H 12 VAL QG2 1.80 
HA 13 TYR QB 1.80 
HA 13 TYR QR 1.80 
HA 14 PHE QR 1.80 
HB2 14 PHE QR 1.80 
HG2 14 PHE QR 1.80 
o 14 PHE N 2.70 
o 14 PHE H 1.80 
11 AIB 
H 12 VAL QG1 1.80 
QQB 15 CYS QB 1.80 
12VAL 
HA 15 CYS QB 1.80 
QG2 13 TYR H 1.80 
QG2 13 TYR QR 1.80 
QG2 16 HID HE]. 1.80 
QG1 13 TYR H 1.80 
QG1 13 TYR QR 1.80 
13 TYR 
H 13 TYR QR 1.80 
QB 14 PHE H 1.80 
QB 14 PHE QR 1.80 
QR 14 PHE H 1.80 
QR 14 PHE HA 1.80 
QR 16 HID HD2 1.80 
14 PHE 
H 14 PHE QR 1.80 
QR 17 LEU HG 1.80 
QR 17 LEU QD1 1.80 
15 CYS 
QB 16 HID HE]. 1.80 
QB 16 HID HD2 1.80 
QB 17 LEU QD1 1.80 
16 HID 
HD2 17 LEU QD1 1.80 
17 LEU 
H 17 LEU QD1 1.80 
QD1 18 ASP H 1.80 
19 ILE 
QG2 20 ILE H 1.80 
20 ILE 
QG2 21 TRP H 1.80 
QD1 21 TRP HD1 1.80 	see Appendix IV 
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Table II.d :Torsional angle constraints ofLJP1. 
2 Ser Phi -105.0 -165.0 
5 Ser Phi -95.0 -155.0 
6 Leu Phi -104.0 -164.0 
7 Leu Phi -89.0 -149.0 
8 Asp Phi -92.0 -152.0 
9Lys Phi -93.0 -153.0 
10 Glu Phi -88.0 -148.0 
12 Val Phi -87.0 -147.0 
13 Tyr Phi -88.0 -148.0 
14 Phe Phi -92.0 -152.0 
15 Cys Phi -87.0 -147.0 
16 His Phi -88.0 -148.0 
17 Leu Phi -88.0 -148.0 
18 Asp Phi -111.0 -171.0 
19 Ile Phi -124.0 -184.0 
20 Ile Phi -122.0 -182.0 
21 Trp Phi -120.0 -180.0 
Table II.e :Hydrogen bond constraints ofLJP1. 
lower upper (A) 
6Leu 0 lOGlu N 2.7 3.0 
6Leu 0 lOGlu H 1.8 2.0 
7Leu 0 ilAib N 2.7 3.0 
7Leu 0 ilAib H 1.8 2.0 
9Lys 0 13 Tyr N 2.7 3.0 
9Lys 0 13 Tyr H 1.8 2.0 
lOGlu 0 14Phe N 2.7 3.0 
lOGlu 0 14Phe H 1.8 2.0 
Table II.f 	: 
3JNw Coupling constants ofLJP1. 
Hz 
2Ser 6.1 
5 Ser 4.8 
6Leu 6.0 
7Leu 4.0 
8 Asp 4.4 
9Lys 4.5 
lOGlu 4.0 
12 Val 3.9 
13 Tyr 4.0 
l4Phe 4.4 
15 Cys 3.9 
16 His 4.0 
l7Leu 4.0 
18 Asp 6.8 
19 Ile 8.3 
20 Ile 8.0 
21 Trp 7.9 
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Appendix ifi 
Additional NMR and structure calculation details of UP 26 
Table III.a: NOE constraints of UP 26 used for DIANA calculation: Peak numbers, 
peak assignments (F2 Fl), lower constraints and upper constraints. 
1 2 3 4 
ASG_POS1 ASG_POS2 LOWER UPPER 
1 P1 ser2.h ser2.ha 1.80 2.50 
2 P2 ser2.h cysl.ha 1.80 2.50 
3 P3 ala3.h ser2.ha 1.80 3.90 
4 P4 a1a3.h ala3.ha 1.80 5.00 
5 P5 ala3.h ser2.b.bl 1.80 5.00 
6 P6 asp8.h asp8.ha 1.80 2.50 
7 P7 asp8.h 1eu7.ha 1.80 2.50 
8 P8 aspl8.h aspl8.ha 1.80 3.90 
9 P9 asp18.h leul7.ha 1.80 2.50 
10 P10 ser4.h ser4.ha 1.80 5.00 
11 P11 ser4.h ala3.ha 1.80 5.00 
12 P12 ser4.h ser4.hbl 1.80 5.00 
13 P13 ser4.h ser4.hb2 1.80 5.00 
14 P14 g1u10.h lys9.ha 1.80 5.00 
15 P15 phel4.h phel4.ha 1.80 3.90 
16 P16 phel4.h tyrl3.ha 1.80 5.00 
17 P17 ser5.h ser5.ha 1.80 5.00 
18 P18 ser5.h ser4.ha 1.80 5.00 
1 2 3 4 
ASGPOS1 ASGPOS2 LOWER UPPER 
19 P19 ser5.h ser5.hbl 1.80 5.00 
20 P20 ser5.h ser5.hb2 1.80 5.00 
21 P21 leu6.h ser5.ha 1.80 3.90 
22 P22 leu6.h leu6.ha 1.80 3.90 
23 P23 leu6.h ser5.hbl 1.80 3.90 
24 P24 leu6.h ser5.hb2 1.80 5.00 
25 P25 cysls.h cysls.ha 1.80 5.00 
26 P26 cysls.h va112.ha 1.80 5.00 
27 P27 cys15.h phel4.ha 1.80 5.00 
28 P28 hid16.h hidl6.ha 1.80 5.00 
29 P29 hid16.h cysl5.ha 1.80 5.00 
30 P30 hid16.h tyrl3.ha 1.80 5.00 
31 P31 lys9.h asp8.ha 1.80 3.90 
32 P32 lys9.h leu6.ha 1.80 5.00 
33 P33 lys9.h lys9.ha 1.80 3.90 
34 P34 trp2l.h trp2l.ha 1.80 5.00 
35 P35 trp2l.h ile20.ha 1.80 2.50 
36 P36 leu7.h sers.ha 1.80 5.00 
37 P37 leu7.h leu6.ha 1.80 5.00 
1 2 3 4 
ASG_POS1 ASG_POS2 LOWER UPPER 
38 P38 leu7.h leu7.ha 1.80 5.00 
39 P39 tyrl3.h tyrl3.ha 1.80 5.00 
40 P40 tyrl3.h glulO.ha 1.80 5.00 
41 P41 tyrl3.h va112.ha 1.80 5.00 
42 P42 1eu17.h hidl6.ha 1.80 5.00 
43 P43 1eu17.h phel4.ha 1.80 5.00 
44 P44 1eu17.h 1eu17.ha 1.80 3.90 
45 P45 leul7.h va112.ha 1.80 5.00 
46 P46 i1e20.h i1e20.ha 1.80 5.00 
47 P47 11e20.h 11e19.ha 1.80 5.00 
48 P48 11e19.h asp18.ha 1.80 3.90 
49 P49 ilel9.h i1e19.ha 1.80 2.50 
50 P50 trp2l.he3 trp2l.ha 1.80 5.00 
51 P51 va112.h lys9.ha 1.80 5.00 
52 P52 va112.h va112.ha 1.80 3.90 
53 P53 hid16.hel cysl5.qb 1.80 5.60 
54 P54 a1a3.h ala3.qb 1.80 6.00 
55 P55 asp8.h asp8.hbl 1.80 5.00 
56 P56 asp8.h asp8.hb2 1.80 5.00 
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1 2 3 4 
ASG_POS]. ASG_POS2 LOWER UPPER 
57 P57 asp8.h 1eu7.qb 1.80 4.50 
58 P58 asp8.h leu7.hg 1.80 3.90 
59 P59 aspl8.h aspl8.hbl 1.80 3.90 
60 P60 aspl8.h aspl8.hb2 1.80 3.90 
61 P61 aspl8.h leul7.qb 1.80 5.60 
62 P62 aspl8.h leul7.hg 1.80 2.50 
63 P63 phel4.h phel4.hbl 1.80 3.90 
64 P64 phel4.h phel4.hb2 1.80 3.90 
65 P65 phel4.h tyrl3.qb 1.80 4.50 
66 P66 pheld.h leul7.hg 1.80 3.90 
67 P67 glulO.h glulO.hgl 1.80 5.00 
68 P68 glulO.h glulO.hg2 1.80 5.00 
69 P69 glulO.h glulO.qb 1.80 3.10 
70 P70 glulO.h lys9.hbl 1.80 2.50 
71 P71 glulO.h lys9.qd 1.80 5.60 
72 P72 glulO.h lys9.hb2 1.80 3.90 
73 P73 ser4.h ala3.qb 1.80 6.00 
74 P74 hidl6.hel 1eu17.qqd 1.80 5.60 
75 P75 aspl8.h leul7.qqd 1.80 5.60 
1 2 3 4 
ASGPOS1 ASGPOS2 LOWER UPPER 
76 P76 aibll.h glulO.qb 1.80 3.10 
77 P77 aibll.h aibll.qqb 1.80 3.10 
78 P78 leu6.h leu6.qb 1.80 3.10 
79 P79 leu6.h leu6.hg 1.80 5.00 
80 P80 cysl5.h cysls.qb 1.80 3.10 
81 P81 cysls.h leul7.hg 1.80 5.00 
82 P82 cysl5.h leul7.qqd 1.80 5.60 
83 P83 hidl6.h hidl6.hbl 1.80 3.90 
84 P84 hidl6.h hidl6.hb2 1.80 2.50 
85 P85 lys9.h asp8.hb2 1.80 5.00 
86 P86 lys9.h lys9.hbl 1.80 2.50 
87 P87 lys9.h lys9.qd 1.80 5.60 
88 P88 lys9.h lys9.hb2 1.80 2.50 
89 P89 lys9.h lys9.qg 1.80 3.10 
90 P90 trp2l.h trp2l.hbl 1.80 5.00 
91 P91 trp2l.h trp2l.hb2 1.80 3.90 
92 P92 trp2l.h i1e20.hb 1.80 5.00 
93 P93 trp2l.h ile20.qg2 1.80 6.00 
94 P94 tyrl3.h tyrl3.qb 1.80 3.10 
1 2 3 4 
ASG_POS1 ASG_POS2 LOWER UPPER 
95 P95 tyrl3.h vall2.hb 1.80 3.90 
96 P96 tyrl3.h va112.qgl 1.80 6.00 
97 P97 tyrl3.h vall2.qg2 1.80 6.00 
98 P98 1eu7.h leu7.qb 1.80 3.10 
99 P99 leu7.h leu7.hg 1.80 5.00 
100 P100 leu7.h leu7.qqd 1.80 4.50 
101 P101 1eu17.h leul7.qb 1.80 4.50 
102 P102 1eu17.h leul7.hg 1.80 2.50 
103 P103 leul7.h 1eu17.qqd 1.80 5.60 
104 P104 ile20.h ile20.hb 1.80 5.00 
105 P105 ile20.h ile20.hgll 1.80 5.00 
106 P106 ile20.h ile20.hgl2 1.80 5.00 
107 P107 ile20.h ile20.qg2 1.80 6.00 
108 P108 ile20.h ilel9.qg2 1.80 6.00 
139 P109 ilel9.h ilel9.hb 1.80 3.90 
110 P110 11e19.h ilel9.hgll 1.80 3.90 
111 P111 ilel9.h 11e19.hgl2 1.80 3.90 
112 P112 11e19.h ilel9.qg2 1.80 6.00 
113 P113 vall2.h vall2.hb 1.80 3.90 
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1 2 3 4 
ASG_POS1 ASG_POS2 LOWER UPPER 
114 P114 va112.h aibll.qqb 1.80 4.50 
115 P115 vall2.h vall2.qgl 1.80 6.00 
116 P116 va112.h vall2.qg2 1.80 6.00 
117 P117 phel4.qr phel4.ha 1.80 3.90 
118 P118 phel4.qr glulO.ha 1.80 5.00 
119 P121 phel4.qr tyrl3.qb 1.80 5.60 
120 P122 phel4.qr g1u10.hg2 1.80 5.00 
121 P123 phel4.qr glu].0.qb 1.80 5.60 
122 P124 phel4.qr 1eu17.hg 1.80 2.50 
123 P125 phel4.qr leul7.qqd 1.80 5.60 
124 P128 hidl6.hd2 cysls.qb 1.80 5.60 
125 P129 hidl6.hd2 leul7.qqd 1.80 5.60 
126 P130 trp2l.hdl trp2l.ha 1.80 5.00 
127 P133 tyrl3.qr phel4.ha 1.80 5.00 
128 P134 tyrl3.qr tyrl3.ha 1.80 3.90 
129 P135 tyrl3.qr glulO.ha 1.80 3.90 
130 P136 tyrl3.qr tyrl3.qb 1.80 3.10 
131 P137 tyrl3.qr vall2.qg2 1.80 6.00 
132 P141 leul7.h hidl6.hbl 1.80 2.50 
1 2 3 4 
ASG_POS1 ASG_POS2 LOWER UPPER 
133 P142 leul7.h h1d16.hb2 1.80 3.90 
134 P145 ala3.h ser4.h 1.80 5.00 
135 P146 asp8.h lys9.h 1.80 5.00 
136 P147 asp8.h leu7.h 1.80 3.90 
137 P148 aspl8.h 1eu17.h 1.80 3.90 
138 P149 aspl8.h i1e19.h 1.80 2.50 
139 P150 glulO.h lys9.h 1.80 3.90 
140 P151 phel4.h tyrl3.h 1.80 2.50 
141 P152 1eu6.h leu7.h 1.80 3.90 
142 P153 h±d16.h leul7.h 1.80 2.50 
143 P154 glulO.h vall2.h 1.80 5.00 
144 P155 aibll.h vall2.h 1.80 3.90 
145 P156 tyrl3.h vall2.h 1.80 2.50 
146 P157 11e20.h ilel9.h 1.80 5.00 
147 P159 phel4.h phel4.qr 1.80 5.00 
148 P160 phel4.h tyrl3.qr 1.80 5.00 
149 P161 tyrl3.h tyrl3.qr 1.80 5.00 
150 P163 phel4.qr tyrl3.qr 1.80 5.00 
151 P168 ser2.ha ser2.hbl 1.80 5.00 
1 2 3 4 
ASGPOS1 ASG_POS2 LOWER UPPER 
152 P169 ser5.ha sers.hbl 1.80 5.00 
153 P170 sers.ha ser5.hb2 1.80 5.00 
154 P171 ser4.ha ser4.hbl 1.80 5.00 
155 P172 ser4.ha ser4.hb2 1.80 3.90 
156 P173 cysl5.ha cysl5.qb 1.80 5.60 
157 P174 phel4.ha phel4.hbl 1.80 3.90 
158 P175 phel4.ha phel4.hb2 1.80 5.00 
159 P176 cysl.ha cysl.hbl 1.80 2.50 
160 P178 asp8.ha asp8.hbl 1.80 3.90 
161 P179 asp8.ha asp8.hb2 1.80 2.50 
162 P180 cysl.ha cysl.hb2 1.80 3.90 
163 P181 tyrl3.ha tyrl3.qb 1.80 4.50 
164 P182 leu7.ha glulO.hgl 1.80 5.00 
165 P183 leu7.ha glulO.qb 1.80 4.50 
166 P184 glulO.ha tyrl3.qb 1.80 5.60 
167 P185 glulO.ha glulO.hgl 1.80 3.90 
168 P186 glulO.ha glulO.hg2 1.80 5.00 
169 P187 glulO.ha glulO.qb 1.80 4.50 
170 P188 lys9.ha vall2.hb 1.80 5.00 
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1 2 3 4 
ASG_POS]. ASG_POS2 LOWER UPPER 
171 P189 lys9.ha lys9.hbl 1.80 2.50 
172 P190 lys9.ha lys9.qd 1.80 5.60 
173 P191 g].ulO.ha aibll.qqb 1.80 5.60 
174 P192 lys9.ha lys9.qg 1.80 5.60 
175 P193 1ys9.ha vall2.qgl 1.80 6.00 
176 P194 leu7.ha leu7.qb 1.80 5.60 
177 P195 leu7.ha leu7.hg 1.80 5.00 
178 P196 1eu7.ha leu7.qdl 1.80 6.00 
179 P197 leu7.ha leu7.qd2 1.80 6.00 
180 P198 i1e19.ha 11e19.hb 1.80 5.00 
181 P201 ilel9.ha i1e19.qg2 1.80 6.00 
182 P202 i1e19.ha ilel9.qdl 1.80 6.00 
183 P203 ile20.ha ile20.hb 1.80 5.00 
184 P206 ile20.ha ile20.qg2 1.80 6.00 
185 P207 leu6.ha lys9.hbl 1.80 5.00 
186 P208 leu6.ha 1eu6.qb 1.80 4.50 
187 P209 leu6.ha leu6.hg 1.80 5.00 
188 P210 leu6.ha leu6.qdl 1.80 6.00 
189 P211 leu6.ha leu6.qd2 1.80 6.00 
1 2 3 4 
ASGPOS1 ASGPOS2 LOWER UPPER 
190 P212 1eu17.ha leul7.qb 1.80 5.60 
191 P213 1eu17.ha leul7.hg 1.80 3.90 
192 P214 leul7.ha leul7.qqd 1.80 4.50 
193 P215 ala3.ha ala3.qb 1.80 6.00 
194 P218 phel4.ha leul7.qb 1.80 4.50 
195 P219 asp8.ha aibll.qqb 1.80 5.60 
196 P220 vall2.ha cysl5.qb 1.80 5.60 
97 P221 vall2.ha vall2.hb 1.80 5.00 
198 P222 vall2.ha aibll.qqb 1.80 5.60 
199 P225 trp2l.hbl trp2l.hb2 1.80 5.00 
200 P226 phel4.hbl phel4.hb2 1.80 3.90 
201 P227 cysl.hbl cysl.hb2 1.80 3.90 
202 P228 asp8.hbl asp8.hb2 1.80 2.50 
203 P229 aspl8.hbl aspl8.hb2 1.80 2.50 
204 P230 phel4.hbl leul7.hg 1.80 5.00 
205 P231 phel4.hb2 leul7.hg 1.80 5.00 
206 P232 asp8.hbl aibll.qqb 1.80 5.60 
207 P233 asp8.hb2 aibll.qqb 1.80 4.50 
208 P234 cysl5.gb leul7.hg 1.80 5.60 
1 2 3 4 
ASG_POS1 ASGPOS2 LOWER UPPER 
209 P235 cysls.qb 1eu17.qqd 1.80 6.20 
210 P236 glulO.hgl glulO.hg2 1.80 2.50 
211 P239 vall2.hb vall2.qgl 1.80 6.00 
212 P240 vall2.hb vall2.qg2 1.80 6.00 
213 P242 lys9.hbl lys9.hb2 1.80 5.00 
214 P246 ile20.hb ile20.qg2 1.80 6.00 
215 P249 i1e19.hb ilel9.qg2 1.80 6.00 
216 P250 ilel9.hb ilel9.qdl 1.80 6.00 
217 P252 ile20.hgll ile20.qdl 1.80 6.00 
218 P256 ile20.hgl2 ile2O.qdl 1.80 6.00 
19 P264 lys9.hb2 lys9.qg 1.80 5.60 
220 P266 leul7.hg leul7.qgd 1.80 5.60 
Atom definitions can be found in Appendix IV 
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Table Ill.b : Modified upper distance constraints of LJP26 obtained form DIANA 
calculation. These constraints were used for later calculations (section 4.3). 
1 CYS 
HA 1 CYS HB1 2.50 
HA 2SER H 2.50 
2 SER 
H 2SER HA 2.50 
HB1 3 ALA H 5.00 
3 ALA 
H 4SER H 5.00 
5 SER 
HA 7 LEU H 5.00 
HB2 6 LETJ H 5.00 
HB1 6 LEU H 3.90 
6 LEU 
H 6LEU QB 3.10 
H 6LEtJ HG 5.00 
H 7LETJ H 3.90 
HA 6 LEU QD1 6.00 
HA 6 LEtJ QD2 6.00 
HA 9LYS H 5.00 
HA 9 LYS HB1 5.00 
7 LEU 
H 7LEU QB 3.10 
H 7LETJ HG 5.00 
H 7 LEU QQD 4.50 
H 8ASP H 3.90 
HA 7 LEU QD1 6.00 
HA 7 LEU QD2 6.00 
HA 8ASP H 2.50 
HA 10 GLU QB 4.50 
HA 10 GLU HG1 5.00 
QB 8 ASP H 4.50 
HG 8 ASP H 3.90 
o 11 AIB N 3.00 
o ii AIB H 2.00 
S ASP 
H 8ASP HA 2.50 
H 9LYS H 5.00 
HA 8 ASP H32 2.50 
HA 11 AIB QQB 5.60 
HB2 9 LYS H 5.00 
HB2 11 AIB QQB 4.50 
HB1 11 AIB QQB 5.60 
o 12 VAL N 3.00 
o 12 VAL H 2.00 
9 LYS 
H 9 LYS HB2 2.50 
H 9 LYS HB1 2.50 
H 9 LYS QG 3.10 
H 9 LYS QD 5.60 
H 10 GLU H 3.90 
HA 9 LYS HB1 2.50 
HA 9 LYS QD 5.60 
HA 12 VAL H 5.00 
HA 12 VAL HB 5.00 
HA 12 VAL QG1 6.00 
HB2 10 GLU H 3.90 
HB1 10 GLU H 2.50 
QD 10 GLU H 5.60 
o 13 TYR N 3.00 
0 13 TYR H 2.00 
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10 GLU 
H 10 GLTJ QB 3.10 
H 10 GLU HG2 5.00 
H 10 GLU HG1 5.00 
H 12VAL H 5.00 
HA 10 GLTJ HG1 3.90 
HA 11 AIB QQB 5.60 
HA 13 TYR H 5.00 
HA 13 TYR QB 5.60 
HA 13 TYR QR 3.90 
HA 14 PHE QR 5.00 
QB 11 AIB H 3.10 
QB 14 PHE QR 5.60 
HG2 14 PHE QR 5.00 
o 14 PHE N 3.00 
o 14 PHE H 2.00 
11 AIB 
H 11 AIB QQB 3.10 
H 12 VAL H 3.90 
QQB 12 VAL HA 5.60 
o 15 CYS N 3.00 
o 15 CYS H 2.00 
12 VAL 
H 12 VAL HB 3.90 
H 13 TYR H 2.50 
HA 15 CYS H 5.00 
HA 15 CYS QB 5.60 
HA 17 LED H 5.00 
HB 13 TYR H 3.90 
QG2 13 TYR H 6.00 
QG2 13 TYR QR 6.00 
QG1 13 TYR H 6.00 
0 16 HID N 3.00 
0 16 HID H 2.00 
13 TYR 
H 13 TYR QB 3.10 
H 13 TYR QR 5.00 
H 14 PHE H 2.50 
HA 16 HID H 5.00 
QB 14 PHE H 4.50 
QE 14 PHE QR 5.60 
QR 14 PHE H 5.00 
QR 14 PHE HA 5.00 
QR 14 PHE QR 5.00 
0 17LEU N 3.00 
0 17LETJ H 2.00 
14 PHE 
H 14 PHE HB2 3.90 
H 14 PHE HB1 3.90 
H 14 PHE QR 5.00 
H 17 LED HG 3.90 
HA 14 PHE QR 3.90 
HA 17 LEU H 5.00 
HA 17 LED QB 4.50 
HB2 17 LEU HG 5.00 
HB1 17 LEU HG 5.00 
QR 17 LED HG 2.50 
QR 17 LEU QQD 5.60 
15CYS 
H 15 CYS QB 3.10 
H 17 LEU HG 5.00 
H 17 LED QQD 5.60 
QB 16 HID HE1 5.60 
QB 16 HID HD2 5.60 
QB 17 LEU HG 5.60 
QB 17 LEt) QQD 6.20 
16 HID 
H 16 HID HB2 2.50 
H 16 HID HB1 3.90 
H 17LEU H 2.50 
HB2 17 LED B 3.90 
HB1 17 LED H 2.50 
HE1 17 LED QQD 5.60 
HD2 17 LED QQD 5.60 
17 LEU 
H 17 LED HG 2.50 
H 17 LED QQD 5.60 
H 18 ASP H 3.90 
HA 17 LED HG 3.90 
HA 18 ASP H 2.50 
QB 18 ASP H 5.60 
HG 18 ASP H 2.50 
QQD 18 ASP H 5.60 
18 ASP 
H 18 ASP HB2 3.90 
H 18 ASP HB1 3.90 
H 19ILE H 2.50 
19 ILE 
H 19 ILE HA 2.50 
H 19 ILE HB 3.90 
H 19 ILE HG12 3.90 
H 19 ILE HG11 3.90 
H 20 ILE H 5.00 
QG2 20 ILE H 6.00 
20 ILE 
H 20 ILE HG12 5.00 
H 20 ILE HG11 5.00 
HA 21 TRP H 2.50 
HB 21 TRP H 5.00 
QG2 21 TRP H 6.00 
21 TRP 
H 21 TRP HB2 3.90 
HA 21 TRP HD1 5.00 
HA 21 TRP HE3 5.00 
see Appendix IV 
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Table III.c: Modified lower distance constraints of LJP26 obtained form DIANA 
calculation. These constraints were used for later calculations (section 4.3). 
7 LEU 
H 7LEU QQD 1.80 
HA 10 GLU QB 1.80 
QB 8 ASP H 1.80 
8 ASP 
HA 11 AIB QQB 1.80 
HB2 11 AIB QQB 1.80 
HB1 11 AIB QQB 1.80 
9 LYS 
H 9 LYS QG 1.80 
H 9 LYS QD 1.80 
HA 9 LYS QD 1.80 
HA 12 VAL QG1 1.80 
QD 10 GLU H 1.80 
10 GLtJ 
HA 11 AIB QQB 1.80 
HA 13 TYR QB 1.80 
HA 13 TYR QR 1.80 
HA 14 PHE QR 1.80 
QB 11 AIB H 1.80 
QB 14 PHE QR 1.80 
HG2 14 PHE QR 1.80 
11 AIB 
QQB 12 VAL HA 1.80 
12 VAL 
HA 15 CYS QB 1.80 
QG2 13 TYR H 1.80 
QG2 13 TYR QR 1.80 
QG1 13 TYR H 1.80 
13 TYR 
H 13 TYR QR 1.80 
QB 14 PHE H 1.80 
QB 14 PHE QR 1.80 
QR 14 PHE H 1.80 
QR 14 PHE HA 1.80 
QR 14 PHE QR 1.80 
14 PHE 
H 14 PHE QR 1.80 
HA 17 LEU QB 1.80 
QR 17 LEU HG 1.80 
QR 17 LEtJ QQD 1.80 
15 CYS 
H 17 LEU QQD 1.80 
QB 16 HID HE1 1.80 
QB 16 HID HD2 1.80 
QB 17 LEU HG 1.80 
QB 17 LEU QQD 1.80 
16 HID 
HE1 17 LEU QQD 1.80 
HD2 17 LEU QQD 1.80 
17 LEU 
H 17 LEU QQD 1.80 
QB 18 ASP H 1.80 
QQD 18 ASP H 1.80 
19 ILE 
QG2 20 ILE H 1.80 
20 ILE 
QG2 21 TRP H 1.80 
Atom definitions can be found in Appendix IV 
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Table III.d : Torsional angle constraints of LJP26. 
2 Ser Phi -104.0 -164.0 
3 Ala Phi -96.0 -156.0 
4 Ser Phi -107.0 -167.0 
5 Ser Phi -101.0 -161.0 
7 Leu Phi -89.0 -149.0 
8 Asp ' Phi -111.0 -171.0 
9Lys Phi -88.0 -148.0 
10 Glu Phi -96.0 -156.0 
12 Val Phi -89.0 -149.0 
13 Tyr Phi -92.0 -152.0 
14 Phe Phi -102.0 -162.0 
16 His Phi -103.0 -163.0 
17Leu Phi -111.0 -171.0 
18 Asp Phi -111.0 -171.0 
19 lie Phi -123.0 -183.0 
20 Ile Phi -128.0 -188.0 
21 Trp Phi -120.0 -180.0 
Table III.e : Hydrogen bond constraints of LJP26 
lower upper (A) 
6Leu 0 lOGlu N 2.7 3.0 
6Leu 0 lOGlu H 1.8 2.0 
7Leu 0 ilAib N 2.7 3.0 
7Leu 0 ilAib H 1.8 2.0 
9 Lys 0 13 Tyr N 2.7 3.0 
9Lys 0 13 Tyr H 1.8 2.0 
lOGlu 0 14Phe N 2.7 3.0 
lOGlu 0 14Phe H 1.8 2.0 





5 Ser 5.6 
7Leu 	4.1 
8 Asp 1 6.9 
9Lys 	3.9 
lOGlu 4.9 
12 Val 	4.0 
13 Tyr 4.4 
l4Phe 	5.7 
16 His 5.8 
l7Leu 	6.9 
18 Asp 6.9 
19 lie 	8.3 




Table IV Nomenclature for real atoms and pseudoatoms in DIANA 
Real DIANA Pseudoatoms 
atoms atoms 
Basic NH H 
ctH HA  
aH(2H) HA1,HA2 QA  
13H HB  
PH (211) HB1,HB2 QB  
3H (3H) HB1, H132, HB3 QB  
3H (2 x 3H) HB1 1, HB12, HB13 




yH HG  
yH (2H) HG1, HG2 QG  
yH (311) HG1, HG2, HG3 QG  
Ile.'yHs (21-1) HG1 1, HG12 QG1  
Ile/Thr.yHs (31-1) HG21, HG22, HG23 QG2  
Val.yHs (2 x 3H) HG1 1, HG12, HG13 




H (2H) HD1, HD2 QD  
oH (311) HD 1, HD2, HD3 QD  
Ile.OHs (311) HD1 1, HD12, HD13 QD1  
Leu.OHs (2 x 3H) HD1 1, HD12, HD13 




H (211) HE1, HE2 QE  
,H (3H) HE1, HE2, RE3 QE  
Other carbonyl C, 0 C, 0  
amide  N 
CB  
yC/yCs CG/CG1,CG2   
YS SG  
OC/OCs CD/CD1,CD2  
OS SD  
EC CE  
CZ  
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Real atoms DIANA atoms Pseudoatoms (for all 
aromatic protons) 
Aromatics His. 1H (NH) HD1  
2H HE1  
4H HD2  
Phe.211 HD1 QR 
3H HE1 
4H HZ  
5H HE2  
6H HD2  
Tyr.2H HD1 QR 
3H HE1  
5H HE2  
6H HD2  
OH OH,HH  
Trp.1H(NH) HE1  
2H HD1  
4H HE3  
5H HZ3  
6H HH2  
711 HZ2  












OE1, 0E2  
Asn.CO 
side chain NI-12  
CG 
OD1 
HD2 1, HD22 QD2 
Gln.CO 
side chain NH2 
CD 
OE1 
HE2 1, HE22 QE2 
Lys7NH3 HZ I, HZ2, HZ3 QZ 
Arg.side chain NH 
side chain NH2 
NH 
HE 
NH1, NH2 
HH11,H1-112 QH1 
HH21,}{H22 QH2 
